
<html lang="en"     class="pb-page"  data-request-id="c66c35f3-c36e-46ff-b222-8539e47bb34d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2012.55.issue-21;article:article:10.1021/jm201710f;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design and Synthesis of a Novel Series of Bicyclic Heterocycles As Potent γ-Secretase Modulators" /></meta><meta name="dc.Creator" content="Francois  Bischoff" /></meta><meta name="dc.Creator" content="Didier  Berthelot" /></meta><meta name="dc.Creator" content="Michel  De Cleyn" /></meta><meta name="dc.Creator" content="Gregor  Macdonald" /></meta><meta name="dc.Creator" content="Garrett  Minne" /></meta><meta name="dc.Creator" content="Daniel  Oehlrich" /></meta><meta name="dc.Creator" content="Serge  Pieters" /></meta><meta name="dc.Creator" content="Michel  Surkyn" /></meta><meta name="dc.Creator" content="Andrés A.  Trabanco" /></meta><meta name="dc.Creator" content="Gary  Tresadern" /></meta><meta name="dc.Creator" content="Sven  Van Brandt" /></meta><meta name="dc.Creator" content="Ingrid  Velter" /></meta><meta name="dc.Creator" content="Mirko  Zaja" /></meta><meta name="dc.Creator" content="Herman  Borghys" /></meta><meta name="dc.Creator" content="Chantal  Masungi" /></meta><meta name="dc.Creator" content="Marc  Mercken" /></meta><meta name="dc.Creator" content="Harrie J. M.  Gijsen" /></meta><meta name="dc.Description" content="The design and the synthesis of several chemical subclasses of imidazole containing γ-secretase modulators (GSMs) is described. Conformational restriction of pyridone 4 into bicyclic pyridone isost..." /></meta><meta name="Description" content="The design and the synthesis of several chemical subclasses of imidazole containing γ-secretase modulators (GSMs) is described. Conformational restriction of pyridone 4 into bicyclic pyridone isost..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 8, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm201710f" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm201710f" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm201710f" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm201710f" /></link>
        
    
    

<title>Design and Synthesis of a Novel Series of Bicyclic Heterocycles As Potent γ-Secretase Modulators | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm201710f" /></meta><meta property="og:title" content="Design and Synthesis of a Novel Series of Bicyclic Heterocycles As Potent γ-Secretase Modulators" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0016.jpeg" /></meta><meta property="og:description" content="The design and the synthesis of several chemical subclasses of imidazole containing γ-secretase modulators (GSMs) is described. Conformational restriction of pyridone 4 into bicyclic pyridone isosteres has led to compounds with high in vitro and in vivo potency. This has resulted in the identification of benzimidazole 44a as a GSM with low nanomolar potency in vitro. In mouse, rat, and dog, this compound displayed the typical γ-secretase modulatory profile by lowering Aβ42 and Aβ40 levels combined with an especially pronounced increase in Aβ38 and Aβ37 levels while leaving the total levels of amyloid peptides unchanged." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm201710f"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm201710f">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm201710f&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm201710f&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm201710f&amp;href=/doi/10.1021/jm201710f" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9089-9106</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm201715d" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm201724m" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Synthesis of a Novel Series of Bicyclic Heterocycles As Potent γ-Secretase Modulators</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francois++Bischoff">Francois Bischoff</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Didier++Berthelot">Didier Berthelot</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michel++De+Cleyn">Michel De Cleyn</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregor++Macdonald">Gregor Macdonald</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Garrett++Minne">Garrett Minne</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Oehlrich">Daniel Oehlrich</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Serge++Pieters">Serge Pieters</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michel++Surkyn">Michel Surkyn</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andr%C3%A9s+A.++Trabanco">Andrés A. Trabanco</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Tresadern">Gary Tresadern</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sven++Van+Brandt">Sven Van Brandt</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ingrid++Velter">Ingrid Velter</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mirko++Zaja">Mirko Zaja</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Herman++Borghys">Herman Borghys</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chantal++Masungi">Chantal Masungi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marc++Mercken">Marc Mercken</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Harrie+J.+M.++Gijsen">Harrie J. M. Gijsen</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Janssen Research & Development, Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium</span></div><div class="corresp-info"><strong>*</strong>Phone: +32-14-606830. Fax: +32-14-605344. E-mail: <a href="/cdn-cgi/l/email-protection#cfa7a8a6a5bcaaa18fa6bbbce1a5a1a5e1aca0a2"><span class="__cf_email__" data-cfemail="28404f41425b4d4668415c5b06424642064b4745">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm201710f&amp;href=/doi/10.1021%2Fjm201710f" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9089–9106</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 31, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 December 2011</li><li><span class="item_label"><b>Published</b> online</span>8 June 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 November 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm201710f" title="DOI URL">https://doi.org/10.1021/jm201710f</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9089%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFrancois%2BBischoff%252C%2BDidier%2BBerthelot%252C%2BMichel%2BDe%2BCleyn%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D21%26contentID%3Djm201710f%26title%3DDesign%2Band%2BSynthesis%2Bof%2Ba%2BNovel%2BSeries%2Bof%2BBicyclic%2BHeterocycles%2BAs%2BPotent%2B%25CE%25B3-Secretase%2BModulators%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9106%26publicationDate%3DNovember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm201710f"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5087</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">52</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm201710f" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Synthesis of a Novel Series of Bicyclic Heterocycles As Potent γ-Secretase Modulators&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Francois&quot;,&quot;last_name&quot;:&quot;Bischoff&quot;},{&quot;first_name&quot;:&quot;Didier&quot;,&quot;last_name&quot;:&quot;Berthelot&quot;},{&quot;first_name&quot;:&quot;Michel&quot;,&quot;last_name&quot;:&quot;De Cleyn&quot;},{&quot;first_name&quot;:&quot;Gregor&quot;,&quot;last_name&quot;:&quot;Macdonald&quot;},{&quot;first_name&quot;:&quot;Garrett&quot;,&quot;last_name&quot;:&quot;Minne&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Oehlrich&quot;},{&quot;first_name&quot;:&quot;Serge&quot;,&quot;last_name&quot;:&quot;Pieters&quot;},{&quot;first_name&quot;:&quot;Michel&quot;,&quot;last_name&quot;:&quot;Surkyn&quot;},{&quot;first_name&quot;:&quot;Andrés&quot;,&quot;last_name&quot;:&quot;A. Trabanco&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Tresadern&quot;},{&quot;first_name&quot;:&quot;Sven&quot;,&quot;last_name&quot;:&quot;Van Brandt&quot;},{&quot;first_name&quot;:&quot;Ingrid&quot;,&quot;last_name&quot;:&quot;Velter&quot;},{&quot;first_name&quot;:&quot;Mirko&quot;,&quot;last_name&quot;:&quot;Zaja&quot;},{&quot;first_name&quot;:&quot;Herman&quot;,&quot;last_name&quot;:&quot;Borghys&quot;},{&quot;first_name&quot;:&quot;Chantal&quot;,&quot;last_name&quot;:&quot;Masungi&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;Mercken&quot;},{&quot;first_name&quot;:&quot;Harrie&quot;,&quot;last_name&quot;:&quot;J. M. Gijsen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;9089-9106&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm201710f&quot;},&quot;abstract&quot;:&quot;The design and the synthesis of several chemical subclasses of imidazole containing γ-secretase modulators (GSMs) is described. Conformational restriction of pyridone 4 into bicyclic pyridone isosteres has led to compounds with high in vitro and in vivo potency. This has resulted in the identification of benzimidazole 44a as a GSM with low nanomolar potency in vitro. In mouse, rat, and dog, this compound displayed the typical γ-secretase modulatory profile by lowering Aβ42 and Aβ40 levels combined with an especially pronounced increase in Aβ38 and Aβ37 levels while leaving the total levels of amyloid peptides unchanged.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201710f&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201710f" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201710f&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201710f" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201710f&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201710f" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm201710f&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201710f&amp;href=/doi/10.1021/jm201710f" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm201710f" /></input><a href="/doi/pdf/10.1021/jm201710f" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm201710f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm201710f%26sid%3Dliteratum%253Aachs%26pmid%3D22650177%26genre%3Darticle%26aulast%3DBischoff%26date%3D2012%26atitle%3DDesign%2Band%2BSynthesis%2Bof%2Ba%2BNovel%2BSeries%2Bof%2BBicyclic%2BHeterocycles%2BAs%2BPotent%2B%25CE%25B3-Secretase%2BModulators%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D21%26spage%3D9089%26epage%3D9106%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jmcmar.2012.55.issue-21/production/jmcmar.2012.55.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The design and the synthesis of several chemical subclasses of imidazole containing γ-secretase modulators (GSMs) is described. Conformational restriction of pyridone <b>4</b> into bicyclic pyridone isosteres has led to compounds with high in vitro and in vivo potency. This has resulted in the identification of benzimidazole <b>44a</b> as a GSM with low nanomolar potency in vitro. In mouse, rat, and dog, this compound displayed the typical γ-secretase modulatory profile by lowering Aβ42 and Aβ40 levels combined with an especially pronounced increase in Aβ38 and Aβ37 levels while leaving the total levels of amyloid peptides unchanged.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/55/21"><issue-title>Alzheimer's Disease</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32387" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32387" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is a chronic and progressive neurodegenerative disorder characterized by the deposition of extraneuronal amyloid plaques and intraneuronal neurofibrillary tangles of hyperphosphorylated tau protein in the limbic and cortical regions of the brain.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> These pathological depositions were first discovered in 1906 by Alois Alzheimer during the autopsy of patients with loss of memory, cognition, and behavioral stability.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Nowadays, AD is the leading form of dementia and the third leading cause of death after cardiovascular disease and cancer.</div><div class="NLM_p">AD does not have a simple etiology, but a substantial body of evidence supports the amyloid hypothesis which supposes that the accumulation of the amyloid-β peptide (Aβ) caused by altered production or clearance is the causative event in AD.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Aβ-peptides are derived from the amyloid precursor protein (APP) by two sequential proteolytic cleavages. The first cleavage of APP is catalyzed by the aspartyl protease BACE1 (β-secretase), yielding a soluble N-terminal fragment (sAPP) which is excreted from the cell, and a short membrane-bound C-terminal fragment (C99). The latter is a substrate for γ-secretase, and it is cleaved at variable positions of the transmembrane domain to release a 37–43 amino acid long Aβ-peptide. The two most common forms of Aβ produced in this way are Aβ40 and Aβ42, containing 40 and 42 amino acid residues respectively. It is the longer and more hydrophobic Aβ42 that forms the nucleus of the amyloid plaques and is thought to cause the neurotoxicity associated with AD.</div><div class="NLM_p">The search for γ-secretase inhibitors (GSIs) that lower the production of all Aβ isoforms has been a first strategy to prevent the formation of amyloid plaques. Several GSIs have moved to the clinic, and their progress has been reviewed recently.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The development of the most advanced compound, semagacestat, was interrupted during a phase III clinical trial as it was associated with worsening of clinical measures of cognition and an increase in the risk of skin cancer. Multiple reasons have been proposed to explain the lack of efficacy and observed side effects, including the rebound effect on Aβ42 at low levels of semagacestat, poor selectivity versus Notch cleavage, and accumulation of neurotoxic C99.<a onclick="showRef(event, 'cit4b ref5'); return false;" href="javascript:void(0);" class="ref cit4b ref5">(4b, 5)</a> In contrast to GSIs, γ-secretase modulators (GSMs) are defined as molecules that change the relative proportion of the Aβ isoforms while maintaining the rate at which APP is processed.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Targeted modulation of γ-secretase activity in such a way that the release of the longer amyloidogenic Aβ-peptides, especially Aβ42, is disfavored with regard to the shorter and more soluble Aβ-peptides, especially Aβ37 and Aβ38, has been and still is an important strategy to tackle AD.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Mechanistically, GSMs have been postulated to act as activators of the γ-secretase complex, enhancing the stepwise cleavage of APP toward the shorter Aβ-peptides.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In a recent study to further discriminate between modulation and inhibition, a GSM successfully improved cognitive deficits in APP-transgenic mice whereas a GSI caused cognitive impairment likely due to accumulation of C99.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">Two major classes of compounds are known to modulate the γ-secretase activity.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The first of these are carboxylic acids derived from nonsteroidal anti-inflammatory drugs (NSAIDs).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Initial examples of this class, such as tarenflurbil (<b>1</b>), were of low potency and displayed poor brain penetration, resulting in the failure of <b>1</b> in phase III clinical trials (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Subsequent, more potent analogues suffered from very high lipophilicity, limiting the potential use of these compounds as GSMs. The second class of GSMs is characterized by non-NSAID-scaffolds without a carboxylic acid group. These were initially reported by Neurogenetics in 2004, claiming imidazole containing compounds of general structure <b>2</b> as Aβ-modulating agents with potencies below 1 μM.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Subsequent work by Eisai has led to E-2012 (<b>3</b>), the first compound from this series entering the clinic (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> However, further development of E-2012 was halted due to lenticular toxicity in preclinical trials.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Compound <b>3</b> was used as a starting point for the design of our own non-NSAID γ-secretase modulators for the treatment of AD.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of γ-secretase modulators. In vitro data were obtained from in-house experiments. The IC<sub>50</sub> values are a mean of at least three determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The cinnamide group in <b>3</b> has an <i>E</i> orientation of the double bond. Our first hit was obtained by speculating that an NH linker as in compound <b>4</b> would preserve a similar geometry due to favorable electrostatic interaction between the NH and the carbonyl oxygen. Also, a steric clash between the carbonyl and the methoxyphenyl ring of <b>4</b> would disfavor alternative conformations. Computational modeling of <b>4</b> suggested that the orientation as sketched was the most energetically favorable conformation.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> This type of aminopyridones has also been described by Schering/Merck, including <b>4</b>.<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a> Despite the conformational similarity between <b>3</b> and <b>4</b>, subsequent testing of both compounds in vitro showed a loss in potency of <b>4</b> versus <b>3</b> (550 vs 81 nM, respectively). Upon oral administration in mice at 30 mg/kg, no significant change in Aβ brain levels was observed after 4 h for <b>4</b>, while dosing of <b>3</b> resulted in a 43% reduction of Aβ42 levels. To improve the in vitro potency and in vivo activity of <b>4</b>, we set out to further conformationally restrict the aminopyridone scaffold in <b>4</b>. In this paper, we will discuss our findings in this area and the development of a number of subseries with high in vitro and in vivo potency.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42828" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42828" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All the final compounds were synthesized via a Buchwald coupling between the anilino- or bromo-derivatives <b>I</b> and the corresponding halo- or anilino- heterocylic intermediates <b>II</b>, respectively (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis of Intermediates <b>I</b></h3><div class="NLM_p">In a first approach, the aniline precursors (<b>I</b>, R′′ = NH<sub>2</sub>) were prepared in two steps, starting from commercially available 4-halo-nitroarenes, as exemplified for anilines <b>8</b>(<b>a</b>,<b>c</b>,<b>f</b>) in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Nucleophilic aromatic substitution of a 4-halide in <b>5</b> with 4-methylimidazole gave a mixture of regioisomers, from which <b>7</b> was isolated in good yield. Subsequent catalytic hydrogenation of the nitro functionality in <b>7</b> provided the desired anilines <b>8</b>(<b>a</b>,<b>c</b>,<b>f</b>) in good yields. <b>8a</b> could then be submitted to Sandmeyer reaction conditions to provide the bromo precursor <b>11</b> (<b>I</b>, R′′ = Br). In another approach, the selective substitution of the 5-bromide in 2,5-dibromopyridine with 4-methylimidazole followed by a copper oxide amination with ammonium hydroxide afforded aniline <b>8e</b>.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Alternatively, compounds <b>8b</b> and <b>8d</b> were prepared in one step, via an Ullmann type coupling of the 4-methylimidazole with 4-halo-anilines <b>9b</b> and <b>9d</b>, respectively.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Separation of the two regioisomers provided the major, and desired, regioisomers <b>8b</b> and <b>8d</b> in good yields. A different approach was used for synthesis of the pyridylmethoxy derivative <b>14</b>. Regioselective nucleophilic addition of sodium methoxide to commercially available 3-amino-2,6-dibromopyridine provided the methoxypyridylamine <b>12</b>.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The amine moiety in <b>12</b> was converted to the desired 4-methylimidazole ring in <b>13</b> in a sequence of reactions that included formylation with acetic formic anhydride,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> followed by alkylation with 1-chloropropanone and finally ring closure of the resulting formyloxopropyl amine with ammonium acetate. Bromo-intermediate <b>13</b> could easily be converted to amino-derivative <b>14</b> via copper oxide catalyzed amination with ammonium hydroxide.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Route Towards Intermediates <b>I</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-methylimidazole, K<sub>2</sub>CO<sub>3</sub>, DMSO, 150 °C, 6 h; (b) H<sub>2</sub>, Pd(C), MeOH, 50 °C, 12 h; (c) NaNO<sub>2</sub>, H<sub>2</sub>SO<sub>4</sub>, 10 °C, 30 min, then CuBr, HBr; 10 °C to rt, 1 h; (d) 4-methylimidazole, CuI, 1,10-phenanthroline, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 130 °C, 2 d; (e) NaOMe, 1,4-dioxane, rt, 8 h; (f) AcOH, HCO<sub>2</sub>H, THF, 60 °C, 12 h; (g) 1-chloropropanone, KI, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 12 h; (h) NH<sub>4</sub>OAc, AcOH, 100 °C, 1 h; (i) Cu<sub>2</sub>O, NH<sub>4</sub>OH, ethylene glycol, 100 °C, 16 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthesis of Intermediates <b>II</b></h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6"> Imidazopyridines</h4><div class="NLM_p">The imidazopyridine nucleus <b>17</b> was prepared by condensation of 2-amino-3-bromopyridine <b>15</b> with α-haloketones <b>16</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Imidazopyridines and Benzimidazole Building Blocks<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EtOH, reflux, 4 h; (b) RCOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h; (c) AcOH, HCl, MW 150 °C, 30 min; (d) LiHMDS, R′Br, THF, 0–150 °C, 1–4 h; (e) Fe, AcOH, 60 °C, 1 h; (f) MeNH<sub>2</sub>, EtOH, 0 °C–rt, 15 h; (g) Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 15 h then AcOH, HCl, 100 °C, 2 h.</p></p></figure></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8"> Benzimidazoles</h4><div class="NLM_p">The initial synthesis of benzimidazole analogues involved acylation of 1,2-diamino-3-nitrobenzene (<b>18</b>) to provide the corresponding anilides (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). These compounds were then condensed to a benzimidazole ring system <b>19</b> at 150 °C in strong acidic conditions under microwave irradiation. Selective alkylation at N1 of <b>19</b> with the corresponding alkylbromides, followed by reduction of the nitro moiety, gave the desired 1,2-substituted 4-amino-benzimidazoles <b>20</b>(<b>a</b>,<b>b</b>,<b>c</b>,<b>e</b>).</div><div class="NLM_p last">Alternatively, benzimidazoles <b>23</b>(<b>a</b>,<b>d</b>,<b>f</b>,<b>h</b>) were prepared from 2-bromo-6-fluoro-nitrobenzene (<b>21</b>). Aromatic nucleophilic substitution on <b>21</b> with methylamine followed by reduction of the nitro functionality provided aniline <b>22</b>, which was cyclized with acyl derivatives <b>25</b> to provide <b>23</b> in good yields.</div></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Indazoles</h4><div class="NLM_p">Condensation of 3-bromo-2-nitrotoluene <b>24</b> with dimethylformamide dimethyl acetal (DMF-DMA) in the presence of pyrrolidine, followed by oxidation with NaIO<sub>4</sub>, gave 3-bromo-2-nitrobenzaldehyde <b>26</b> in a modest 20% yield over two steps (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Alternatively, oxidation of the commercially available 3-chloro-2-nitrobenzyl alcohol <b>25</b> gave the 3-chloro analogue <b>27</b>, which was also used to synthesize the final products. Reductive amination of benzaldehydes <b>26</b> and <b>27</b> with the corresponding anilines or benzylamines, followed by reduction of the nitro group with concomitant cyclization to the indazole nucleus, provided <b>28</b>.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The 3-position of <b>28a</b> and <b>28c</b> was also methylated using lithium diisopropyl amide (LDA) and methyl iodide in THF to provide bromo indazoles <b>29a</b> and <b>29c</b>, respectively.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0005.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Indazole and Benzoxazole Building Blocks<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DMF–DMA, pyrrolidine, 115 °C, 22 h; (b) NaIO<sub>4</sub>, DMF/H<sub>2</sub>O, 3 h, rt; (c) PCC, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h; (d) R(CH<sub>2</sub>)<sub><i>n</i></sub>NH<sub>2</sub>, sodium triacetoxyborohydride, HOAc, 1,2-dichloroethane, rt, 3 h; (e) SnCl<sub>2</sub>·2H<sub>2</sub>O, EtOH, 40 °C, 16 h; (f) LDA, THF, −78 to 0 °C, 15 min, MeI, −78 °C to rt, 16 h; (g) (1) NaNO<sub>2</sub>, 6N aq HCl soln, H<sub>2</sub>O, 30 min, 60 °C, (2) <i>t-</i>butylmercaptan, EtOH, 1 h, 0 °C; (h) KO<i>t</i>Bu, DMSO, 2 h, rt; (i) R<sub>2</sub>SO<sub>4</sub>, toluene, 16 h, 110 °C or RBr, <i>N</i>-methyl-dicyclohexylamine, DMF, 16 h, 30 °C; (j) RCOCl, THF, rt, 15 h; (k) CuI, 1,10-phenantroline, Cs<sub>2</sub>CO<sub>3</sub>, DME, 90 °C, 15 h.</p></p></figure><div class="NLM_p last">This synthetic route proceeded smoothly when the R substituent at the 2-position of indazoles was an aromatic ring. When R was an alkyl substituent, the major product of the cyclization step (e) in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> was a reduced diamino-derivative such as <b>30</b>, which was not isolated. Therefore an alternative route for the preparation of the 2-alkyl indazoles was applied, starting from 2-bromo-6-methylaniline <b>31</b>. Diazotation of <b>31</b> followed by condensation with <i>t</i>-butylmercaptan afforded diazene <b>32</b>. Subsequently, <b>32</b> underwent cyclization to indazole <b>33</b> by treatment with potassium <i>t</i>-butylate.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a><i>N</i>-Alkylation of <b>33</b>, either with a dialkylsulfate, or with an alkylhalide, gave a mixture of the two regioisomers <b>34</b> and <b>35</b>, which could be separated via chromatography.</div></div><div id="sec2_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Benzoxazoles</h4><div class="NLM_p last">The synthesis of benzoxazole analogues is shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Acylation of dibromoaniline <b>36</b> with the corresponding acyl chlorides provided anilides <b>37</b>. In turn, these compounds were submitted to cyclization via Ullmann-type coupling conditions in the presence of a catalytic Cu(I)–phenanthroline system<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> to give bromobenzoxazoles <b>38</b> in good to excellent yields.</div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Biology</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80577" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80577" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Cellular in Vitro Assay</h3><div class="NLM_p last">All compounds were tested using SKNBE2 cells carrying the APP 695–wild type according to modification of the assay as described.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The cell/compound mixtures were incubated overnight at 37 °C, 5% CO<sub>2</sub>. Aβ42 and Aβtotal concentrations were quantified in the cell supernatant using sandwich immunoassays via the Alphalisa technology (Perkin-Elmer). To obtain the reported IC<sub>50</sub> values, the data are calculated as percentage of the maximum amount of Aβ42 or Aβtotal measured in the absence of the test compound. The IC<sub>50</sub> represents the concentration of a compound that is required for reducing the Aβ peptide levels by 50%. In this assay, a GSM will lead to a lowering of Aβ42 while leaving Aβtotal levels unchanged. Other mechanisms of lowering the Aβ levels, such as γ- or β-secretase inhibition or cytotoxicity, would result in lowering of all Aβ peptides levels, including Aβtotal. None of the described compounds showed a significant lowering of the Aβtotal levels up to the highest concentration tested (10 μM), confirming that they are not γ- or β-secretase inhibitors.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vivo Mouse Screening Assay</h3><div class="NLM_p">To determine the effect on Aβ42 and Aβtotal levels upon acute administration of a compound in vivo, nontransgenic CD1 mice were used. Compounds were formulated as suspensions in 20% of Captisol (a sulfobutyl ether of β-cyclodextrin) in water and administered as a single oral dose of 30 mg/kg. After four hours, the animals were sacrificed and their brains dissected in two. One half was used for quantification of Aβ levels using sandwich immunoassays. The other half was analyzed for compound levels and compared to compound levels in blood plasma collected at the same time point. Each quoted value is the mean of at least six animals. Changes in Aβ peptide levels are expressed as a percentage relative to untreated animals. Reduction of Aβ peptide levels of greater than 20% are considered significant. In all runs, compound <b>3</b> was dosed as the positive control. In agreement with the cellular in vitro data (vide supra), none of the tested compounds showed a significant lowering of the Aβtotal levels.</div><div class="NLM_p last">Further biological experiments are explained in the next section and detailed in the <a class="ref internalNav" href="#sec6" aria-label="Experimental Section">Experimental Section</a> or <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73845" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73845" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Imidazopyridines</h3><div class="NLM_p">To regain the loss in potency, when going from cinnamide <b>3</b> to aminopyridone <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), we set up to investigate conformational restriction of <b>4</b>. Assuming that the proposed intramolecular hydrogen bond in <b>4</b> would indeed mimic the conformation of the cinnamide <b>3</b>, the <i>N</i>-pyridone benzyl substituent was targeted, being the most flexible part of the molecule. A bioisosteric replacement of a pyridone by an imidazopyridine heterocycle has been described as a successful strategy for other targets<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and would preserve the intramolecular hydrogen bond arrangement present in <b>4</b>. The 4-fluorophenyl ring present in both <b>3</b> and <b>4</b> can be oriented in two ways on the imidazopyridine ring, and both regioisomers were prepared (<b>39</b> and <b>40</b>, Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Only regioisomer <b>40</b>, in which the aromatic ring was attached to the 2-position, showed an improvement of in vitro activity.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Although with an IC<sub>50</sub> of 182 nM still lower in potency than cinnamide <b>3</b>, this now translated in vivo into a 35% reduction of Aβ42 levels in mouse brain 4 h after an oral dose of 30 mg/kg.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0006.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Rationale for the Synthesis of Imidazopyridine <b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Mouse in vivo at 30 mpk po after 4 h (<i>n</i> = 6) expressed as a percentage of Aβ42 lowering in brain compared with untreated animals.</p></p></figure><div class="NLM_p">Given this result, the influence of various substituents at the 2-position of the imidazopyridine ring in <b>40</b> was evaluated. The most relevant data are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. In general, an aromatic substituent at the 2-position of imidazopyridines brought good in vitro potency, with a range of ring substitutions being allowed. For instance, replacing the <i>para</i>-fluorine atom on the aromatic ring in <b>40a</b> by an electron donating <i>meta</i>-methoxy group (<b>40b</b>) slightly increased the potency. A reasonable in vitro activity was also achieved with an unsubstituted phenyl ring (<b>40c</b>). The introduction of a weak basic center, such as a 3-pyridyl ring in <b>40f</b>, led to a loss of primary activity. When the hydrogen atom at the 3-position of the imidazopyridines was replaced by a bulkier group, such as a methyl group, potency was improved further, see <b>40c</b> versus <b>40d</b>. Most of the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, which were screened in vivo in mice, displayed a moderate 20–40% lowering of Aβ42 brain levels, with total levels of Aβ peptides remaining unchanged. No clear correlation could be observed between in vitro potency and in vivo activity, even upon consideration of compound brain levels. An effort was made to correlate in vivo activity with the estimated free brain concentration, using the fraction unbound in brain (<i>f</i><sub>u,brain</sub>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> For most in vivo active compounds, <i>f</i><sub>u,brain</sub> was less than 0.1% and therefore could not be accurately determined. Nevertheless, we observed that many compounds demonstrated robust vivo activity while the estimated free brain concentration was substantially lower than the in vitro IC<sub>50</sub> for Aβ42 lowering. Notably, <b>40e</b> was one of the most potent compounds in vivo with 44% lowering of Aβ42 levels after 4 h, despite relatively low brain levels and <i>f</i><sub>u,brain</sub> < 0.03%. In terms of ADME parameters, most of the 2-aryl substituted analogues had poor kinetic solubility at pH = 7.4 (<2 μM) and were cytochrome P450 (CyP) inhibitors and hERG channel binders (data not shown). Replacement of the 2-aryl group on the imidazopyridine nucleus by various alkyl groups (<b>40h</b>–<b>40j</b>) resulted in active compounds and did increase the solubility but overall did not improve the ADME profile. Compound <b>40g</b>, bearing a benzyl substituent, was one of the most potent analogues in vivo, lowering the Aβ42 levels with 44% in mice at 30 mg/kg per os (po). Upon oral dosing, most analogues of the imidazopyridine series displayed high compound plasma levels despite their low solubility. On the other hand, the most soluble compound within this series, the tetrahydropyranyl (THP) derivative <b>40j</b> (kinetic solubility at pH 7.4 = 75 μM), had no significant effect on Aβ42 levels in vivo despite moderate in vitro activity, good brain levels, and <i>f</i><sub>u,brain</sub> = 1.9%, highlighting again the disconnect between free brain concentrations and vivo activity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro/in Vivo Activities, Brain/Plasma Levels, and Solubility for Imidazopyridines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0007.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R′</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub>(nM)Aβ42<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">brain levels (μM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">plasma levels (μM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">inhib Aβ42 vivo (%)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">182</td><td class="colsep0 rowsep0" align="center">11.7 ± 0.7</td><td class="colsep0 rowsep0" align="center">17.2 ± 0.7</td><td class="colsep0 rowsep0" align="center">35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-MeO-Ph</td><td class="colsep0 rowsep0" align="char" char=".">138</td><td class="colsep0 rowsep0" align="center">3.0 ± 0.3</td><td class="colsep0 rowsep0" align="center">11.1 ± 0.7</td><td class="colsep0 rowsep0" align="center">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="char" char=".">339</td><td class="colsep0 rowsep0" align="center">16.2 ± 1.1</td><td class="colsep0 rowsep0" align="center">26.3 ± 1.6</td><td class="colsep0 rowsep0" align="center">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40d</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="center">5.4 ± 0.4</td><td class="colsep0 rowsep0" align="center">16.0 ± 2.0</td><td class="colsep0 rowsep0" align="center">34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40e</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="center">1.2 ± 0.3</td><td class="colsep0 rowsep0" align="center">4.9 ± 0.8</td><td class="colsep0 rowsep0" align="center">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40f</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-pyridyl</td><td class="colsep0 rowsep0" align="char" char=".">1216</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40g</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph-CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="center">6.2 ± 0.3</td><td class="colsep0 rowsep0" align="center">17.5 ± 0.7</td><td class="colsep0 rowsep0" align="center">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40h</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">442</td><td class="colsep0 rowsep0" align="center">13.6 ± 1.5</td><td class="colsep0 rowsep0" align="center">15.5 ± 1.6</td><td class="colsep0 rowsep0" align="center">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40i</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-Bu</td><td class="colsep0 rowsep0" align="char" char=".">194</td><td class="colsep0 rowsep0" align="center">4.9 ± 0.3</td><td class="colsep0 rowsep0" align="center">10 ± 0.2</td><td class="colsep0 rowsep0" align="center">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40j</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">THP</td><td class="colsep0 rowsep0" align="char" char=".">213</td><td class="colsep0 rowsep0" align="center">5.6 ± 0.4</td><td class="colsep0 rowsep0" align="center">11.3 ± 0.7</td><td class="colsep0 rowsep0" align="center">7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">IC<sub>50</sub> represents the concentration of a compound that is required for reducing the Aβ42 level by 50%. The IC<sub>50</sub> values are a mean of at least three determinations. The confidence intervals for the IC<sub>50</sub> values are reported in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Plasma and brain samples were analyzed for the tested compound using a qualified research LC-MS/MS method. Data are expressed as the geometric mean values of at least 4 runs ± the standard error of the mean (SEM). nd: not determined.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Mouse in vivo at 30 mpk p.o. after 4 h (<i>n</i> = 6) expressed as a percentage of Aβ42 lowering in brain compared with untreated animals. nd: not determined.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Mouse in vivo at 20 mpk p.o. after 4 h (<i>n</i> = 4) expressed as a percentage of Aβ42 lowering in brain compared with vehicle treated animals.</p></div></div></div><div class="NLM_p">Having identified activity with the imidazopyridines <b>40</b>, alternative bicyclic systems were synthesized which also contained a hydrogen bond acceptor in the same position relative to the NH linker (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). These examples included benzimidazole, benzoxazole, and indazole heterocycles. A preference was given to compounds bearing a relatively large substituent R at the 2-position of the heterocyclic nucleus in order to preserve the preferred orientation established within the imidazopyridine series <b>40</b>.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Isosteres of imidazopyridines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Benzimidazoles</h3><div class="NLM_p">In general, the benzimidazole series retained the potency of the imidazopyridines and showed a similar SAR profile as for the imidazopyridines (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The positive influence on potency of an additional substituent R′ at the 3-position of the benzimidazole nucleus became even more apparent in this series, with <b>41a</b> being at least 10-fold less potent than <b>41b</b> and <b>41c</b>. For compound <b>41b</b>, the high in vitro potency translated into a good in vivo efficacy, this compound lowered the levels of Aβ42 peptides in mouse by 43%. As in the imidazopyridine series, a drop in potency was observed when small aliphatic substituents were introduced at the 2-position of the benzimidazole ring (<b>41g</b>). Larger alkyl substituents, such as in <b>41h</b>, retained good in vitro potency, and despite a lower metabolic stability (data not shown), this compound displayed high brain levels which translated to a 45% reduction of Aβ42 levels.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro/in Vivo Activities, Brain/Plasma Levels, and Solubility for Benzimidazoles</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0009.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="center" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R′</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> Aβ42 (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">brain levels (μM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">plasma levels (μM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">inhib Aβ42 vivo (%)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">203</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="center">7.0 ± 0.6</td><td class="colsep0 rowsep0" align="left">17.3 ± 1.3</td><td class="colsep0 rowsep0" align="center">43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41c</b></td><td class="colsep0 rowsep0" align="left">iPr</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41d</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3-OMePh</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="center">5.5 ± 0.5</td><td class="colsep0 rowsep0" align="left">19 ± 1.0</td><td class="colsep0 rowsep0" align="center">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41e</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2,4-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="center">10.3 ± 0.8</td><td class="colsep0 rowsep0" align="left">27 ± 1.6</td><td class="colsep0 rowsep0" align="center">54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41f</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-F-Ph-CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="center">4.8 ± 0.4</td><td class="colsep0 rowsep0" align="left">15.7 ± 1.8</td><td class="colsep0 rowsep0" align="center">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41g</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">1660</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41h</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">iBu</td><td class="colsep0 rowsep0" align="char" char=".">107</td><td class="colsep0 rowsep0" align="center">10.8 ± 1.3</td><td class="colsep0 rowsep0" align="left">14.1 ± 1.3</td><td class="colsep0 rowsep0" align="center">45</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">IC<sub>50</sub> represents the concentration of a compound that is required for reducing the Aβ42 level by 50%. The IC<sub>50</sub> values are a mean of at least three determinations. The confidence intervals for the IC<sub>50</sub> values are reported in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a></p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Plasma and brain samples were analyzed for the tested compound using a qualified research LC-MS/MS method. Data are expressed as the geometric mean values of at least four runs ± the standard error of the mean (SEM). nd: not determined.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Mouse in vivo at 30 mpk po after 4 h (<i>n</i> = 6, except for <b>41(d,f)</b>, where <i>n</i> = 4) expressed as a percentage of Aβ42 lowering in brain compared with untreated animals. nd: not determined.</p></div></div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Indazoles</h3><div class="NLM_p">Also compounds from the indazole (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) series turned out to be highly potent. The most active in vitro compounds were substituted on the 2-position of the indazole nucleus with an aromatic ring either directly connected (<b>42a</b>–<b>c</b>) or via a methylene spacer (<b>42d</b>). Again, additional substitution on the 3-position, for instance with a methyl group, resulted in an improvement of the primary activity (<b>42c</b> versus <b>42b</b>). In the case of an alkyl substituent on the 2-position, good in vitro activity was retained with a <i>n</i>-butyl group (<b>42f</b>), whereas a smaller substituent such as a methyl group (<b>42e</b>) led to a poorly active compound. Several compounds demonstrated in vivo activity, with up to 41% inhibition of Aβ42 lowering in mouse for compound <b>42c</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro/in Vivo Activities, Brain/Plasma Levels, and Solubility for Indazoles</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0010.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R′</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM) Aβ42<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">brain levels (μM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">plasma levels (μM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">inhib Aβ42 vivo (%)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42a</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2,4-diF-Ph</td><td class="colsep0 rowsep0" align="char" char=".">133</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-OMe-Ph</td><td class="colsep0 rowsep0" align="char" char=".">131</td><td class="colsep0 rowsep0" align="center">6.9 ± 0.3</td><td class="colsep0 rowsep0" align="center">12.8 ± 0.6</td><td class="colsep0 rowsep0" align="center">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42c</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3-OMe-Ph</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="center">4.7 ± 1.0</td><td class="colsep0 rowsep0" align="center">14.4 ± 0.6</td><td class="colsep0 rowsep0" align="center">41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph-CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="center">6.8 ± 0.6</td><td class="colsep0 rowsep0" align="center">11.6 ± 1.0</td><td class="colsep0 rowsep0" align="center">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">2252</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42f</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-Bu</td><td class="colsep0 rowsep0" align="char" char=".">363</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">IC<sub>50</sub> represents the concentration of a compound that is required for reducing the Aβ42 level by 50%. The IC<sub>50</sub> values are a mean of at least three determinations. The confidence intervals for the IC<sub>50</sub> values are reported in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Plasma and brain samples were analyzed for the tested compound using a qualified research LC-MS/MS method. Data are expressed as the geometric mean values of at least four runs ± the standard error of the mean (SEM). nd: not determined.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Mouse in vivo at 30 mpk po after 4 h (<i>n</i> = 6) expressed as a percentage of Aβ42 lowering in brain compared with vehicle treated animals. nd: not determined.</p></div></div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Benzoxazoles</h3><div class="NLM_p">Benzoxazole derivatives were clearly less active than their imidazopyridine or benzimidazole analogues (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). For instance 4-F-Ph derivative <b>43a</b> was almost 2 orders of magnitude less active than the corresponding imidazopyridine <b>40a</b>. In this series, the most active compounds were substituted either with an alkyl substituent on the 2-position of the benzoxazole nucleus (<b>43d</b>) or an alkylaryl substituent (<b>43c</b>). However, both compounds were not potent enough to significantly reduce Aβ42 levels in vivo.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro/in Vivo Activities, Brain/Plasma Levels, and Solubility for Benzoxazoles</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0011.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM) Aβ42<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">brain levels (μM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">plasma levels (μM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">inhib Aβ42 vivo (%)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43a</b></td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">5289</td><td class="colsep0 rowsep0" align="center">11.6 ± 1.1</td><td class="colsep0 rowsep0" align="center">6.4 ± 0.3</td><td class="colsep0 rowsep0" align="center">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43b</b></td><td class="colsep0 rowsep0" align="left">2-OMePh</td><td class="colsep0 rowsep0" align="char" char=".">2113</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43c</b></td><td class="colsep0 rowsep0" align="left">4-F-Ph-CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="char" char=".">696</td><td class="colsep0 rowsep0" align="center">6.8 ± 0.7</td><td class="colsep0 rowsep0" align="center">9.4 ± 1.0</td><td class="colsep0 rowsep0" align="center">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43d</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>Bu</td><td class="colsep0 rowsep0" align="char" char=".">603</td><td class="colsep0 rowsep0" align="center">10 ± 2.4</td><td class="colsep0 rowsep0" align="center">4.7 ± 0.9</td><td class="colsep0 rowsep0" align="center">18</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">IC<sub>50</sub> represents the concentration of a compound that is required for reducing the Aβ42 level by 50%. The IC<sub>50</sub> values are a mean of at least three determinations. The confidence intervals for the IC<sub>50</sub> values are reported in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Plasma and brain samples were analyzed for the tested compound using a qualified research LC-MS/MS method. Data are expressed as the geometric mean values of at least four runs ± the standard error of the mean (SEM).</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Mouse in vivo at 30 mpk po after 4 h (<i>n</i> = 6) expressed as a percentage of Aβ42 lowering in brain compared with vehicle treated animals. nd: not determined.</p></div></div></div><div class="NLM_p">The high potency of compounds across the imidazopyridine, benzimidazole, and indazole series underlines the benefit of conformational restriction of the original pyridone core in <b>4</b>. Additionally, the cyclization promotes a beneficial orientation of the aromatic substituent at the 2-position and allows augmentation of the hydrogen bonding capability of the sp2 nitrogen at the 1-position. The same heterocyclic nitrogen can form an intramolecular interaction to the NH aniline linker and stabilize an <i>E</i>-like conformation similar to <b>3</b> and <b>4</b>.</div><div class="NLM_p">The most potent compounds within the various series are those where the aromatic substituent at the 2-position is pushed out of the plane of the central bicyclic heteroaromatic ring. This is achieved by the presence of a small alkyl substituent at the 3-position of the imidazopyridines, benzimidazoles, and indazoles (steric clash indicated in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The inherent lack of such a substituent in the benzoxazoles can explain the overall lower potency of this series. Nonplanarity is also achieved by using ortho-substituted aromatic rings or replacing the aromatic ring with a benzylic or alkyl group. Indeed, in the benzoxazole series all these variations led to an increase in potency (<b>43a</b> versus <b>43b</b>, <b>43c</b>, and <b>43d</b>, respectively).</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Factors influencing the potency in the bicyclic heterocycles series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The carbonyl of the cinnamide <b>3</b> and pyridone <b>4</b> as well as the heterocyclic sp<sup>2</sup> nitrogen in the series presented here all maintain a hydrogen bond acceptor in the same position. It was expected that this is an important feature for the activity of these molecules. The hydrogen bonding capability of the heterocyclic nitrogen (N1, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) was evaluated by calculating the minimum electrostatic potential, <i>V</i><sub>min</sub>, for this atom. This parameter has been shown to be a useful predictor for hydrogen bond strength.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> A weak correlation (<i>r</i><sup>2</sup> 0.38) was seen between the <i>V</i><sub>min</sub> descriptor and activity, with more negative values of <i>V</i><sub>min</sub> and therefore stronger H-bond acceptor capability correlating with potency, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for more details. When comparing analogous molecules, the imidazopyridine and benzimidazoles had the strongest hydrogen bond acceptor potential, while the benzoxazole tended to be the weakest. The hydrogen bond acceptor capabilities of the heterocyclic acceptor were modulated by the introduction of a methyl substituent at the 3-position, as in methyl substituted <b>41b</b>, <i>V</i><sub>min</sub> −25.7 kcal/mol, and unsubstituted <b>41a</b>, <i>V</i><sub>min</sub> −20.3 kcal/mol. The effects of the methyl are likely 2-fold: electron donating and, as discussed before, disturbing the planarity between the benzimidazole and the 4-F-phenyl- substituent and thereby reducing electron delocalization. Although there was weak overall correlation, a single descriptor is unlikely to capture all properties important for activity and the correlation was seen to break down as more structural diversity at the 2-position was included. Nevertheless, the calculations illustrate an important consideration in the design of the target molecules.</div><div class="NLM_p">In general, the designed series of compounds showed moderate to excellent in vitro activity, which in some cases translated in very good lowering of Aβ42 peptides in vivo. In contrast to γ-secretase inhibitors, no relevant reduction in Aβtotal levels was observed for any of the tested compounds and no inhibition of Notch processing up to the highest concentration tested (10 μM, data not shown). In all chemical classes, the high potency was accompanied by high lipophilicity (in general, cLogP >5) and a TPSA below 75 Å, explaining the good brain penetration.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> However, the majority of compounds also suffered from hERG binding with IC<sub>50</sub>s below 1 μM, CyP inhibition and low solubility, particularly at pH = 7.4 (data not shown). These unfavorable ADME properties can likely be attributed to the combination of high lipophilicity and low TPSA.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Despite the low solubility, most of the compounds had good oral bioavailability, with high levels in plasma and brain. We speculate that this is likely related to the weakly basic character of the imidazole moiety (p<i>K</i><sub>a</sub> 5–6), helping to solubilize the compounds in the acidic environment of the stomach, for subsequent absorption in the small intestine.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Among the most potent in vivo γ-secretase modulators were benzimidazoles <b>41b</b> and <b>41e</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), which prompted us to further explore the benzimidazole series. To improve the drug-likeness, analogues were designed in which the benzimidazole nucleus (see Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) was kept constant while variations were made on the methoxyphenyl ring as illustrated in compounds <b>44a</b>–<b>44f</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0015.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Aza benzimidazole analogues. The IC<sub>50</sub> values are a mean of at least three determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro/in Vivo Activities, Brain/Plasma Levels, Solubility, and hERG Binding of Methoxyphenyl Variations</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0013.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0014.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> represents the concentration of a compound that is required for reducing the Aβ42 level by 50%. The IC<sub>50</sub> values are a mean of at least three determinations. The confidence intervals for the IC<sub>50</sub> values are reported in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Plasma and brain samples were analyzed for the tested compound using a qualified research LC-MS/MS method. Data are expressed as the geometric mean values of at least six runs ± the standard error of the mean (SEM). nd: not determined.</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">Mouse in vivo at 30 mpk po after 4 h (<i>n</i> = 6, except for <b>44a</b> where <i>n</i> = 4) expressed as a percentage of Aβ42 lowering in brain compared with untreated animals.</p></div><div class="footnote" id="t5fn4"><sup>Table d</sup><p class="last">Inhibition of binding of tritiated dofetilide to the human ether-a-go-go related gene (hERG) expressed in HEK-293 cells.</p></div></div><div></div></div><div class="NLM_p">In the majority of these modifications, the in vitro potency remained below 100 nM, which in vivo translated in the reduction of Aβ42 levels. Gratifyingly, some of the in vitro ADME parameters were also improved. For example, where compound <b>41b</b> inhibited the hERG channel with an IC<sub>50</sub> of 2 μM, several of the analogues had an IC<sub>50</sub> above 5 μM. Compound <b>44a</b> showed the best in vivo lowering of Aβ42 peptides (62%) in mouse brain 4 h after a dose of 30 mg/kg po, most likely related to the improved brain/plasma ratio compared to <b>41b</b> and other <b>44</b> analogues. Additional nitrogen analogues <b>44g</b> and <b>44h</b> were also prepared (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Compound <b>44g</b>, with the N-atom transferred to the benzimidazole and ortho to the aniline linker, maintained the in vitro activity but showed a lower reduction of the Aβ42 peptides. Interestingly, with ortho N-atoms present in both adjacent rings to the amino linker as in <b>44h</b>, the in vitro activity of <b>44h</b> was reduced 10-fold compared to <b>44a</b> or <b>44g</b>. This may be due to an electronically induced unfavorable torsion angle between the two heteroaromatic rings in <b>44h</b>.</div><div class="NLM_p">Compound <b>44a</b> remained the best analogue of the benzimidazole series and also one of the most potent GSMs reported to date. The compound was extensively evaluated for its in vitro ADME properties and in vivo potency in several species. The most relevant physicochemical and in vitro data are tabulated in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. The metabolic stability of <b>44a</b> was shown to be good across multiple species with a low turnover in human, mouse, and rat microsomes and a moderate turnover in dog microsomes.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In human liver microsomes, no reactive metabolites were observed upon trapping experiments with glutathione or cyanide (data not shown). <b>44a</b> was a moderate to weak inhibitor of cytochromes P450, with IC<sub>50</sub> values varying from 2.9 to more than 30 μM for the different isoforms in human liver microsomes. No genotoxicity alerts were found in the Ames II<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> or GreenScreen HC<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> tests. In accordance with the high lipophilicity of <b>44a</b>, over 98% plasma protein binding was observed across species. The weak affinity of <b>44a</b> to bind to the hERG channel (IC<sub>50</sub> 8.5 μM) translated into only a weak effect on the potassium membrane current recorded with an automated patch-clamp system (30% inhibition at 3 μM versus 17% for vehicle). Compound <b>44a</b> was poorly soluble across pH range (<0.001 mg/mL at pH 4 and pH 7.4, Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>), but it did solubilize in a strongly acidic environment (1.2–2.3 mg/mL in 0.01 N HCl).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> To have an estimate of the solubility of <b>44a</b> in the gastro-intestinal tract (GI tract), the solubility was determined also in the fasted-state and fed-state simulated intestinal fluid buffers (FaSSIF and FeSSIF respectively, Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> In the FeSSIF test, <b>44a</b> showed an improved, albeit low solubility of 20 μg/mL (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). The fact that <b>44a</b> had a moderate melting point of 139 °C (see <a class="ref internalNav" href="#sec6" aria-label="Experimental Section">Experimental Section</a>) would also suggest a better solubility across the GI tract than that determined with the pH 4 and pH 7.4 buffers.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a><b>44a</b> displayed a moderate permeability in MDR1-expressing LLC-PK1 cells (LLC-MDR1, 8 × 10<sup>–6</sup> cm/s, Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>),<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> with no indication of P-glycoprotein mediated efflux (0.5 efflux ratio).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro Drug-Like Profile of <b>44a</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">assay</th><th class="colsep0 rowsep0" align="center"><b>44a</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LogP</td><td class="colsep0 rowsep0" align="left">5.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">Metabolic Stability (% Conversion)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">CyP450 Inhibition, IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3A4 (midazolam)</td><td class="colsep0 rowsep0" align="left">8.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3A4 (testosterone)</td><td class="colsep0 rowsep0" align="left">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2D6 (dextrometorphan)</td><td class="colsep0 rowsep0" align="left">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2C9 (tolbutamide)</td><td class="colsep0 rowsep0" align="left">21.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2C19 (<i>S</i>-mephenytoin)</td><td class="colsep0 rowsep0" align="left">3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1A2 (phenacetin)</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">Genotoxicity</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ames II<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></td><td class="colsep0 rowsep0" align="left">negative</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GreenScreen HC<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></td><td class="colsep0 rowsep0" align="left">negative</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">Plasma Protein Binding (% free)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">0.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG patch clamp (%inh, at 3 μM)</td><td class="colsep0 rowsep0" align="left">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">Thermodynamic Solubility</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> buffer pH 4.0</td><td class="colsep0 rowsep0" align="left"><0.001 mg/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> buffer pH 7.4</td><td class="colsep0 rowsep0" align="left"><0.001 mg/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> 0.01N HCl</td><td class="colsep0 rowsep0" align="left">1.17–2.33mg/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> FaSSIF</td><td class="colsep0 rowsep0" align="left">0.003 mg/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> FeSSIF</td><td class="colsep0 rowsep0" align="left">0.020 mg/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">Permeability (LLC-MDR1 Cells)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Papp (A–B) (10<sup>–6</sup>cm/s)</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Papp (B–A) (10<sup>–6</sup>cm/s)</td><td class="colsep0 rowsep0" align="left">4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Metabolism after incubation of <b>44a</b> at 1 μM with liver microsomes for 15 min.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Inhibition of the metabolism of isoform specific substrates (given in parentheses) in human liver microsomes. The IC<sub>50</sub> values are given as a mean of three determinations.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">A–B = apical to basolateral; B–A = basolateral to apical.</p></div></div></div><div class="NLM_p">In addition, <b>44a</b> was screened on 51 receptors and transporters and 37 enzymes in a selectivity screen performed at CEREP.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Selectivity overall was good, and the only interactions greater than 50% at 10 μM were with NK3 (71%) and with the Na<sup>+</sup> channel (site 2, 60%).</div><div class="NLM_p">For the in vivo evaluation, <b>44a</b> was first tested further in mouse at multiple time points at a dose of 10 and 30 mg/kg po and including measurement of Aβ38 (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). A dose dependent reduction in Aβ42 was observed, with a concomitant increase in Aβ38 levels. As expected for a GSM, no significant change in Aβ total level was observed, although at 8 h a tendency of reduction was observed. After 24 h, Aβ levels were normalized, except for the Aβ42 level at the 30 mg/kg dose, where still some reduction appeared to be present (77 ± 3% versus vehicle). In this experiment, an additional analysis was performed at 48 h, at which time-point also Aβ42 levels had returned to normal (101 ± 7% versus vehicle, plasma and brain levels of <b>44a</b> below quantifiable limit (BQL), data not shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0018.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Changes in mouse brain Aβ-levels after a single 10 and 30 mg/kg dose of <b>44a</b>. Expressed as mean % change versus <i>T</i> = 0 h, <i>n</i> = 4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Standard pharmacokinetic (PK) studies in multiple species revealed a good and rapid absorption in mouse and dog and a good and slow absorption in rat. Bioavailability for all species was high in rat (95%), mouse (100%), and dog (64%). Detailed PK data can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Although these PK data were generated with <b>44a</b> formulated as a solution (1 mg/mL in 20% aqueous SBE-β-cyclodextrin solution at pH 4), a comparable exposure was observed when dosed as a methocell suspension. Subsequent in vivo experiments were therefore carried out using methocell suspensions. We recently reported on the use of a canine model to evaluate efficacy and safety of γ-secretase inhibitors (GSIs) and GSMs.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> In Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, the effect of <b>44a</b> on Aβ38, 40, and 42 in beagle dog cerebrospinal fluid (CSF) is shown after a single oral dose of 20 mg/kg, as determined via MesoScale Discovery analysis. At 8 h, an increase of 84% in Aβ38 and a decrease of 36% and 48% of the longer Aβ-isoforms Aβ40 and Aβ42, respectively, were observed. After 24 h, the Aβ levels were normalized again. Although the compound levels were substantially higher at 4 h than at 8 h, at 4 h only a marginal reduction in Aβ40 and Aβ42 was seen. This can be explained by a delay in Aβ-level changes in CSF compared to brain, where the actual production of Aβ peptides is taking place.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0019.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Changes in dog CSF Aβ-levels after a single 20 mg/kg dose of <b>44a</b>. Expressed as mean % change versus <i>T</i> = 0 h, <i>n</i> = 4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To bridge the data obtained in mouse brain with those in dog CSF, in a subsequent experiment rats were treated with 10 mg/kg of <b>44a</b> in order to investigate its efficacy to modulate the release of Aβ-peptides in brain and CSF within the same species. In addition, the MesoScale analysis was expanded to include the measurement of Aβ37 levels. In agreement with the experiments in mouse and dog, a decrease in Aβ40 and Aβ42 was seen in both brain and CSF. The shorter isoforms Aβ37 and Aβ38 were increased, with an especially strong increase in Aβ37 of 4-fold in brain and 8-fold in CSF (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Apart from this difference in change for the shorter Aβ species, in rat no significant difference or time delay was observed for the Aβ changes in brain versus CSF.</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0020.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Changes in rat brain and CSF Aβ and compound levels of <b>44a</b> after a single oral dose (10 mg/kg). Expressed as mean % change versus <i>T</i> = 0 h, <i>n</i> = 5.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02776" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02776" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The present studies described the successful application of conformational restriction of aminopyridone <b>4</b> into pyridone isosteres such as imidazopyridines, benzimidazoles, benzoxazoles, and indazoles, resulting in new series of GSMs with good in vitro and in vivo activity. The potency was enhanced further by inducing nonplanarity between the central bicyclic heterocycle and the pendant 2-substituent. (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Despite the low solubility across the series, good oral bioavailability combined with acceptable brain penetration resulted in considerable reductions in Aβ42 levels in mouse brain without significant changes in Aβtotal levels. Replacement of the methoxyphenyl ring with a methoxypyridyl ring has led to <b>44a</b> with an improved drug-like profile and enhanced in vivo activity. Benzimidazole analogue <b>44a</b> had an IC<sub>50</sub> of 16 nM in lowering Aβ42 in a cellular assay and displayed good in vivo activity across species such as mouse, rat, and dog. In all three species, a typical γ-secretase modulatory profile was observed with a decrease in the longer Aβ-isoforms Aβ40 and Aβ42 and an increase in the shorter isoforms Aβ37 and Aβ38. Unlike carboxylic acid-derived GSMs recently described<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> with no effect on Aβ40 levels, <b>44a</b> is efficient in lowering Aβ40, suggesting a different mode of interaction with the γ-secretase complex. The especially strong increase in the short Aβ-peptides Aβ37 and Aβ38 after treatment with <b>44a</b> is noteworthy. Currently, little is known about the toxicity or relevance to plaque formation of these more soluble isoforms Aβ37 and Aβ38. Studies with compounds such as <b>44a</b> may provide further insight in the role of these isoforms.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> As many of the GSMs described to date, the series detailed in this paper, including <b>44a</b>, is suffering from suboptimal physicochemical properties: low solubility, high lipophilicity, and high aromaticity.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> For <b>44a</b>, this has translated into signs of liver toxicity after dosing in dog at 20 mg/kg.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Further optimization of the drug-like properties of this series is ongoing. For this work, <b>44a</b> will be serving as a benchmark for potency, as well as in studies toward required changes of Aβ-levels needed for disease modification of Alzheimer’s disease.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00086" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00086" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Chemistry</h3><div class="NLM_p">Melting points were determined with a DSC823e (Mettler-Toledo) and were measured with a temperature gradient of 30 °C/min. The reported values are peak values. <sup>1</sup>H NMR spectra were recorded with Bruker Avance DPX 400 and 360 spectrometers, and chemical shifts (δ) are expressed in parts per million (ppm) with TMS as internal standard. Elemental analyses were performed with a Carlo-Erba EA1110 analyzer. Mass spectral data were obtained via GC-MS analysis, using an Agilent 6890 series GC combined with a 5973N mass selected detector. Combustion analytical results were within 0.4% of the theoretical values except when noted otherwise. For all tested and final compounds where no analytical purity is mentioned, compounds were confirmed >95% pure via HPLC methods. The analytical LC measurement was performed using an Acquity UPLC (Waters) system comprising a binary pump, a sample organizer, a column heater (set at 55 °C), a diode array detector (DAD), and a bridged ethylsiloxane/silica hybrid (BEH) C18 column (1.7 μm, 2.1 mm × 50 mm; Waters Acquity) with a flow rate of 0.8 mL/min. Two mobile phases (mobile phase A consisting of 0.1% formic acid in H<sub>2</sub>O/methanol 95/5; mobile phase B consisting of methanol) were used to run a gradient condition from 95% A and 5% B to 5% A and 95% B in 1.3 min and held for 0.2 min. An injection volume of 0.5 μL was used. Cone voltage was 10 V for positive ionization mode and 20 V for negative ionization mode. Flow from the column was split to a mass spectrometer. The MS detector was configured with an electrospray ionization source. Mass spectra were acquired by scanning from 100 to 1000 in 0.18 s using a dwell time of 0.02 s. The capillary needle voltage was 3.5 kV, and the source temperature was maintained at 140 °C. Nitrogen was used as the nebulizer gas. Sensitive reactions were performed under nitrogen. Commercial solvents were used without any pretreatment. Preparative HPLC purifications were carried out using a Shandon Hyperprep column: C18 base deactivated silica (BDS), 8 μm, 250 g, I.D. 5 cm, and eluting with a gradient of three subsequent mobile phases (phase A, a 0.25% NH<sub>4</sub>HCO<sub>3</sub> solution in water; phase B, CH<sub>3</sub>OH; phase C, CH<sub>3</sub>CN).</div><div class="NLM_p">In general, final compounds obtained as solids were triturated with diisopropylether (DIPE). Alternatively, some compounds were precipitated and isolated as HCl salt by dissolving them in diethylether, followed by the addition of a 1N HCl solution in diethylether.</div><div class="NLM_p last">Compounds <b>3</b><a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and <b>4</b><a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a> were synthesized according to literature procedures.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-(2-Methoxy-4-nitro-phenyl)-4-methyl-1<i>H</i>-imidazole (<b>7a</b>)</h3><div class="NLM_p last">A mixture of 1-chloro-2-methoxy-4-nitrobenzene (150 g, 0.8 mol), 4-methyl-1<i>H</i>-imidazole (131.3 g, 1.6 mol), and K<sub>2</sub>CO<sub>3</sub> (110.5 g, 0.8 mol) in DMSO (1.5 L) was reacted in an autoclave under a N<sub>2</sub> atmosphere for 6 h at 150 °C. The reaction mixture was poured into ice–water (6 L). The solid was filtered and washed with water, and then it was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and further washed with water. The residue was partitioned between CH<sub>2</sub>Cl<sub>2</sub> and water. The organic layer was dried over MgSO<sub>4</sub>, filtered, and then the filtrate was concentrated. The residue was purified by chromatography over silica gel (eluent: CH<sub>2</sub>Cl<sub>2</sub>/methanol 100/0 to 97/3). The desired fractions were collected and the solvent was evaporated. The residue was triturated in DIPE, filtered off and dried to give 48.5 g (26%) of <b>7a</b>; mp 136.9 °C. 1H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 2.17 (s, 3 H), 3.99 (s, 3 H), 7.31 (s, 1 H), 7.70 (d, <i>J</i> = 8.4 Hz, 1 H), 7.95 (dd, <i>J</i> = 8.8, 2.5 Hz, 1 H), 7.97–8.01 (m, 2 H). MS (ESI) <i>m</i>/<i>z</i> 234 [M + H]<sup>+</sup>.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 3-Methoxy-4-(4-methyl-imidazol-1-yl)-phenylamine (<b>8a</b>)</h3><div class="NLM_p last">To a solution of <b>7a</b> (48.5 g, 0.21 mol) in MeOH (1 L) was added Pd/C (10%, 5.0 g), and the resulting suspension was stirred at 50 °C under an atmospheric pressure of H<sub>2</sub> overnight, until 3 equiv of H<sub>2</sub> were absorbed. The catalyst was filtered over dicalite. The filtrate was concentrated, and the resulting residue was suspended in DIPE and stirred for 1 h. The solid was filtered and dried to yield 39.9 g (94%) of <b>8a</b>; mp 128.3 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 2.10 (s, 3 H), 3.67 (s, 3 H), 5.37 (br s, 2 H), 6.17 (dd, <i>J</i> = 8.0, 2.2 Hz, 1 H), 6.34 (d, <i>J</i> = 2.2 Hz, 1 H), 6.88 (s, 1 H), 6.91 (d, <i>J</i> = 8.4 Hz, 1 H), 7.49 (d, <i>J</i> = 1.4 Hz, 1 H). MS (ESI) <i>m</i>/<i>z</i> 204 [M + H]<sup>+</sup>.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-Methoxy-5-(4-methyl-imidazol-1-yl)-pyridin-2-ylamine (<b>8b</b>)</h3><div class="NLM_p last">A solution of <i>tert</i>-butyl (5-iodo-4-methoxy-pyridin-2-yl)-carbamate (1.2 g, 3.4 mmol), K<sub>2</sub>CO<sub>3</sub> (947 mg, 6.9 mmol), 4-methyl-1<i>H</i>-imidazole (394 mg, 4.8 mmol), CuI (653 mg, 3.4 mmol), and 1,10-phenanthroline (618 mg, 3.4 mmol) in DMF (15 mL) was degassed and stirred for 6 days at 120 °C. The reaction mixture was cooled to room temperature and filtered through dicalite. The filtrate was concentrated, and the residue was dissolved in EtOAc and washed with a saturated aqueous NaHCO<sub>3</sub> solution and brine. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude residue was purified via reversed phase HPLC to provide 120 mg (17%) of <b>8b</b>. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ (ppm) 2.28 (s, 3 H), 3.82 (s, 3 H), 4.65 (br s, 2 H), 6.09 (s, 1 H), 6.79 (br s, 1 H), 7.52 (br s, 1 H), 7.89 (br s, 1 H). MS (ESI) <i>m</i>/<i>z</i> 205 [M + H]<sup>+</sup>.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 5-Methoxy-6-(4-methyl-imidazol-1-yl)-pyridin-3-ylamine (<b>8c</b>)</h3><div class="NLM_p last">Na<sub>2</sub>CO<sub>3</sub> (528 mg, 5 mmol) and 4-methyl-1<i>H</i>-imidazole (409 mg, 5 mmol) were added to a solution of 2-chloro-3-methoxy-5-nitro-pyridine (940 mg, 5 mmol) in DMF (10 mL). The reaction mixture was stirred at 100 °C for 16 h, and then it was cooled to room temperature and the solvent was evaporated under reduced pressure. The residue was dissolved in EtOAc and was washed with water. The water layer was extracted with EtOAc, and the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude residue (<b>7c</b>) was added to a suspension of iron powder (835 mg, 15 mmol) in acetic acid (10 mL). The reaction mixture was stirred at 60 °C for 1 h, after which the solvent was evaporated. The residue was dissolved in EtOAc and washed with a saturated aqueous solution of NaHCO<sub>3</sub> and brine. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated to provide 245 mg (21%) of <b>8c</b>, which was used as such in the next reaction. MS (ESI) <i>m</i>/<i>z</i> 205 [M + H]<sup>+</sup>.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 5-(4-Methyl-imidazol-1-yl)-pyridin-2-ylamine (<b>8d</b>)</h3><div class="NLM_p last">CuI (8.26 g, 43.4 mmol) was added to a solution of Cs<sub>2</sub>CO<sub>3</sub> (9.4 g, 28.9 mmol), 4-methyl-1<i>H</i>-imidazole (5.9 g, 72.3 mmol), and 5-bromo-pyridin-2-ylamine (5 g, 29 mmol) in DMSO (100 mL). The reaction mixture was stirred at 130 °C for 2 days, after which it was cooled to room temperature, triturated in acetonitrile, and filtered. The filtrate was concentrated, and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was washed with water, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by flash column chromatography over silica gel (eluent: CH<sub>2</sub>Cl<sub>2</sub>/(7N NH<sub>3</sub> in MeOH), 100/0 to 96/4) to provide 160 mg of <b>8d</b>. The water layer was concentrated until a precipitate started to form. The solid was filtered, yielding an additional 628 mg of <b>8d</b> (15% overall yield) as a single regioisomer. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ (ppm) 2.29 (s, 3 H), 4.68 (br s, 2 H), 6.58 (d, <i>J</i> = 8.8 Hz, 1 H), 6.87 (s, 1 H), 7.42 (dd, <i>J</i> = 8.8, 2.56 Hz, 1 H), 7.60 (s, 1 H), 8.11 (d, <i>J</i> = 2.9 Hz, 1 H). MS (ESI) <i>m</i>/<i>z</i> 175 [M + H]<sup>+</sup> .</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 6-(4-Methyl-imidazol-1-yl)-pyridin-3-ylamine (<b>8e</b>)</h3><div id="sec6_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Step 1. Synthesis of 5-Bromo-2-(4-methyl-imidazol-1-yl)-pyridine</h4><div class="NLM_p last">K<sub>2</sub>CO<sub>3</sub> (8.8 g, 63 mmol) and 4-methyl-1<i>H</i>-imidazole (3.5 g, 42 mmol) were added to a solution of 2,5-dibromo-pyridine (5 g, 21 mmol) in <i>N</i>-methyl-2-pyrrolidone (50 mL). The reaction mixture was stirred at 85 °C for 16 h, and then it was cooled to room temperature and partitioned between CH<sub>2</sub>Cl<sub>2</sub> and water. The two layers were separated, and the organic layer was dried over MgSO<sub>4</sub> and concentrated under reduced pressure (85 °C at 10 mmHg) to provide 3.3 g (62%) of the title compound as a mixture of regioisomers (85/10). MS (ESI) <i>m</i>/<i>z</i> 238 [M + H]<sup>+</sup>.</div></div><div id="sec6_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Step 2. Synthesis of <b>8e</b></h4><div class="NLM_p last">A 250 mL stainless steel autoclave was charged with a solution of the intermediate from step 1 (2.8 g, 12 mmol) in THF (10 mL). Ammonia (90 mL) and Cu<sub>2</sub>O (90 mg, 0.6 mmol) were added. The autoclave was closed, and the reaction mixture was stirred and heated at 150 °C for 18 h. The mixture was allowed to cool to room temperature and extracted three times with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified via reversed phase HPLC to provide 250 mg (12%) of <b>8e</b>. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ (ppm) 2.29 (d, <i>J</i> = 1.1 Hz, 3 H), 3.76 (br s, 2 H), 7.11 (d, <i>J</i> = 1.1 Hz, 1 H), 7.11 (s, 1 H), 7.22–7.24 (m, 1 H), 7.93 (dd, <i>J</i> = 2.2, 1.5 Hz, 1 H), 8.07 (d, <i>J</i> = 1.5 Hz, 1 H). MS <i>m</i>/<i>z</i> 175 [M + H]<sup>+</sup>.</div></div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 3-Fluoro-4-(4-methyl-imidazol-1-yl)-phenylamine (<b>8f</b>)</h3><div id="sec6_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Step 1. Synthesis of 1-(2-Fluoro-4-nitro-phenyl)-4-methyl-1<i>H</i>-imidazole (<b>7f</b>)</h4><div class="NLM_p last">K<sub>2</sub>CO<sub>3</sub> (15.3 g, 111 mmol) and 4-methyl-1<i>H</i>-imidazole (9.1 g, 111 mmol) were added to a solution of 3,4-difluoro-nitrobenzene (15 g, 92 mmol) in DMF (200 mL). The reaction mixture was stirred at 125 °C for 4 h. The reaction mixture was cooled down to room temperature, diluted with water, and extracted with EtOAc. The organic layer was dried over MgSO<sub>4</sub> and concentrated. The residue was purified via reversed phase. The desired fractions were collected, and the solvent was evaporated and coevaporated with methanol, yielding 13 g (64%) of <b>7f</b>. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ (ppm) 2.32 (s, 3 H), 7.01–7.17 (m, 1 H), 7.51–7.66 (m, 1 H), 7.88 (s, 1 H), 8.08–8.28 (m, 2 H). MS (ESI) <i>m</i>/<i>z</i> 222 [M + H]<sup>+</sup>.</div></div><div id="sec6_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Step 2. Synthesis of <b>8f</b></h4><div class="NLM_p last">Intermediate <b>7f</b> (7.5 g, 34 mmol) and 1 mL of 4% thiophene solution in DIPE were added to a solution of 1 g of palladium on carbon (10% Pd) in methanol (150 mL). The reaction mixture was stirred at 25 °C under hydrogen atmosphere until 3 equiv of H<sub>2</sub> were absorbed. The catalyst was removed by filtration over dicalite. The filtrate was concentrated, and the residue was triturated in heptane, filtered, and dried in vacuo to 6.4 g (100% yield) of <b>7f</b>, which was used as such in the next step. MS (ESI) <i>m</i>/<i>z</i> 192 [M + H]<sup>+</sup>.</div></div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1-(4-Bromo-2-methoxy-phenyl)-4-methyl-1<i>H</i>-imidazole (<b>11</b>)</h3><div class="NLM_p last">A solution of <b>8a</b> (20.0 g, 98.4 mmol) in AcOH (200 mL) was added at 10 °C to a stirred solution of NaNO<sub>2</sub> (7.47 g, 108 mmol) in concd H<sub>2</sub>SO<sub>4</sub> (160 mL) at such a rate that the temperature of the reaction was maintained below 10 °C. After addition was completed, the resulting mixture was stirred at room temperature for 30 min before being added dropwise to a stirred solution of CuBr (28.2 g, 197 mmol) in 48% HBr (200 mL). The ensuing reaction was stirred for 1 h and then diluted with ice–water (1 L). The resulting white precipitate was filtered, washed with water, and then suspended in a biphasic mixture of CH<sub>2</sub>Cl<sub>2</sub> and saturated aqueous Na<sub>2</sub>CO<sub>3</sub> solution (1:1). The resulting slurry was filtered over dicalite. The layers were separated, and the organic layer was washed with a diluted ammonia solution. The organic phase was dried over MgSO<sub>4</sub>, filtered, and concentrated to give a first batch of <b>11</b> (8.1 g) as a brown solid. The aqueous filtrate was brought to pH = 10 by addition of solid Na<sub>2</sub>CO<sub>3</sub> and then extracted 3 times with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic extracts were washed with diluted ammonia until the disappearance of the blue color of the water phase. The organic phase was dried over MgSO<sub>4</sub> and filtered. The first batch of <b>11</b> was added to the filtrate, which was concentrated to give 24.0 g of the title compound (91.3%) as a brown solid; mp 69.4–70.7 °C. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ (ppm) 2.27 (s, 3 H), 3.83 (s, 3 H), 6.84–6.89 (m, 1 H), 7.10 (dd, <i>J</i> = 7.3, 1.1 Hz, 1 H), 7.13 (d, <i>J</i> = 1.8 Hz, 1 H), 7.15 (s, 1 H), 7.63 (d, <i>J</i> = 1.4 Hz, 1 H). MS (ESI) <i>m</i>/<i>z</i> 267 [M + H]<sup>+</sup>.</div></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 6-Bromo-2-methoxy-pyridin-3-ylamine (<b>12</b>)</h3><div class="NLM_p last">NaOCH<sub>3</sub> (176 g, 3.3 mol) was added portionwise to a solution of 3-amino-2,6-dibromopyridine (100 g, 0.4 mol) in 1,4-dioxane (1 L), and the resulting mixture was refluxed for 3 h. The reaction mixture was then allowed to cool to room temperature, after which it was poured into an aqueous saturated NH<sub>4</sub>Cl solution (2 L). After stirring for 30 min, diethyl ether (2 L) was added and the bilayer was stirred for 30 min. The layers were separated, and the aqueous layer was diluted with water (1.5 L) and then extracted with diethyl ether (6 × 500 mL). The combined organic layers were washed brine (2 × 500 mL), dried over MgSO<sub>4</sub>, and concentrated. The residue was purified by silica gel chromatography (eluent: CH<sub>2</sub>Cl<sub>2</sub>) to provide 67 g (78%) of <b>12</b>, as a brown–orange solid. GC-MS <i>m</i>/<i>z</i> 202.</div></div><div id="sec6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 6-Bromo-2-methoxy-3-(4-methyl-imidazol-1-yl)-pyridine (<b>13</b>)</h3><div id="sec6_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Step 1. Synthesis of <i>N</i>-(6-Bromo-2-methoxy-pyridin-3-yl)-formamide</h4><div class="NLM_p last">A mixture of formic acid (12.8 mL, 340 mmol) and acetic acid anhydride (8.54 mL, 91 mmol) was stirred at room temperature for 40 min. Subsequently, a solution of 3-amino-6-bromo-2-methoxy-pyridine (<b>12</b>) (5.0 g, 24.6 mmol) in THF (30 mL) was added dropwise, and the resulting reaction mixture was stirred overnight at 60 °C. The mixture was cooled and poured into ice–water. The resulting solid was filtered, washed with water, and dried to give 5.2 g (76%) of the title compound, which was used as such in the next step. MS (ESI) <i>m</i>/<i>z</i> 231 [M + H]<sup>+</sup></div></div><div id="sec6_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Step 2. Synthesis of <i>N</i>-(6-Bromo-2-methoxy-pyridin-3-yl)-<i>N</i>-(2-oxo-propyl)-formamide</h4><div class="NLM_p last">1-Chloro-propan-2-one (4.34 g, 46.9 mmol) was added dropwise to a mixture of <i>N</i>-(6-bromo-2-methoxy-pyridin-3-yl)-formamide (5.2 g, 18.8 mmol), KI (0.34 g, 2.0 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (21.4 g, 66 mmol) in DMF (50 mL). The reaction mixture was stirred at room temperature overnight, and then it was poured into ice–water and extracted with EtOAc. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was triturated with DIPE, filtered, and dried to give 4.43 g (82%) of the title compound. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ (ppm) 2.18 (s, 3 H), 4.00 (s, 3 H), 4.48 (s, 2 H), 7.14 (d, <i>J</i> = 8.0 Hz, 1 H), 7.49 (d, <i>J</i> = 8.0 Hz, 1 H), 8.23 (s, 1 H). GC-MS <i>m</i>/<i>z</i> 286.</div></div><div id="sec6_11_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Step 3. Synthesis of <b>13</b></h4><div class="NLM_p last"><i>N</i>-(6-Bromo-2-methoxy-pyridin-3-yl)-<i>N</i>-(2-oxo-propyl)-formamide (4.4 g, 15.3 mmol) was added to a mixture of NH<sub>4</sub>OAc (5.41 g, 70.2 mmol) in AcOH (50 mL). The reaction mixture was heated at reflux for 1 h, and then it was cooled to room temperature and poured into ice–water. The mixture was brought to pH 9 via the addition of an aqueous NaOH solution (50% w/v), and then it was extracted with EtOAc. The organic layer was separated, dried over MgSO<sub>4</sub>, filtered, and concentrated to give 3.0 g (73%) of <b>13</b> as a solid, which was used as such in the next step. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ (ppm) 2.29 (s, 3 H), 4.03 (s, 3 H), 6.92 (t, <i>J</i> = 1.1 Hz, 1 H), 7.17 (d, <i>J</i> = 8.0 Hz, 1 H), 7.40 (d, <i>J</i> = 7.7 Hz, 1 H), 7.73 (d, <i>J</i> = 1.4 Hz, 1 H). MS (ESI) <i>m</i>/<i>z</i> 268 [M + H]<sup>+</sup>.</div></div></div><div id="sec6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 6-Methoxy-5-(4-methyl-imidazol-1-yl)-pyridin-2-ylamine (<b>14</b>)</h3><div class="NLM_p last">Cu<sub>2</sub>O (166 mg, 1.16 mmol) and ammonia (24 mL) were added to a solution of <b>13</b> (3.12 g, 11.64 mmol) in ethylene glycol (25 mL). The mixture was stirred at 100 °C during 16 h. It was then cooled, diluted with water, and extracted with EtOAc. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The residue was triturated with DIPE to yield 1.51 g (63%) of <b>14</b> as a light-brown solid. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ (ppm) 2.28 (s, 3 H), 3.89 (s, 3 H), 4.45 (br s, 2 H), 6.10 (d, <i>J</i> = 8.0 Hz, 1 H), 6.80 (s, 1 H), 7.29 (d, <i>J</i> = 8.0 Hz, 1 H), 7.55 (s, 1 H). MS (ESI) <i>m</i>/<i>z</i> 205 [M + H]<sup>+</sup>.</div></div><div id="sec6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 8-Bromo-2-(4-fluoro-phenyl)-imidazo[1,2-a]pyridine (<b>17a</b>)</h3><div class="NLM_p last">A solution of 2-amino-3-bromopyridine (50.0 g, 0.29 mol) and 4-fluorophenacyl bromide (75.3 g, 0.35 mol) in ethanol (300 mL) was stirred at reflux temperature for 17 h. After this time, the reaction mixture was cooled to room temperature. The resulting precipitate was filtered, and the filtrate was partially concentrated to result in a second crop of precipitate. The combined precipitates were triturated with acetonitrile and ethanol. The resulting solid was suspended in a saturated aqueous solution of NaHCO<sub>3</sub> (500 mL) and stirred for 30 min. Then, the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was recrystallized from EtOAc, to provide 46.5 g (55%) of <b>17a</b> as a white solid; mp 165.3 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 6.83 (t, <i>J</i> = 6.9 Hz, 1 H), 7.29 (m, 2 H), 7.60 (d, <i>J</i> = 7.3 Hz, 1 H) 8.02 (m, <i>J</i> = 5.8 Hz, 2 H) 8.53 (s, 1 H) 8.56 (d, <i>J</i> = 7.0 Hz, 1 H). MS (ESI) <i>m</i>/<i>z</i> 291 [M + H]<sup>+</sup>.</div></div><div id="sec6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-(4-Fluoro-phenyl)-4-nitro-1<i>H</i>-benzimidazole (<b>19a</b>, R = 4-F-Ph, R′ = H)</h3><div id="sec6_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Step 1 Synthesis of <i>N</i>-(2-amino-3-nitro-phenyl)-4-fluoro-benzamide</h4><div class="NLM_p last">A solution of 1,2-diamino-3-nitrobenzene (1.53 g, 10 mmol), triethylamine (2.78 mL, 20 mmol), and 4-fluorobenzoyl chloride (1.58 g, 10 mmol) in a mixture of CH<sub>2</sub>Cl<sub>2</sub>/acetonitrile (2/1, 75 mL) was stirred at room temperature for 2 h. After this time, the reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and washed with water (20 mL). The two layers were separated, and the organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated. The resulting residue triturated with DIPE to give 2.3 g (83%) of the title compound; mp 181.5 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 6.70 (dd, <i>J</i> = 8.6, 7.5 Hz, 1 H), 7.21 (s, 2 H), 7.32–7.42 (m, 2 H), 7.48 (dd, <i>J</i> = 7.3, 1.1 Hz, 1 H), 7.99 (dd, <i>J</i> = 8.8, 1.4 Hz, 1 H), 8.05–8.16 (m, 2 H), 9.89 (s, 1 H). MS (ESI) <i>m</i>/<i>z</i> 551 [2M + H]<sup>+</sup>.</div></div><div id="sec6_14_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Step 2. Synthesis of <b>19a</b></h4><div class="NLM_p last">A solution of <i>N</i>-(2-amino-3-nitro-phenyl)-4-fluoro-benzamide (1.35 g, 5.0 mmol) and concd aq HCl (0.5 mL, 6.0 mmol) in acetic acid (15.0 mL) was submitted to microwave irradiation at 150 °C, for 30 min. The reaction mixture was cooled to room temperature, and the product precipitated upon cooling. The precipitate was filtered, washed with acetic acid and DIPE, and then dried to provide 1.00 g (69%) of <b>19a</b> as HCl salt. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 6.82 (br. s, 2 H), 7.36–7.58 (m, 3 H), 8.16 (t, <i>J</i> = 8.0 Hz, 2 H), 8.37–8.56 (m, 2 H). MS (ESI) <i>m</i>/<i>z</i> 258 [M + H]<sup>+</sup>.</div></div></div><div id="sec6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 2-(4-Fluoro-phenyl)-1-methyl-1<i>H</i>-benzimidazol-4-ylamine (<b>20b</b>, R = 4-F-Ph, R′ = Me)</h3><div id="sec6_15_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Step 1. Synthesis of 2-(4-Fluoro-phenyl)-1-methyl-4-nitro-1<i>H</i>-benzimidazole</h4><div class="NLM_p last">A solution of lithium hexamethyldisilazide (1 M in THF, 2.96 mL, 2.96 mmol) was added dropwise at 0 °C to a solution of <b>19</b> (290 mg, 0.99 mmol) in THF (10 mL) under a flow of nitrogen, and the resulting mixture was stirred at this temperature for 30 min. Then CH<sub>3</sub>I (92 μL, 1.48 mmol) was added and the resulting mixture was stirred at 55 °C for 12 h. The reaction was quenched with brine. The organic layer was separated, dried over MgSO<sub>4</sub>, filtered, and concentrated. The resulting residue was triturated with a DIPE/2-propanol mixture. The precipitate was filtered and dried to provide 160 mg (60%) of the title compound. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 3.97 (s, 3 H), 7.41–7.55 (m, 3 H), 7.93–8.02 (m, 2 H), 8.12 (ddd, <i>J</i> = 12.9, 8.1, 0.8 Hz, 2 H). MS (ESI) <i>m</i>/<i>z</i> 272 [M + H]<sup>+</sup>.</div></div><div id="sec6_15_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Step 2. Synthesis of <b>20b</b></h4><div class="NLM_p last">Iron (812 mg, 14.5 mmol) was added to a solution of 2-(4-fluoro-phenyl)-1-methyl-4-nitro-1<i>H</i>-benzimidazole (750 mg, 2.76 mmol) in AcOH (50 mL), and the resulting mixture was mechanically stirred at 60 °C for 1 h. After this time, the solvent was removed under reduced pressure. The resulting residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and washed with a saturated aqueous solution of NaHCO<sub>3</sub> and then brine. The organic layer was separated, active charcoal and MgSO<sub>4</sub> were added, and the resulting mixture stirred at room temperature for 20 min. Filtration over dicalite, followed by concentration of the filtrate, yielded 250 mg (37%) of <b>20b</b>. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 3.77 (s, 3 H), 6.41 (d, <i>J</i> = 7.3 Hz, 1 H), 6.73 (d, <i>J</i> = 8.0 Hz, 1 H), 6.98 (t, <i>J</i> = 7.9 Hz, 1 H), 7.37–7.43 (m, 2 H), 7.84–7.90 (m, 2 H). MS (ESI) <i>m</i>/<i>z</i> 242 [M + H]<sup>+</sup>.</div></div></div><div id="sec6_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 3-Bromo-<i>N</i>1-methyl-benzene-1,2-diamine (<b>22</b>)</h3><div class="NLM_p last">A solution of methylamine in ethanol (8M, 100 mL, 0.8 mol) was added at 0–5 °C to 1-bromo-3-fluoro-2-nitro-benzene (19.8 g, 90 mmol). The mixture was stirred overnight at room temperature, and then the solvent was evaporated and the residue was partitioned between water and CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated to provide 20 g (96%) of crude (3-bromo-2-nitro-phenyl)-methyl-amine, which was dissolved in HOAc (150 mL). Iron powder (15 g, 269 mmol) was added, and the resulting suspension was stirred and heated at 60 °C for 1 h. The reaction mixture was concentrated in vacuo, and the residue was partitioned between CH<sub>2</sub>Cl<sub>2</sub> and a saturated aqueous NaHCO<sub>3</sub> solution. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated to give 14 g (80%) of <b>22</b>, which was used as such in the next step. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ (ppm) 2.87 (s, 3 H), 3.73 (br s, 3 H), 6.60 (dd, <i>J</i> = 7.8, 1.3 Hz, 1 H), 6.71 (t, <i>J</i> = 8.1 Hz, 1 H), 6.95 (dd, <i>J</i> = 8.1, 1.1 Hz, 1 H). GC-MS <i>m</i>/<i>z</i> 200.</div></div><div id="sec6_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 4-Bromo-2-(4-fluoro-phenyl)-1-methyl-1<i>H</i>-benzimidazole (<b>23a</b>, R = 4-F-Ph, R′ = Me)</h3><div class="NLM_p last">4-Fluoro-benzoylchloride (5.5 g, 34.7 mmol) was added at room temperature to a solution of <b>22</b> (10.0 g, 39.8 mmol) and triethylamine (8.05 g, 79.6 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (250 mL), and the resulting mixture was stirred for 15 h. The reaction mixture was quenched with water, and the two layers were separated. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was dissolved in HOAc (100 mL), and concd aq HCl (3 mL), and the resulting solution was stirred for 2 h at 100 °C. The solvent was removed by evaporation, and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and washed with a saturated aqueous NaHCO<sub>3</sub> solution. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was triturated with DIPE/2-propanol and then filtered to give 6.8 g (64%) of <b>23a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 3.88 (s, 3 H), 7.24 (t, <i>J</i> = 7.7 Hz, 1 H), 7.40–7.47 (m, 2 H), 7.49 (dd, <i>J</i> = 7.7, 0.8 Hz, 1 H), 7.66 (dd, <i>J</i> = 8.1, 0.8 Hz, 1 H), 7.90–7.97 (m, 2 H). MS (ESI) <i>m</i>/<i>z</i> 305 [M + H]<sup>+</sup> .</div></div><div id="sec6_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 3-Bromo-2-nitro-benzaldehyde (<b>26</b>)</h3><div class="NLM_p last">A mixture of 3-bromo-2-nitrotoluene (10 g, 46.3 mmol), <i>N</i>,<i>N</i>-dimethylformamide dimethyl acetal (16.5 g, 139 mmol), and pyrrolidine (3.3 g, 46.3 mmol) was heated at 115 °C for 22 h. The reaction mixture was cooled to 0 °C, and a cooled solution of NaIO<sub>4</sub> (29.7 g, 139 mmol) in DMF (75 mL) and water (100 mL) was added dropwise. After the addition, the reaction mixture was allowed to warm to room temperature. The suspension was filtered on dicalite and washed with EtOAc (400 mL). The filtrate was washed with water (2 × 150 mL), and the organic layer was concentrated. The residue was purified by flash chromatography over silica gel (eluent: heptane/CH<sub>2</sub>Cl<sub>2</sub> 1/1 to 0/1). The product fractions were collected, and the solvent was evaporated to give 2.72 g (20%) of <b>26a</b>, which was used as such in the next step. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ ppm 7.59 (t, <i>J</i> = 7.9 Hz, 1 H), 7.92–7.96 (m, 2 H), 9.90 (s, 1 H).</div></div><div id="sec6_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 7-Bromo-2-(3-methoxy-phenyl)-2<i>H</i>-indazole (<b>28b</b>, R = 3-CH<sub>3</sub>O-Ph, R′ = H)</h3><div id="sec6_19_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Step 1. Synthesis of (3-Bromo-2-nitro-benzyl)-(3-methoxy-phenyl)-amine</h4><div class="NLM_p last">To a solution of 3-bromo-2-nitro-benzaldehyde (5.5 g, 23.9 mmol), 3-methoxy-aniline (2.94 g, 23.9 mmol), and HOAc (7.18 g, 119 mmol) in 1,2-dichloroethane (60 mL) was added sodium triacetoxyborohydride (7.6 g, 35.8 mmol). The reaction mixture was stirred for 3 h at room temperature. The reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with an aqueous 10% K<sub>2</sub>CO<sub>3</sub> solution and brine. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified via reversed phase HPLC. The desired fraction was collected and the solvent was evaporated, yielding 5.68 g (70%) of the title compound. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ (ppm) 3.75 (s, 3 H), 4.18 (br s, 1 H), 4.38 (s, 2 H), 6.11 (t, <i>J</i> = 2.4 Hz, 1 H), 6.19 (ddd, <i>J</i> = 8.1, 2.4, 0.9 Hz, 1 H), 6.27–6.36 (m, 1 H), 7.08 (t, <i>J</i> = 8.1 Hz, 1 H), 7.31 (t, <i>J</i> = 8.1 Hz, 1 H), 7.48–7.64 (m, 2 H). MS (ESI) <i>m</i>/<i>z</i> 337 [M + H]<sup>+</sup>.</div></div><div id="sec6_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Step 2. Synthesis of <b>28b</b></h4><div class="NLM_p last">To a solution of (3-bromo-2-nitro-benzyl)-(3-methoxy-phenyl)-amine (5.68 g, 16.8 mmol) in EtOH (100 mL) was added tin chloride dihydrate (7.6 g, 34 mmol). The reaction mixture was stirred at 40–60 °C overnight. The solvent was evaporated, and CH<sub>2</sub>Cl<sub>2</sub> was added together with a small amount of water. The mixture was filtered on dicalite, and the filtrate was washed with water. The water layer was extracted with CH<sub>2</sub>Cl<sub>2</sub>, and the organic layer was dried over MgSO<sub>4</sub> and concentrated. The residue was purified by flash chromatography on silica gel (eluent: heptane/CH<sub>2</sub>Cl<sub>2</sub> 40/60 to 0/100) to yield 3.63 g (71%) of <b>27b</b>. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ (ppm) 3.92 (s, 3 H), 6.92–7.04 (m, 2 H), 7.39–7.50 (m, 2 H), 7.51–7.59 (m, 2 H), 7.67 (d, <i>J</i> = 8.4 Hz, 1 H), 8.49 (s, 1 H). MS (ESI) <i>m</i>/<i>z</i> 303 [M + H]<sup>+</sup>.</div></div></div><div id="sec6_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 7-Bromo-2-(3-methoxy-phenyl)-3-methyl-2<i>H</i>-indazole (<b>29c</b>, R = 3-CH<sub>3</sub>O-Ph, R′ = Me)</h3><div class="NLM_p last">A 2 M LDA-solution in THF (7.4 mL, 14.8 mmol) was added dropwise to a solution of <b>28b</b> (3 g, 9.9 mmol) in THF (50 mL) at −78 °C. The reaction mixture was allowed to warm up to 0 °C, stirred at 0 °C for 5 min, and then cooled again to −78 °C. CH<sub>3</sub>I (0.92 mL, 14.8 mmol) was added, and the reaction mixture was allowed to warm up to room temperature. After stirring for 16 h, water was added and the water layer was extracted with diethyl ether. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by flash chromatography on silica gel (eluent: heptane/CH<sub>2</sub>Cl<sub>2</sub> 50/50 to 0/100) to yield 2.2 g (70%) of <b>29c</b>. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.64 (s, 3 H), 3.85 (s, 3 H), 6.98 (dd, <i>J</i> = 8.4, 7.3 Hz, 1 H), 7.10–7.19 (m, 1 H), 7.20–7.29 (m, 2 H), 7.48–7.56 (m, 1 H), 7.58 (d, <i>J</i> = 7.3 Hz, 1 H), 7.81 (d, <i>J</i> = 8.4 Hz, 1 H). MS (ESI) <i>m</i>/<i>z</i> 317 [M + H]<sup>+</sup>.</div></div><div id="sec6_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>N</i>-(2,6-Dibromo-phenyl)-3-methyl-butyramide (<b>37d</b>, R = <i>i</i>-Bu)</h3><div class="NLM_p last">Isovaleryl chloride (2.9 mL, 23.9 mmol) was added at room temperature to a solution of 2,6-dibromoaniline (2.00 g, 7.98 mmol) in THF (30 mL). The reaction mixture was stirred at room temperature overnight, and then it was diluted with EtOAc and the organic phase was washed with a saturated aqueous NaHCO<sub>3</sub> solution, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was triturated with heptane, filtered, extensively washed with heptanes, and then dried to yield 2.19 g (82%) of <b>37d</b>. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ (ppm) 1.09 (d, <i>J</i> = 6.2 Hz, 6 H), 2.16–2.41 (m, 3 H), 6.97 (br s, 1 H), 7.03 (t, <i>J</i> = 8.1 Hz, 1 H), 7.59 (d, <i>J</i> = 8.1 Hz, 2 H). MS (ESI) <i>m</i>/<i>z</i> 334 [M + H]<sup>+</sup> .</div></div><div id="sec6_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 4-Bromo-2-isobutyl-benzooxazole (<b>38d</b>, R = <i>i</i>-Bu)</h3><div class="NLM_p last">A mixture of <b>37d</b> (0.21 g, 0.63 mmol), CuI (12 mg, 0.063 mmol), Cs<sub>2</sub>CO<sub>3</sub> (0.31 g, 0.94 mmol), and 1,10-phenantroline (23 mg, 0.125 mmol) in DME (3 mL) was stirred at 90 °C in a sealed tube overnight. The mixture was partitioned between water and CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by flash column chromatography over silica gel (eluent: heptane/CH<sub>2</sub>Cl<sub>2</sub>, 30/70) to give 110 mg (69%) of <b>38d</b>. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ (ppm) 1.04 (d, <i>J</i> = 6.6 Hz, 6 H), 2.23–2.42 (m, 1 H), 2.85 (d, <i>J</i> = 7.3 Hz, 2 H), 7.18 (t, <i>J</i> = 8.1 Hz, 1 H), 7.44 (d, <i>J</i> = 8.1 Hz, 1 H), 7.48 (d, <i>J</i> = 8.1 Hz, 1 H). MS ESI <i>m</i>/<i>z</i> 254 [M + H]<sup>+</sup>.</div></div><div id="sec6_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> [2-(4-Fluoro-phenyl)-imidazo[1,2-<i>a</i>]pyridin-8-yl]-[3-methoxy-4-(4-methyl-imidazol-1-yl)-phenyl]-amine (<b>40a</b>)</h3><div class="NLM_p last">Sodium <i>tert</i>-butoxide (0.77 g, 8 mmol), BINAP (93 mg, 0.15 mmol), Pd(OAc)<sub>2</sub> (22 mg, 0.1 mmol), and <b>8a</b> (0.72 g, 3 mmol) were added to a solution of <b>17a</b> (0.58 g, 2 mmol) in toluene (15 mL), and the mixture was purged with N<sub>2</sub> for 5 min. The reaction mixture was stirred and heated at 100 °C overnight under a N<sub>2</sub> atmosphere. The reaction mixture was cooled to room temperature, water was added, and the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified via reversed phase HPLC. The desired fraction were collected, and the solvent was evaporated. The residue was crystallized from CH<sub>3</sub>CN/DIPE. The solid was collected and dried to give 0.42 g (51%) of <b>40a</b>; mp 209.2 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 2.15 (s, 3 H), 3.80 (s, 3 H), 6.80 (t, <i>J</i> = 6.9 Hz, 1 H), 6.98–7.08 (m, 3 H), 7.22–7.34 (m, 4 H), 7.68 (d, <i>J</i> = 1.4 Hz, 1 H), 8.01–8.10 (m, 3 H), 8.38 (s, 1 H), 8.46 (s, 1 H). MS (ESI) <i>m</i>/<i>z</i> 414 [M + H]<sup>+</sup>. HRMS calcd for C<sub>24</sub>H<sub>21</sub>FN<sub>5</sub>O (M + H)<sup>+</sup>, 414.1730, found, 414.1739.</div></div><div id="sec6_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> [2-(4-Fluoro-phenyl)-1-methyl-1<i>H</i>-benzoimidazol-4-yl]-[3-methoxy-4-(4-methyl-imidazol-1-yl)-phenyl]-amine (<b>41 b</b>)</h3><div class="NLM_p last">Compound <b>41b</b> was prepared starting from <b>11</b> and <b>20b</b> in a manner identical to the preparation of <b>40a</b>. The crude residue was purified via column chromatography on silica gel [eluent: CH<sub>2</sub>Cl<sub>2</sub>/(7N NH<sub>3</sub> in MeOH), 100/0 to 97/3)] to give <b>41b</b> in 63% yield; mp 130.9 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 2.14 (s, 3 H), 3.74 (s, 3 H), 3.86 (s, 3 H), 6.93 (dd, <i>J</i> = 8.5, 2.2 Hz, 1 H), 7.01 (s, 1 H), 7.12–7.23 (m, 5 H), 7.43 (t, <i>J</i> = 8.8 Hz, 2 H), 7.63 (d, <i>J</i> = 1.3 Hz, 1 H), 7.92 (dd, <i>J</i> = 8.6, 5.5 Hz, 2 H), 8.46 (s, 1 H). MS (ESI) <i>m</i>/<i>z</i> 428 [M + H]<sup>+</sup>. Anal. (C<sub>25</sub>H<sub>22</sub>FN<sub>5</sub>O) C, H, N. HRMS calcd for C<sub>25</sub>H<sub>23</sub>FN<sub>5</sub>O (M + H)<sup>+</sup>, 428.1886; found, 428.1882.</div></div><div id="sec6_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> [2-(3-Methoxy-phenyl)-3-methyl-2<i>H</i>-indazol-7-yl]-[3-methoxy-4-(4-methyl-imidazol-1-yl)-phenyl]-amine (<b>42c</b>)</h3><div class="NLM_p last">Cs<sub>2</sub>CO<sub>3</sub> (0.47 g, 1.44 mmol), X-Phos (50 mg, 0.105 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (44 mg, 0.048 mmol), and <b>8a</b> (97 mg, 0.48 mmol) were added to a solution of <b>28c</b> (152 mg, 0.48 mmol) in <i>tert</i>-butanol (10 mL), and the mixture was purged with N<sub>2</sub> for 5 min. The reaction mixture was stirred and heated at 110 °C for 20 h under a N<sub>2</sub> atmosphere. The reaction mixture was cooled to room temperature, and water was added. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by column chromatography on silica gel (eluent: CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 100/0 to 95/5) to yield 0.13 g (62%) of <b>42c</b>; mp 184.4 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 2.14 (s, 3 H), 2.64 (s, 3 H), 3.75 (s, 3 H), 3.84 (s, 3 H), 6.92–7.00 (m, 2 H), 7.01 (s, 1 H), 7.09–7.16 (m, 3 H), 7.19 6 (d, <i>J</i> = 8.5 Hz, 1 H), 7.23–7.31 (m, 3 H), 7.52 (t, <i>J</i> = 8.4 Hz, 1 H), 7.63 (d, <i>J</i> = 1.1 Hz, 1 H), 8.33 (s, 1 H). MS (ESI) <i>m</i>/<i>z</i> 440 [M + H]<sup>+</sup>. HRMS calcd for C<sub>26</sub>H<sub>26</sub>N<sub>5</sub>O<sub>2</sub> (M + H)<sup>+</sup>, 440.2086; found, 440.2083.</div></div><div id="sec6_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (2-Isobutyl-benzooxazol-4-yl)-[3-methoxy-4-(4-methyl-imidazol-1-yl)-phenyl]-amine (<b>43d</b>)</h3><div class="NLM_p last">Compound <b>43d</b> was prepared starting from <b>8a</b> and <b>38a</b> in a manner identical to the preparation of <b>42c</b>, yielding 71% of <b>43d</b>. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ (ppm) 1.05 (d, <i>J</i> = 6.7 Hz, 6 H), 2.23–2.36 (m, 1 H), 2.30 (s, 3 H), 2.81 (d, <i>J</i> = 7.2 Hz, 2 H), 3.81 (s, 3 H), 6.72 (s, 1 H), 6.86–6.91 (m, 3 H), 7.03–7.09 (m, 1 H), 7.16 (d, <i>J</i> = 9.1 Hz, 1 H), 7.19–7.24 (m, 2 H), 7.62 (d, <i>J</i> = 1.3 Hz, 1 H). MS(ESI) <i>m</i>/<i>z</i> 377 [M + H]<sup><b>+</b></sup>. HRMS calcd for C<sub>22</sub>H<sub>25</sub>N<sub>4</sub>O<sub>2</sub> (M + H)<sup>+</sup>, 377.1977; found, 377.1970.</div></div><div id="sec6_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> [2-(4-Fluoro-phenyl)-1-methyl-1<i>H</i>-benzoimidazol-4-yl]-[6-methoxy-5-(4-methyl-imidazol-1-yl)-pyridin-2-yl]-amine (<b>44a</b>)</h3><div class="NLM_p last">To a solution of <b>23a</b> (6.0 g, 19.6 mmol) in <i>tert</i>-butanol (250 mL) were added aniline <b>14</b> (4.0 g, 19.66 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (1.44 g, 1.57 mmol), X-Phos (2.25 g, 4.72 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (19.23 g, 59.0 mmol) under a N<sub>2</sub> atmosphere. The reaction mixture was heated at 100 °C for 3 h. The solvent was evaporated. Then water was added and the mixture was extracted twice with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by flash column chromatography [eluent: CH<sub>2</sub>Cl<sub>2</sub>/(7N NH<sub>3</sub> in MeOH) 100/0 to 96/4]. The product fractions were collected and concentrated. The residue was triturated with DIPE and dried, yielding 5.34 g (63.4%) of <b>44a</b>; mp 139.3 °C. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ (ppm) 2.31 (s, 3 H), 3.86 (s, 3 H), 4.08 (s, 3 H), 6.60 (d, <i>J</i> = 8.4 Hz, 1 H), 6.84–6.91 (m, 1 H), 7.04 (dd, <i>J</i> = 8.0, 0.7 Hz, 1 H), 7.22–7.27 (m, 1 H), 7.28–7.32 (m, 1 H), 7.34 (d, <i>J</i> = 1.0 Hz, 1 H), 7.42 (d, <i>J</i> = 8.0 Hz, 1 H), 7.62–7.66 d, <i>J</i> = 1.0 Hz, 1 H), 7.72–7.80 (m, 2 H), 7.93 (s, 1 H), 8.19 (d, <i>J</i> = 8.0 Hz, 1 H). ESI(MS) <i>m</i>/<i>z</i> 429 [M + H]<sup>+</sup>. Anal. (C<sub>24</sub>H<sub>21</sub>FN<sub>6</sub>O) C, H, N. HRMS calcd for C<sub>24</sub>H<sub>22</sub>FN<sub>6</sub>O (M + H)<sup>+</sup>, 429.1839; found, 429.1854.</div></div><div id="sec6_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> [2-(4-Fluoro-phenyl)-1-methyl-1<i>H</i>-benzoimidazol-4-yl]-[4-methoxy-5-(4-methyl-imidazol-1-yl)-pyridin-2-yl]-amine (<b>44b</b>)</h3><div class="NLM_p last">Compound <b>44b</b> was prepared starting from <b>8b</b> and <b>23a</b> in a manner identical to the preparation of <b>42c</b>. The crude residue was purified by flash column chromatography over silica gel (eluent: CH<sub>2</sub>Cl<sub>2</sub>/(7N NH<sub>3</sub> in MeOH), 100/0 to 96/4), yielding 100 mg (40%) of <b>44b</b>. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 2.15 (s, 3 H), 3.83 (s, 3 H), 3.86 (s, 3 H), 7.05 (s, 1 H), 7.13–7.27 (m, 3 H), 7.45 (t, <i>J</i> = 9.0 Hz, 2 H), 7.67 (s, 1 H), 6 7.95 (dd, <i>J</i> = 8.8, 5.5 Hz, 2 H), 8.08 (s, 1 H), 8.32 (d, <i>J</i> = 7.3 Hz, 1 H), 9.05 (s, 1 H). MS (ESI) <i>m</i>/<i>z</i> 429 [M + H]<sup>+</sup>. HRMS calcd for C<sub>24</sub>H<sub>22</sub>FN<sub>6</sub>O (M + H)<sup>+</sup>, 429.1839; found, 429.1840.</div></div><div id="sec6_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> [2-(4-Fluoro-phenyl)-1-methyl-1<i>H</i>-benzoimidazol-4-yl]-[5-methoxy-6-(4-methyl-imidazol-1-yl)-pyridin-3-yl]-amine (<b>44c</b>)</h3><div class="NLM_p last">Sodium <i>tert</i>-butoxide (288 mg, 3.0 mmol), BINAP (94 mg, 0.15 mmol), Pd(OAc)<sub>2</sub> (23 mg, 0.1 mmol), and <b>23a</b> (305 mg, 1 mmol) were added to a solution of <b>8c</b> (245 mg, 1.2 mmol) in toluene (15 mL), and the mixture was purged with N<sub>2</sub> for 5 min. The reaction mixture was stirred and heated at 150 °C for 5 h under microwave irradiation, and then it was cooled to room temperature. Water was added, and the mixture was extracted CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was separated, dried (MgSO<sub>4</sub>), filtered, and concentrated. The residue was purified via reversed phase HPLC, to provide 79 mg (18%) of <b>44c</b>. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 2.16 (s, 3 H), 3.84 (s, 3 H), 3.86 (s, 3 H), 7.14–7.27 (m, 3 H), 7.37 (s, 1 H), 7.43 (t, <i>J</i> = 9.0 Hz, 2 H), 7.53 (d, <i>J</i> = 2.2 Hz, 1 H), 7.92 (dd, <i>J</i> = 8.8, 5.5 Hz, 2 H), 8.03 (d, <i>J</i> = 2.2 Hz, 1 H), 8.04 (br s, 1 H), 8.69 (s, 1 H). MS (ESI) <i>m</i>/<i>z</i> 429 [M + H]<sup>+</sup>. HRMS calcd for C<sub>24</sub>H<sub>22</sub>FN<sub>6</sub>O (M + H)<sup>+</sup>, 429.1839; found, 429.1853.</div></div><div id="sec6_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> [2-(4-Fluoro-phenyl)-1-methyl-1<i>H</i>-benzoimidazol-4-yl]-[5-(4-methyl-imidazol-1-yl)-pyridin-2-yl]-amine (<b>44d</b>)</h3><div class="NLM_p last">Compound <b>44d</b> was prepared starting from <b>8d</b> and <b>23a</b> in a manner identical to the preparation of <b>42c</b>. The residue was purified by flash column chromatography over silica gel (eluent: CH<sub>2</sub>Cl<sub>2</sub>/(7N NH<sub>3</sub> in MeOH), 100/0 to 98/2) to provide 50 mg (16%) of <b>44d</b>. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ (ppm) 2.31 (s, 3 H), 3.86 (s, 3 H), 6.93 (s, 1 H), 6.99–7.06 (m, 2 H), 7.26 (t, 2 H), 7.34 (t, <i>J</i> = 8.2 Hz, 1 H), 7.53 (dd, <i>J</i> = 8.8, 2.7 Hz, 1 H), 7.66 (s, 1 H), 7.76 (dd, <i>J</i> = 8.5, 5.3 Hz, 2 H), 7.92 (s, 1 H), 8.24 (d, <i>J</i> = 8.0 Hz, 1 H), 8.36 (d, <i>J</i> = 2.7 Hz, 1 H). MS (ESI) <i>m</i>/<i>z</i> 399 [M + H]<sup>+</sup>. HRMS calcd for C<sub>23</sub>H<sub>20</sub>FN<sub>6</sub> (M + H)<sup>+</sup>, 399.1733; found, 399.1724.</div></div><div id="sec6_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> [2-(4-Fluoro-phenyl)-1-methyl-1<i>H</i>-benzoimidazol-4-yl]-[6-(4-methyl-imidazol-1-yl)-pyridin-3-yl]-amine (<b>44e</b>)</h3><div class="NLM_p last">Compound <b>44e</b> was prepared starting from <b>8e</b> and <b>23a</b> in a manner identical to the preparation of <b>42c</b>. The crude residue was purified by flash column chromatography over silica gel (eluent: CH<sub>2</sub>Cl<sub>2</sub>/(7N NH<sub>3</sub> in MeOH), 100/0 to 98/2). The product fractions were collected, yielding 95 mg (23%) of <b>44e</b>. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ (ppm) 2.31 (d, <i>J</i> = 0.7 Hz, 3 H), 3.86 (s, 3 H), 6.95–7.04 (m, 2 H), 7.11 (d, J =7.3 Hz, 1 H), 7.17–7. 32 (m, 5 H), 7.69–7.80 (m, 3 H), 8.16 (d, <i>J</i> = 1.1 Hz, 1 H), 8.45 (d, <i>J</i> = 2.6 Hz, 1 H). MS (ESI) <i>m</i>/<i>z</i> 399 [M + H]<sup>+</sup>. HRMS calcd for C<sub>23</sub>H<sub>20</sub>FN<sub>6</sub> (M + H)<sup>+</sup>, 399.1733; found, 399.1767.</div></div><div id="sec6_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> [3-Fluoro-4-(4-methyl-imidazol-1-yl)-phenyl]-[2-(4-fluoro-phenyl)-1-methyl-1<i>H</i>-benzoimidazol-4-yl]-amine (<b>44f</b>)</h3><div class="NLM_p last">Compound <b>44f</b> was prepared starting from <b>8f</b> and <b>23a</b> in a manner identical to the preparation of <b>42c</b>. The crude residue was purified by flash column chromatography over silica gel (eluent: CH<sub>2</sub>Cl<sub>2</sub>/(7N NH<sub>3</sub> in MeOH), 100/0 to 98/2). The resulting residue was purified further via reversed phase HPLC to provide 95 mg (23%); mp 116 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm) 2.31 (s, 3 H), 3.85 (s, 3 H), 6.92 (s, 1 H), 6.99–7.03 (m, 1 H), 7.06 (dd, <i>J</i> = 8.7, 2.5 Hz, 1 H), 7.15 (s, 1 H), 7.18–7.30 (m, 6 H), 7.65 (s, 1 H), 7.74 (dd, <i>J</i> = 8.5, 5.3 Hz, 2 H). MS (ESI) <i>m</i>/<i>z</i> 416 [M + H]<sup>+</sup>. HRMS calcd for C<sub>24</sub>H<sub>20</sub>F<sub>2</sub>N<sub>5</sub> (M + H)<sup>+</sup>, 416.1687; found, 416.1680.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Biology</h3><div id="sec7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Cell-Based in Vitro Assay Method</h4><div class="NLM_p">Screening was carried out using SKNBE2 human neuroblastoma cells carrying the hAPP 695–wild type, grown in Dulbecco’s Modified Eagle’s Medium/Nutrient mixture F-12 (DMEM/NUT-mix F-12) (HAM) provided by Invitrogen (cat. no. 10371–029) containing 5% Serum/Fe supplemented with 1% nonessential amino acids, <span class="smallcaps smallerCapital">l</span>-glutamine 2 mM, Hepes 15 mM, penicillin 50 U/mL (units/ml), and streptomycin 50 μg/mL. Cells were grown to near confluency.</div><div class="NLM_p last">The screening was performed using a modification of the assay as described.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Briefly, cells were plated in a 384-well plate at 10<sup>4</sup> cells/well in Ultraculture (Lonza, BE12–725F) supplemented with 1% glutamine (Invitrogen, 25030–024), 1% nonessential amino acid (NEAA), penicillin 50 U/mL, and streptomycin 50 μg/mL in the presence of test compound at different test concentrations. The cell/compound mixture was incubated overnight at 37 °C, 5% CO<sub>2</sub>. The next day, the media were assayed for Aβ42 and Aβtotal by two sandwich immunoassays, using the AphaLisa technology (Perkin-Elmer) according to the manufacturer’s instructions. To quantify the amount of Aβ42 in the cell supernatant, monoclonal antibody specific to the C-terminus of Aβ42 (JRF/cAβ42/26) was coupled to the receptor beads and biotinylated antibody specific to the N-terminus of Aβ (JRF/AβN/25) was used to react with the donor beads. To quantify the amount of Aβtotal in the cell supernatant, monoclonal antibody specific to the N-terminus of Aβ (JRF/AβN/25) was coupled to the receptor beads and biotinylated antibody specific to the mid region of Aβ (biotinylated 4G8) was used to react with the donor beads.</div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Mouse in Vivo Assay Method</h4><div class="NLM_p">Compounds were formulated in 20% of Captisol (a sulfobutyl ether of β-cyclodextrin) in water. The compounds were administered as a single oral dose to overnight fasted, male CD1 Swiss Specific Pathogen Free (SPF) mice (Charles River, Germany). After the desired time of treatment (4 h in the screening model), the animals were sacrificed and Aβ levels were analyzed. Blood was collected by decapitation and exsanguinations in EDTA-treated collection tubes. Blood was centrifuged at 1900<i>g</i> for 10 min (min) at 4 °C and the plasma recovered and flash frozen for later analysis. The brain was removed from the cranium and hindbrain. The cerebellum was removed, and the left and right hemisphere were separated. The left hemisphere was stored at −18 °C for quantitative analysis of test compound levels. The right hemisphere was rinsed with phosphate-buffered saline (PBS) buffer and immediately frozen on dry ice and stored at −80 °C until homogenization for biochemical assays.</div><div class="NLM_p last">Mouse brains were resuspended in 8 volumes of 0.4% diethylamine (DEA)/50 mM NaCl containing protease inhibitors (Roche-11873580001 or 04693159001) per gram of tissue, e.g., for 0.158 g brain, add 1.264 mL of 0.4% DEA. All samples were homogenized in the FastPrep-24 system (MP Biomedicals) using lysing matrix D (MPBio no. 6913–100) at 6 m/s for 20 s. Homogenates were centrifuged at 221300<i>g</i> for 50 min. The resulting high speed supernatants were then transferred to fresh Eppendorf tubes. Nine parts of supernatant were neutralized with 1 part 0.5 M Tris-HCl pH 6.8 and used to quantify Aß-peptide levels. To quantify the amount of Aβ-peptides in the soluble fraction of the brain homogenates, Enzyme-linked immunosorbent assays (ELISA) were used. Briefly, the standards (a dilution of synthetic Aβ42, Bachem, and Aβ38, ANASPEC) were prepared in a 1.5 mL Eppendorf tube in Ultraculture, with final concentrations ranging from 10000 to 0.3 pg/mL. The samples and standards were coincubated with HRPO-labeled N-terminal antibodies for Aβ42 and Aβ38 detection and with the biotinylated mid-domain antibody 4G8 for Aβtotal detection. Then 50 μL of conjugate/sample or conjugate/standards mixtures were added to the antibody-coated plate. The capture antibodies selectively recognize the C-terminal end of Aβ42 and Aβ38 and the N-terminal end for Aβ-total detection. Antibody JRF/cAβ42/26 was used for Aβ42 detection, antibody J&JPRD/Aβ38/5 for Aβ38 detection, and antibody JRF/rAβ/2 for Aβtotal detection. The plate was allowed to incubate overnight at 4 °C in order to allow formation of the antibody–amyloid complex. Following this incubation and subsequent wash steps, the ELISA for Aβ42 and Aβ38 quantification was finished by addition of Quanta Blu fluorogenic peroxidase substrate according to the manufacturer’s instructions (Pierce Corp., Rockford, Il). A reading was performed after 10–15 min (excitation 320 nm/emission 420 nm). For Aβtotal detection, a streptavidine-peroxidase conjugate was added, followed 60 min later by an addional wash step and addition of Quanta Blu fluorogenic peroxidase substrate according to the manufacturer’s instructions (Pierce Corp., Rockford, Il). A reading was performed after 10–15 min (excitation 320 nm/emission 420 nm).</div></div><div id="sec7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Dog and Rat in Vivo Assays</h4><div class="NLM_p last">For details on the in vivo experimental procedures for the dog experiment; see ref <a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">39</a>. The experiments in rat were carried out using male Sprague–Dawley rats of 180–220 g, which were fasted overnight before dosing. <b>44a</b> was dosed via gastric intubation of a 5 mg/mL suspension in 0.5% methocellulose. After the indicated time points (2, 4, 7, and 25 h), the rats were anesthesized in isoflurane, and 50 μL of CSF was sampled from the cisterna magna and frozen on dry ice. Then the animals were sacrificed by decapitation, and blood and brain were collected. Further analysis of compound levels and Aβ levels were performed in analogy to the mouse in vivo assay. Aβ levels in dog and rat derived samples were measured using MesoScale Discovery technology-based sandwich immune-assays. The antibodies against Aβ38 and Aβ42 were the same as described above. For Aβ40, the JRF/cAβ40/28 antibody was used; for Aβ37, the antibody JRD/Aβ37/3 was used.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78"><a href="/doi/suppl/10.1021/jm201710f">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53260" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53260" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthesis and analytical data of all intermediates and final compounds not described in the <a class="ref internalNav" href="#sec6" aria-label="Experimental Section">Experimental Section</a>. Details of the PK studies in mouse, rat, and dog for <b>44a</b>. Description of molecular modeling. Confidence intervals for the cellular Aβ42 IC<sub>50</sub> values. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm201710f/suppl_file/jm201710f_si_001.pdf">jm201710f_si_001.pdf (715.33 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm201710f" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75522" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75522" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harrie J. M. Gijsen</span> - <span class="hlFld-Affiliation affiliation">Janssen Research &
Development, Pharmaceutical
Companies of Johnson & Johnson, Beerse, Belgium</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#fe969997948d9b90be978a8dd0949094d09d9193"><span class="__cf_email__" data-cfemail="731b141a1900161d331a07005d191d195d101c1e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francois Bischoff</span> - <span class="hlFld-Affiliation affiliation">Janssen Research &
Development, Pharmaceutical
Companies of Johnson & Johnson, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Didier Berthelot</span> - <span class="hlFld-Affiliation affiliation">Janssen Research &
Development, Pharmaceutical
Companies of Johnson & Johnson, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michel De Cleyn</span> - <span class="hlFld-Affiliation affiliation">Janssen Research &
Development, Pharmaceutical
Companies of Johnson & Johnson, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregor Macdonald</span> - <span class="hlFld-Affiliation affiliation">Janssen Research &
Development, Pharmaceutical
Companies of Johnson & Johnson, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Garrett Minne</span> - <span class="hlFld-Affiliation affiliation">Janssen Research &
Development, Pharmaceutical
Companies of Johnson & Johnson, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Oehlrich</span> - <span class="hlFld-Affiliation affiliation">Janssen Research &
Development, Pharmaceutical
Companies of Johnson & Johnson, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Serge Pieters</span> - <span class="hlFld-Affiliation affiliation">Janssen Research &
Development, Pharmaceutical
Companies of Johnson & Johnson, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michel Surkyn</span> - <span class="hlFld-Affiliation affiliation">Janssen Research &
Development, Pharmaceutical
Companies of Johnson & Johnson, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrés A. Trabanco</span> - <span class="hlFld-Affiliation affiliation">Janssen Research &
Development, Pharmaceutical
Companies of Johnson & Johnson, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Tresadern</span> - <span class="hlFld-Affiliation affiliation">Janssen Research &
Development, Pharmaceutical
Companies of Johnson & Johnson, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sven Van Brandt</span> - <span class="hlFld-Affiliation affiliation">Janssen Research &
Development, Pharmaceutical
Companies of Johnson & Johnson, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ingrid Velter</span> - <span class="hlFld-Affiliation affiliation">Janssen Research &
Development, Pharmaceutical
Companies of Johnson & Johnson, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mirko Zaja</span> - <span class="hlFld-Affiliation affiliation">Janssen Research &
Development, Pharmaceutical
Companies of Johnson & Johnson, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Herman Borghys</span> - <span class="hlFld-Affiliation affiliation">Janssen Research &
Development, Pharmaceutical
Companies of Johnson & Johnson, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chantal Masungi</span> - <span class="hlFld-Affiliation affiliation">Janssen Research &
Development, Pharmaceutical
Companies of Johnson & Johnson, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc Mercken</span> - <span class="hlFld-Affiliation affiliation">Janssen Research &
Development, Pharmaceutical
Companies of Johnson & Johnson, Beerse, Belgium</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d179e5025-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86727" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86727" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank our co-workers at Cellzome, the members of the Janssen R&D Biology, ADME, and Screening Departments, and the members of the purification and analysis team.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i80" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i80"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i81" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i81"> Abbreviations Used</h2><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid-β peptide</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism and excretion</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">BACE1</td><td class="NLM_def"><p class="first last">β-secretase</p></td></tr><tr><td class="NLM_term">C99</td><td class="NLM_def"><p class="first last">C-terminal fragment obtained after cleavage of APP by BACE1</p></td></tr><tr><td class="NLM_term">Captisol</td><td class="NLM_def"><p class="first last">a sulfobutyl ether of β-cyclodextrin</p></td></tr><tr><td class="NLM_term">CyP</td><td class="NLM_def"><p class="first last">cytochrome P<sub>450</sub></p></td></tr><tr><td class="NLM_term">FaSSIF</td><td class="NLM_def"><p class="first last">fasted state simulated intestinal fluid</p></td></tr><tr><td class="NLM_term">FeSSIF</td><td class="NLM_def"><p class="first last">fed state simulated intestinal fluid</p></td></tr><tr><td class="NLM_term"><i>f</i><sub>u,brain</sub></td><td class="NLM_def"><p class="first last">fraction of compound unbound in brain</p></td></tr><tr><td class="NLM_term">GI</td><td class="NLM_def"><p class="first last">gastro-intestinal</p></td></tr><tr><td class="NLM_term">GSM</td><td class="NLM_def"><p class="first last">γ-secretase modulator</p></td></tr><tr><td class="NLM_term">GSI</td><td class="NLM_def"><p class="first last">γ-secretase inhibitor</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">potassium channel encoded by the human ether-à-go-go related gene</p></td></tr><tr><td class="NLM_term">mpk</td><td class="NLM_def"><p class="first last">milligram of compound per kilogram of animal body weight</p></td></tr><tr><td class="NLM_term">nd</td><td class="NLM_def"><p class="first last">not determined</p></td></tr><tr><td class="NLM_term">NSAIDs</td><td class="NLM_def"><p class="first last">nonsteroidal anti-inflammatory drugs</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">per os</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24338" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24338" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 40 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: from pathology to therapeutic approaches</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3030</span><span class="NLM_x">–</span> <span class="NLM_lpage">3059</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=3030-3059&author=R.+Jakob-Roetneauthor=H.+Jacobsen&title=Alzheimer%E2%80%99s+disease%3A+from+pathology+to+therapeutic+approaches"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DJacobsen%26aufirst%3DH.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520from%2520pathology%2520to%2520therapeutic%2520approaches%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D3030%26epage%3D3059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Berchtold, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotman, C. W.</span><span> </span><span class="NLM_article-title">Evolution in the conceptualization of dementia and Alzheimer’s disease: Greco-Roman period to the 1960s</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1016%2FS0197-4580%2898%2900052-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=9661992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A280%3ADyaK1czisVeluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=173-189&author=N.+C.+Berchtoldauthor=C.+W.+Cotman&title=Evolution+in+the+conceptualization+of+dementia+and+Alzheimer%E2%80%99s+disease%3A+Greco-Roman+period+to+the+1960s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s</span></div><div class="casAuthors">Berchtold N C; Cotman C W</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of aging</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">173-89</span>
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    </div><div class="casAbstract">Most histories of senile dementia commence with Alois Alzheimer's description in 1906 of the first case of Alzheimer's disease, yet the history of senile dementia before 1906 is quite rich, dating back to the ancient Greek and Roman philosophers and physicians.  Over the 2500 years since ancient times, the concept of senile dementia has evolved from a rather vague notion that mental decline occurred inevitably in old age, to become defined today by a distinct set of clinical and pathological features with the potential for treatment and prevention within grasp.  Throughout history, many elderly individuals with unpredictable behavior were sequestered in institutions, and the line between mental disorders and senile dementia was hazy at best.  The identification of Alzheimer's disease at the onset of the 20th century was a turning point for the understanding of senile dementia, and the concepts and histological findings presented by the early researchers of Alzheimer's disease remain relevant still today.  Indeed, these early findings are proving to be a continuing source of insight, as many of the issues debated at the turn of the century remain unresolved still today.  This paper thus traces the history of the evolution of our current conceptualization of Alzheimer's disease from the amorphous Greco-Roman concept of age-associated dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRJYW2UOwdYGwMthz5_Rx5rfW6udTcc2eYqJLQhb_s-vLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1czisVeluw%253D%253D&md5=e9ad87054b18b6d4630cf05e84550fa2</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2898%2900052-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252898%252900052-9%26sid%3Dliteratum%253Aachs%26aulast%3DBerchtold%26aufirst%3DN.%2BC.%26aulast%3DCotman%26aufirst%3DC.%2BW.%26atitle%3DEvolution%2520in%2520the%2520conceptualization%2520of%2520dementia%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Greco-Roman%2520period%2520to%2520the%25201960s%26jtitle%3DNeurobiol.%2520Aging%26date%3D1998%26volume%3D19%26spage%3D173%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Tiraboschi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corey-Bloom, J.</span><span> </span><span class="NLM_article-title">The importance of neurotic plaques and tangles to the development and evolution of AD</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1984</span><span class="NLM_x">–</span> <span class="NLM_lpage">1989</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2004&pages=1984-1989&author=P.+Tiraboschiauthor=L.+A.+Hansenauthor=L.+J.+Thalauthor=J.+Corey-Bloom&title=The+importance+of+neurotic+plaques+and+tangles+to+the+development+and+evolution+of+AD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTiraboschi%26aufirst%3DP.%26aulast%3DHansen%26aufirst%3DL.%2BA.%26aulast%3DThal%26aufirst%3DL.%2BJ.%26aulast%3DCorey-Bloom%26aufirst%3DJ.%26atitle%3DThe%2520importance%2520of%2520neurotic%2520plaques%2520and%2520tangles%2520to%2520the%2520development%2520and%2520evolution%2520of%2520AD%26jtitle%3DNeurology%26date%3D2004%26volume%3D62%26spage%3D1984%26epage%3D1989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Small, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappai, R.</span><span> </span><span class="NLM_article-title">Alois Alzheimer and Alzheimer’s disease: a centennial perspective</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">708</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1111%2Fj.1471-4159.2006.04212.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=17076655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eju7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=708-710&author=D.+H.+Smallauthor=R.+Cappai&title=Alois+Alzheimer+and+Alzheimer%E2%80%99s+disease%3A+a+centennial+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alois Alzheimer and Alzheimer's disease: a centennial perspective</span></div><div class="casAuthors">Small, David H.; Cappai, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">708-710</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The year 2006 is the centenary of the famous presentation of Alois Alzheimer which first described the neuropathol. of Alzheimer's disease (AD).  Since this presentation, enormous progress has been made in understanding the biol. of AD.  The central role of the β-amyloid protein (Aβ) in the pathogenesis of AD and the relationship between plaque and tangle pathol. is now much better understood.  In this article, we review the current status of the amyloid hypothesis of AD and its role in the development of future therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodHVyze5z1W7Vg90H21EOLACvtfcHk0lj6Ht6j491T9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eju7%252FE&md5=27564c272b2bc577bbf4d568ffb7a079</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04212.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04212.x%26sid%3Dliteratum%253Aachs%26aulast%3DSmall%26aufirst%3DD.%2BH.%26aulast%3DCappai%26aufirst%3DR.%26atitle%3DAlois%2520Alzheimer%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520centennial%2520perspective%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D99%26spage%3D708%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lahiri, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y. W.</span><span> </span><span class="NLM_article-title">A proximal gene promoter region for the β-amyloid precursor protein provides a link between development, apotosis and Alzheimer’s disease</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1010</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1010&publication_year=2003&pages=643-647&author=D.+K.+Lahiriauthor=C.+Ghoshauthor=Y.+W.+Ge&title=A+proximal+gene+promoter+region+for+the+%CE%B2-amyloid+precursor+protein+provides+a+link+between+development%2C+apotosis+and+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLahiri%26aufirst%3DD.%2BK.%26aulast%3DGhosh%26aufirst%3DC.%26aulast%3DGe%26aufirst%3DY.%2BW.%26atitle%3DA%2520proximal%2520gene%2520promoter%2520region%2520for%2520the%2520%25CE%25B2-amyloid%2520precursor%2520protein%2520provides%2520a%2520link%2520between%2520development%252C%2520apotosis%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2003%26volume%3D1010%26spage%3D643%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Walsh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Deciphering the molecular basis of memory failure in Alzheimers disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=181-193&author=D.+M.+Walshauthor=D.+J.+Selkoe&title=Deciphering+the+molecular+basis+of+memory+failure+in+Alzheimers+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DDeciphering%2520the%2520molecular%2520basis%2520of%2520memory%2520failure%2520in%2520Alzheimers%2520disease%26jtitle%3DNeuron%26date%3D2004%26volume%3D44%26spage%3D181%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Tolia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Review structure and function of γ-secretase</span> <span class="citation_source-journal">Semin. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=211-218&author=A.+Toliaauthor=B.+De+Strooper&title=Review+structure+and+function+of+%CE%B3-secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTolia%26aufirst%3DA.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DReview%2520structure%2520and%2520function%2520of%2520%25CE%25B3-secretase%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2009%26volume%3D20%26spage%3D211%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Takami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagashima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima-Kawashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funtamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuo, I.</span><span> </span><span class="NLM_article-title">γ-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of β-carboxyl terminal fragment</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">13042</span><span class="NLM_x">–</span> <span class="NLM_lpage">13052</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1523%2FJNEUROSCI.2362-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=19828817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSitL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=13042-13052&author=M.+Takamiauthor=Y.+Nagashimaauthor=Y.+Sanoauthor=S.+Ishiharaauthor=M.+Morishima-Kawashimaauthor=S.+Funtamotoauthor=I.+Yasuo&title=%CE%B3-Secretase%3A+successive+tripeptide+and+tetrapeptide+release+from+the+transmembrane+domain+of+%CE%B2-carboxyl+terminal+fragment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3dR"><div class="casContent"><span class="casTitleNuber">3d</span><div class="casTitle"><span class="NLM_cas:atitle">γ-secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of β-carboxyl terminal fragment</span></div><div class="casAuthors">Takami, Mako; Nagashima, Yu; Sano, Yoshihisa; Ishihara, Seiko; Morishima-Kawashima, Maho; Funamoto, Satoru; Ihara, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">13042-13052</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Amyloid β protein (Aβ), a pathogenic mol. assocd. with Alzheimer's disease, is produced by γ-secretase, which cleaves the β-carboxyl terminal fragment (βCTF) of β-amyloid precursor protein (APP) in the middle of its transmembrane domain.  How the cleavage proceeds within the membrane has long been enigmatic.  We hypothesized previously that βCTF is cleaved first at the membrane-cytoplasm boundary, producing two long Aβs, Aβ48 and Aβ49, which are processed further by releasing three residues at each step to produce Aβ42 and Aβ40, resp.  To test this hypothesis, we used liq. chromatog. tandem mass spectrometry (LC-MS/MS) to quantify the specific tripeptides that are postulated to be released.  Using CHAPSO (3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxyl-1-propanesulfonate)-reconstituted γ-secretase system, we confirmed that Aβ49 is converted to Aβ43/40 by successively releasing two or three tripeptides and that Aβ48 is converted to Aβ42/38 by successively releasing two tripeptides or these plus an addnl. tetrapeptide.  Most unexpectedly, LC-MS/MS quantification revealed an induction period, 3-4 min, in the generation of peptides.  When extrapolated, each time line for each tripeptide appears to intercept the same point on the x-axis.  According to numerical simulation based on the successive reaction kinetics, the induction period exists.  These results strongly suggest that Aβ is generated through the stepwise processing of βCTF by γ-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYC-g_Nhz9QrVg90H21EOLACvtfcHk0lijA6yd3fGqcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSitL%252FM&md5=7123eb2419feeace3500a2ba4f42de43</span></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2362-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2362-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DTakami%26aufirst%3DM.%26aulast%3DNagashima%26aufirst%3DY.%26aulast%3DSano%26aufirst%3DY.%26aulast%3DIshihara%26aufirst%3DS.%26aulast%3DMorishima-Kawashima%26aufirst%3DM.%26aulast%3DFuntamoto%26aufirst%3DS.%26aulast%3DYasuo%26aufirst%3DI.%26atitle%3D%25CE%25B3-Secretase%253A%2520successive%2520tripeptide%2520and%2520tetrapeptide%2520release%2520from%2520the%2520transmembrane%2520domain%2520of%2520%25CE%25B2-carboxyl%2520terminal%2520fragment%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D13042%26epage%3D13052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kreft, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, A.</span><span> </span><span class="NLM_article-title">Recent advances in the identification of γ-secretase inhibitors to clinically test the Aβ oligomer hypothesis of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6169</span><span class="NLM_x">–</span> <span class="NLM_lpage">6188</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900188z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6169-6188&author=A.+F.+Kreftauthor=R.+Martoneauthor=A.+Porte&title=Recent+advances+in+the+identification+of+%CE%B3-secretase+inhibitors+to+clinically+test+the+A%CE%B2+oligomer+hypothesis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1021%2Fjm900188z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900188z%26sid%3Dliteratum%253Aachs%26aulast%3DKreft%26aufirst%3DA.%2BF.%26aulast%3DMartone%26aufirst%3DR.%26aulast%3DPorte%26aufirst%3DA.%26atitle%3DRecent%2520advances%2520in%2520the%2520identification%2520of%2520%25CE%25B3-secretase%2520inhibitors%2520to%2520clinically%2520test%2520the%2520A%25CE%25B2%2520oligomer%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6169%26epage%3D6188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">D’Onofrio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panza, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frisardi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solfrizzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paroni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascavilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seripa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilotto, A.</span><span> </span><span class="NLM_article-title">Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=19-37&author=G.+D%E2%80%99Onofrioauthor=F.+Panzaauthor=V.+Frisardiauthor=V.+Solfrizziauthor=B.+P.+Imbimboauthor=G.+Paroniauthor=L.+Cascavillaauthor=D.+Seripaauthor=A.+Pilotto&title=Advances+in+the+identification+of+%CE%B3-secretase+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Onofrio%26aufirst%3DG.%26aulast%3DPanza%26aufirst%3DF.%26aulast%3DFrisardi%26aufirst%3DV.%26aulast%3DSolfrizzi%26aufirst%3DV.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DParoni%26aufirst%3DG.%26aulast%3DCascavilla%26aufirst%3DL.%26aulast%3DSeripa%26aufirst%3DD.%26aulast%3DPilotto%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520the%2520identification%2520of%2520%25CE%25B3-secretase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D19%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mitani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarimizu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akashiba, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shitaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, N.</span><span> </span><span class="NLM_article-title">Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2037</span><span class="NLM_x">–</span> <span class="NLM_lpage">2050</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1523%2FJNEUROSCI.4264-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=22323718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFantbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=2037-2050&author=Y.+Mitaniauthor=J.+Yarimizuauthor=K.+Saitaauthor=H.+Uchinoauthor=H.+Akashibaauthor=Y.+Shitakaauthor=K.+Niauthor=N.+Matsuoka&title=Differential+effects+between+%CE%B3-secretase+inhibitors+and+modulators+on+cognitive+function+in+amyloid+precursor+protein-transgenic+and+nontransgenic+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice</span></div><div class="casAuthors">Mitani, Yasuyuki; Yarimizu, Junko; Saita, Kyoko; Uchino, Hiroshi; Akashiba, Hiroki; Shitaka, Yoshitsugu; Ni, Keni; Matsuoka, Nobuya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2037-2050</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">γ-Secretase inhibitors (GSIs) reduce amyloid-β (Aβ) peptides but inevitably increase the β-C-terminal fragment (β-CTF) of amyloid precursor protein (APP), potentially having undesirable effects on synapses.  In contrast, γ-secretase modulators (GSMs) reduce Aβ42 without increasing β-CTF.  Although the Aβ-lowering effects of these compds. have been extensively studied, little effort has been made to investigate their effects on cognition.  Here, we compared the effects of two GSIs-(2S)-2-hydroxy-3-methyl-N-[(2S)-1-{[(1S)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-3-benzazepin-1-yl]amino}-1-oxopropan-2-yl]butanamide (LY450139, semagacestat) and (2R)-2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxazol-3-yl)phenyl]methyl]amino-5,5,5-trifluoropentanamide (BMS-708163)-and a second-generation GSM [{(2S,4R)-1-[(4R)-1,1,1-trifluoro-7-methyloctan-4-yl]-2-[4-(trifluoromethyl)phenyl]piperidin-4-yl}acetic acid (GSM-2)] on spatial working memory in APP-transgenic (Tg2576) and nontransgenic mice using the Y-maze task.  While acute dosing with either GSI ameliorated memory deficits in 5.5-mo-old Tg2576 mice, these effects disappeared after 8 d subchronic dosing.  Subchronic dosing with either GSI rather impaired normal cognition in 3-mo-old Tg2576 mice, with no inhibition on the processing of other γ-secretase substrates, such as Notch, N-cadherin, or EphA4, in the brain.  LY450139 also impaired normal cognition in wild-type mice; however, the potency was 10-fold lower than that in Tg2576 mice, indicating an APP-dependent mechanism likely with β-CTF accumulation.  Immunofluorescence studies revealed that the β-CTF accumulation was localized in the presynaptic terminals of the hippocampal stratum lucidum and dentate hilus, implying an effect on presynaptic function in the mossy fibers.  In contrast, both acute and subchronic dosing with GSM-2 significantly ameliorated memory deficits in Tg2576 mice and did not affect normal cognition in wild-type mice.  We demonstrated a clear difference between GSI and GSM in effects on functional consequences, providing new insights into strategies for developing these drugs against Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCQSvDeM5057Vg90H21EOLACvtfcHk0lgjzzY8w0w8PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFantbw%253D&md5=8b822c8ce2e99faaf881dde88c50224b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4264-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4264-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DMitani%26aufirst%3DY.%26aulast%3DYarimizu%26aufirst%3DJ.%26aulast%3DSaita%26aufirst%3DK.%26aulast%3DUchino%26aufirst%3DH.%26aulast%3DAkashiba%26aufirst%3DH.%26aulast%3DShitaka%26aufirst%3DY.%26aulast%3DNi%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DN.%26atitle%3DDifferential%2520effects%2520between%2520%25CE%25B3-secretase%2520inhibitors%2520and%2520modulators%2520on%2520cognitive%2520function%2520in%2520amyloid%2520precursor%2520protein-transgenic%2520and%2520nontransgenic%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D2037%26epage%3D2050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D. J. -C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J. M.</span><span> </span><span class="NLM_article-title">γ-Secretase modulators as potential disease modifying anti-Alzheimer’s drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101168r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=669-698&author=D.+Oehlrichauthor=D.+J.+-C.+Berthelotauthor=H.+J.+M.+Gijsen&title=%CE%B3-Secretase+modulators+as+potential+disease+modifying+anti-Alzheimer%E2%80%99s+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm101168r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101168r%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DBerthelot%26aufirst%3DD.%2BJ.%2B-C.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3D%25CE%25B3-Secretase%2520modulators%2520as%2520potential%2520disease%2520modifying%2520anti-Alzheimer%25E2%2580%2599s%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D669%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hardy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-5&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bergmans, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">γ-Secretases: from cell biology to therapeutic strategies</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=215-225&author=B.+A.+Bergmansauthor=B.+De+Strooper&title=%CE%B3-Secretases%3A+from+cell+biology+to+therapeutic+strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBergmans%26aufirst%3DB.%2BA.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3D%25CE%25B3-Secretases%253A%2520from%2520cell%2520biology%2520to%2520therapeutic%2520strategies%26jtitle%3DNeurology%26date%3D2010%26volume%3D9%26spage%3D215%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Panza, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solfrizzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frisardi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capurso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Introno, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colacicco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendemiale, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capurso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbibo, B. P.</span><span> </span><span class="NLM_article-title">Disease-modifying approach to the treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.2165%2F11315770-000000000-00000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=19655822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOju7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2009&pages=537-555&author=F.+Panzaauthor=V.+Solfrizziauthor=V.+Frisardiauthor=C.+Capursoauthor=A.+D%E2%80%99Intronoauthor=A.+M.+Colaciccoauthor=G.+Vendemialeauthor=A.+Capursoauthor=B.+P.+Imbibo&title=Disease-modifying+approach+to+the+treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Disease-modifying approach to the treatment of Alzheimer's disease: from α-secretase activators to γ-secretase inhibitors and modulators</span></div><div class="casAuthors">Panza, Francesco; Solfrizzi, Vincenzo; Frisardi, Vincenza; Capurso, Cristiano; D'Introno, Alessia; Colacicco, Anna M.; Vendemiale, Gianluigi; Capurso, Antonio; Imbimbo, Bruno P.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">537-555</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">A review.  In the last decade, advances in understanding the neurobiol. of Alzheimer's disease (AD) have translated into an increase in clin. trials assessing various potential AD treatments.  At present, drugs used for the treatment of AD only slightly delay the inevitable symptomatic progression of the disease and do not affect the main neuropathol. hallmarks of the disease, i.e. senile plaques and neurofibrillary tangles.  Brain accumulation of oligomeric species of β-amyloid (Aβ) peptides, the principal components of senile plaques, is believed to play a crucial role in the development of AD.  Based on this hypothesis, huge efforts are being made to identify drugs able to interfere with proteases regulating Aβ formation from amyloid precursor protein (APP).  Compds. that stimulate α-secretase, the enzyme responsible for non-amyloidogenic metab. of APP, are being developed and one of these, EHT-0202, has recently commenced evaluation in a phase II study.  The discovery of inhibitors of β-secretase (memapsin-2, β-amyloid cleaving enzyme-1 [BACE-1]), the enzyme that regulates the first step of amyloidogenic APP metab., has proved to be particularly difficult because of inherent medicinal chem. issues and only one compd. (CTS-21166) has proceeded to clin. testing.  Conversely, several compds. that inhibit γ-secretase, the pivotal enzyme that generates Aβ, have been identified, the most advanced being LY-450139 (semagacestat), presently in phase III clin. development.  There has been considerable disappointment over the failure of a phase III study of tarenflurbil, a compd. believed to modulate the activity of y-secretase, after encouraging phase II findings.  Nevertheless, other promising y-secretase modulators are being developed and are approaching clin. testing.  All these therapeutic approaches increase the hope of slowing the rate of decline in patients with AD and modifying the natural history of this devastating disease within the next 5 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzAE5mGxaRkLVg90H21EOLACvtfcHk0li3ctO6sQS3-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOju7rE&md5=4c311efa2d1d777d67eba5ef68285e6e</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.2165%2F11315770-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11315770-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DPanza%26aufirst%3DF.%26aulast%3DSolfrizzi%26aufirst%3DV.%26aulast%3DFrisardi%26aufirst%3DV.%26aulast%3DCapurso%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Introno%26aufirst%3DA.%26aulast%3DColacicco%26aufirst%3DA.%2BM.%26aulast%3DVendemiale%26aufirst%3DG.%26aulast%3DCapurso%26aufirst%3DA.%26aulast%3DImbibo%26aufirst%3DB.%2BP.%26atitle%3DDisease-modifying%2520approach%2520to%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DDrugs%2520Aging%26date%3D2009%26volume%3D26%26spage%3D537%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Chávez-Gutiérrez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bammens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benilova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandersteen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benurwar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lismont, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Cleynenbreugel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esselmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltfang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serneels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schymkowitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousseau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broersen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The mechanism of γ-secretase dysfunction in familial Alzheimer disease</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2261</span><span class="NLM_x">–</span> <span class="NLM_lpage">2274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=2261-2274&author=L.+Ch%C3%A1vez-Guti%C3%A9rrezauthor=L.+Bammensauthor=I.+Benilovaauthor=A.+Vandersteenauthor=M.+Benurwarauthor=M.+Borgersauthor=S.+Lismontauthor=L.+Zhouauthor=S.+Van+Cleynenbreugelauthor=H.+Esselmannauthor=J.+Wiltfangauthor=L.+Serneelsauthor=E.+Karranauthor=H.+Gijsenauthor=J.+Schymkowitzauthor=F.+Rousseauauthor=K.+Broersenauthor=B.+De+Strooper&title=The+mechanism+of+%CE%B3-secretase+dysfunction+in+familial+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCh%25C3%25A1vez-Guti%25C3%25A9rrez%26aufirst%3DL.%26aulast%3DBammens%26aufirst%3DL.%26aulast%3DBenilova%26aufirst%3DI.%26aulast%3DVandersteen%26aufirst%3DA.%26aulast%3DBenurwar%26aufirst%3DM.%26aulast%3DBorgers%26aufirst%3DM.%26aulast%3DLismont%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DVan%2BCleynenbreugel%26aufirst%3DS.%26aulast%3DEsselmann%26aufirst%3DH.%26aulast%3DWiltfang%26aufirst%3DJ.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DSchymkowitz%26aufirst%3DJ.%26aulast%3DRousseau%26aufirst%3DF.%26aulast%3DBroersen%26aufirst%3DK.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520mechanism%2520of%2520%25CE%25B3-secretase%2520dysfunction%2520in%2520familial%2520Alzheimer%2520disease%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26spage%3D2261%26epage%3D2274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="note"><p class="first last">For comprehensive reviews on work on γ-secretase modulators see: ref <a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">6</a></p></div><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%00empty%00"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Novel γ-secretase modulators: a review of patents from 2008 to 2010</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1517%2F13543776.2011.547479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=21231889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=205-225&author=M.+Petterssonauthor=G.+W.+Kauffmanauthor=C.+W.+am+Endeauthor=N.+C.+Patelauthor=C.+Stiffauthor=T.+P.+Tranauthor=D.+S.+Johnson&title=Novel+%CE%B3-secretase+modulators%3A+a+review+of+patents+from+2008+to+2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel γ-secretase modulators: a review of patents from 2008 to 2010</span></div><div class="casAuthors">Pettersson, Martin; Kauffman, Gregory W.; am Ende, Christopher W.; Patel, Nandini C.; Stiff, Cory; Tran, Tuan P.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-226</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The amyloid precursor protein is first cleaved by β-secretase to generate a 99-residue membrane-bound CTF (C99 or β-CTF), which is subsequently cleaved by γ-secretase to generate amyloid β (Aβ) peptides and the APP intracellular domain.  The amyloidogenic Aβ42 has attracted considerable attention because it is thought to be the most pathogenic species assocd. with Alzheimer's disease progression.  New classes of compds., called γ-secretase modulators (GSMs), have been shown to selectively lower Aβ42 prodn. without shutting down key γ-secretase-dependent signaling pathways.  This has become an important therapeutic strategy aimed at modulating Aβ prodn.  The progress on the clin. development of γ-secretase inhibitors is briefly covered in this review, followed by a discussion of the potential differentiating attributes of GSMs.  Then, the patent literature covering novel GSMs is reviewed, focusing on patents from 2008 to 2010.  Much progress has been made in the past 2 years on developing GSMs with improved potency for lowering the prodn. of Aβ42.  However, many of these chemotypes are in a challenging chem. space and generally possess higher lipophilicity than most CNS drugs.  It will be important to gain a better understanding of the specific target(s) that these GSMs interact with in order to facilitate future drug design efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocCQHiTfGSILVg90H21EOLACvtfcHk0lh1XvsoMyiX7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D&md5=9e52482a492eea96f9f88b59742e38ce</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.547479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.547479%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520%25CE%25B3-secretase%2520modulators%253A%2520a%2520review%2520of%2520patents%2520from%25202008%2520to%25202010%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D205%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zettl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, G.</span><span> </span><span class="NLM_article-title">Exploring the chemical space of γ-secretase modulators</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=402-410&author=H.+Zettlauthor=S.+Weggenauthor=P.+Schneiderauthor=G.+Schneider&title=Exploring+the+chemical+space+of+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZettl%26aufirst%3DH.%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DG.%26atitle%3DExploring%2520the%2520chemical%2520space%2520of%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2010%26volume%3D31%26spage%3D402%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Baumann, S.; Hötteke, N.; Narlawar, R.; Schmidt, B.</span><span> </span><span class="NLM_article-title">γ-Secretase as a target for AD</span>. In  <span class="citation_source-book">Medicinal Chemistry of Alzheimer’s Disease</span>; <span class="NLM_contrib-group">Gil, A. M.</span>, Eds.; <span class="NLM_publisher-name">Transworld Research Network</span>: <span class="NLM_publisher-loc">Trivandrum, India</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=193-224&author=S.+Baumann&author=N.+H%C3%B6tteke&author=R.+Narlawar&author=B.+Schmidtauthor=A.+M.+Gil&title=Medicinal+Chemistry+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBaumann%26aufirst%3DS.%26atitle%3D%25CE%25B3-Secretase%2520as%2520a%2520target%2520for%2520AD%26btitle%3DMedicinal%2520Chemistry%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26aulast%3DGil%26aufirst%3DA.%2BM.%26pub%3DTransworld%2520Research%2520Network%26date%3D2008%26spage%3D193%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Garofalo, A. W.</span><span> </span><span class="NLM_article-title">Patents targeting γ-secretase inhibition and modulation for the treatment of Alzheimer’s disease: 2004–2008</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">703</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1517%2F13543776.18.7.693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntlGgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=693-703&author=A.+W.+Garofalo&title=Patents+targeting+%CE%B3-secretase+inhibition+and+modulation+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+2004%E2%80%932008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10eR"><div class="casContent"><span class="casTitleNuber">10e</span><div class="casTitle"><span class="NLM_cas:atitle">Patents targeting γ-secretase inhibition and modulation for the treatment of Alzheimer's disease: 2004 - 2008</span></div><div class="casAuthors">Garofalo, Albert W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">693-703</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Although Alzheimer's disease has been defined for over a century, at present there is no effective treatment.  Amyloid deposition and plaque formation are widely believed to contribute to the pathol. of the disease.  As the etiol. of plaque formation has become better understood, the search for therapies has bred small mols. capable of inhibiting or regulating the activity of γ-secretase.  This paper reviews patents from the past 4 years claiming modulators or inhibitors of γ-secretase as a treatment for Alzheimer's disease.  One or two compds. from each patent were selected to represent the claimed chem. space.  Compd. selection was influenced by literature accounts, which are also discussed.  Although an attempt has been made to include major contributions in the field, the list of patents reviewed should not be considered exhaustive.  This review seeks to expand upon a previous review covering patents from 2000-2004.  Since then there has been an increase in the no. of structural and mechanistic approaches being pursued and several compds. have entered the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptzyUbNbn4uLVg90H21EOLACvtfcHk0lh1XvsoMyiX7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntlGgu78%253D&md5=a26891676fdd05b0b3c2501824ced28f</span></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.7.693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.7.693%26sid%3Dliteratum%253Aachs%26aulast%3DGarofalo%26aufirst%3DA.%2BW.%26atitle%3DPatents%2520targeting%2520%25CE%25B3-secretase%2520inhibition%2520and%2520modulation%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%25202004%25E2%2580%25932008%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D693%26epage%3D703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Tomita, T.</span><span> </span><span class="NLM_article-title">Secretase inhibitors and modulators for Alzheimer’s disease treatment</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1586%2Fern.09.24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=19402777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Cltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=661-679&author=T.+Tomita&title=Secretase+inhibitors+and+modulators+for+Alzheimer%E2%80%99s+disease+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10fR"><div class="casContent"><span class="casTitleNuber">10f</span><div class="casTitle"><span class="NLM_cas:atitle">Secretase inhibitors and modulators for Alzheimer's disease treatment</span></div><div class="casAuthors">Tomita, Taisuke</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">661-679</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Genetic and biol. studies provide strong evidence that the deposition of amyloid-β peptide (Aβ) contributes to the etiol. of Alzheimer's disease (AD).  Aβ is generated from amyloid-β precursor protein by β- and γ-secretases, which are plausible mol. targets for AD treatment.  Thus, drugs that regulate the prodn. of Aβ by inhibiting or modulating secretase activity could provide effective therapeutics for AD.  Both secretases are transmembrane proteases: β-site amyloid-β precursor protein cleaving enzyme 1, the main neuronal β-secretase, is a single span transmembrane aspartyl protease; γ-secretase is a multiprotein complex comprising four core subunits that are all transmembrane proteins: presenilin, nicastrin, anterior pharynx-defective 1 and presenilin enhancer 2.  Mol. biochem., enzymol. and genetic analyses reveal the mol. mechanisms of these secretases in the generation of Aβ.  Moreover, extensive drug screening and development have enabled some secretase inhibitors and modulators to advance into late-Phase clin. trials.  This review focuses on recent progresses in β- and γ-secretase biol., including the proteolytic mechanism, regulation and compn. of these enzymes.  Moreover, this review discusses the recent development of inhibitors, and provides a direction for the effective treatment of AD through inhibition/modulation of β- and γ-secretase activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSTaWWoZqbULVg90H21EOLACvtfcHk0ljgxi4q4Tyc2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Cltrw%253D&md5=7a3ef95c7c264863698d10fafb347c45</span></div><a href="/servlet/linkout?suffix=cit10f&amp;dbid=16384&amp;doi=10.1586%2Fern.09.24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fern.09.24%26sid%3Dliteratum%253Aachs%26aulast%3DTomita%26aufirst%3DT.%26atitle%3DSecretase%2520inhibitors%2520and%2520modulators%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2009%26volume%3D9%26spage%3D661%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Pissarnitski, D.</span><span> </span><span class="NLM_article-title">Advances in γ-secretase modulation</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=392-402&author=D.+Pissarnitski&title=Advances+in+%CE%B3-secretase+modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPissarnitski%26aufirst%3DD.%26atitle%3DAdvances%2520in%2520%25CE%25B3-secretase%2520modulation%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%26date%3D2007%26volume%3D10%26spage%3D392%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Peretto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Porta, E.</span><span> </span><span class="NLM_article-title">γ-Secretase modulation and its promise for Alzheimer’s disease: a medicinal chemistry perspective</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10h&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.2174%2F156802608783334097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10h&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=18220931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10h&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWnt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=38-46&author=I.+Perettoauthor=E.+La+Porta&title=%CE%B3-Secretase+modulation+and+its+promise+for+Alzheimer%E2%80%99s+disease%3A+a+medicinal+chemistry+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10hR"><div class="casContent"><span class="casTitleNuber">10h</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase modulation and its promise for Alzheimer's disease: a medicinal chemistry perspective</span></div><div class="casAuthors">Peretto, Ilaria; La Porta, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-46</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  γ-Secretase modulation holds the promise for the development of a disease-modifying therapy for Alzheimer's disease (AD).  This novel concept of manipulating the cleavage specificity of the γ-secretase enzyme by pharmacol. means implies that steady state levels of the potentially disease-causing amyloid-β(1-42) peptide can be lowered without the undesired side effects assocd. with full inhibition of this aspartyl-type protease.  Following on from the initial discovery that certain non-steroidal anti-inflammatory drugs (NSAIDs) exhibit properties characteristic of γ-secretase modulators, this class of compds. has been extensively studied and exploited, leading to the discovery of NSAIDs derivs. endowed with improved potency for the redn. of amyloid-β(1-42) peptide prodn.  In addn., a very limited no. of non-NSAID derived γ-secretase modulators has also been recently claimed in the patent literature, suggesting that only a restricted no. of pharmacophores might be involved in the modulation of γ-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYysZpzm8stLVg90H21EOLACvtfcHk0lj17Wwn8BgLzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWnt74%253D&md5=0771c6dc024355e125e2554c446d2423</span></div><a href="/servlet/linkout?suffix=cit10h&amp;dbid=16384&amp;doi=10.2174%2F156802608783334097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608783334097%26sid%3Dliteratum%253Aachs%26aulast%3DPeretto%26aufirst%3DI.%26aulast%3DLa%2BPorta%26aufirst%3DE.%26atitle%3D%25CE%25B3-Secretase%2520modulation%2520and%2520its%2520promise%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D38%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Abdul-Hay, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edirisinghe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatcher, G. R. J.</span><span> </span><span class="NLM_article-title">Selective modulation of amyloid-β peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Aβ levels</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1111%2Fj.1471-4159.2009.06355.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=19702658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOqtLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2009&pages=683-695&author=S.+O.+Abdul-Hayauthor=P.+Edirisingheauthor=G.+R.+J.+Thatcher&title=Selective+modulation+of+amyloid-%CE%B2+peptide+degradation+by+flurbiprofen%2C+fenofibrate%2C+and+related+compounds+regulates+A%CE%B2+levels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Selective modulation of amyloid-β peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Aβ levels</span></div><div class="casAuthors">Abdul-Hay, Samer O.; Edirisinghe, Praneeth; Thatcher, Gregory R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">683-695</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Gamma-secretase modulators (GSMs) include selected non-steroidal anti-inflammatory drugs such as flurbiprofen that selectively lowers the neurotoxic amyloid-β peptide Aβ1-42.  GSMs are attractive targets for Alzheimer's disease, in contrast to 'inverse GSMs,' such as fenofibrate, which selectively increase the level of Aβ1-42.  A methodol. for screening of Aβ modulating drugs was developed utilizing an Aβ-producing neuroblastoma cell line stably transfected with mutant human amyloid precursor protein, immunopptn. of Aβ peptides, and mass spectroscopic quantitation of Aβ1-37/Aβ1-38/Aβ1-40/Aβ1-42 using an Aβ internal std.  The unexpected conclusion of this work was that in this system, drug effects are independent of γ-secretase.  The methodol. recapitulated reported results for modulation of Aβ by GSMs.  However, control expts. in which exogenous Aβ1-40/Aβ1-42 was added (i) to drug-treated wild-type cells or (ii) to conditioned media from these wild-type cells, gave comparable patterns of Aβ modulation.  These results, suggesting that drugs modulate the ability of cell-derived factors to degrade Aβ, was interrogated by adding protease inhibitors and performing mol. wt. cut-off fractionation.  The results confirmed that modulation of Aβ1-40/Aβ1-42 was mediated by selective proteolysis.  Treatment of N2a cells with flurbiprofen or fenofibric acid selectively enhanced Aβ1-42 clearance by extracellular proteolysis; treatment with HCT-1026 or fenofibrate (esters of flurbiprofen and fenobric acid) inhibited clearance of Aβ1-40 and Aβ1-42.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVSboU5xjr9LVg90H21EOLACvtfcHk0lgbaiLqQJ9j3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOqtLfN&md5=57d300269647eb3336290c27f7b7b574</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.06355.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.06355.x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul-Hay%26aufirst%3DS.%2BO.%26aulast%3DEdirisinghe%26aufirst%3DP.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26atitle%3DSelective%2520modulation%2520of%2520amyloid-%25CE%25B2%2520peptide%2520degradation%2520by%2520flurbiprofen%252C%2520fenofibrate%252C%2520and%2520related%2520compounds%2520regulates%2520A%25CE%25B2%2520levels%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D111%26spage%3D683%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Van Broeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsden, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, A.</span><span> </span><span class="NLM_article-title">Chronic treatment with a novel γ-secretase modulator, JNJ-40418677, inhibits amyloid plaque formation in a mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1111%2Fj.1476-5381.2011.01207.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=21232036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1GitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2011&pages=375-389&author=B.+Van+Broeckauthor=J.-M.+Chenauthor=G.+Tretonauthor=M.+Desmidtauthor=C.+Hopfauthor=N.+Ramsdenauthor=E.+Karranauthor=M.+Merckenauthor=A.+Rowley&title=Chronic+treatment+with+a+novel+%CE%B3-secretase+modulator%2C+JNJ-40418677%2C+inhibits+amyloid+plaque+formation+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic treatment with a novel γ-secretase modulator, JNJ-40418677, inhibits amyloid plaque formation in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Van Broeck, B.; Chen, J.-M.; Treton, G.; Desmidt, M.; Hopf, C.; Ramsden, N.; Karran, E.; Mercken, M.; Rowley, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">375-389</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">γ-Secretase modulators represent a promising therapeutic approach for Alzheimer's disease (AD) because they selectively decrease amyloid β 42 (Aβ42), a particularly neurotoxic Aβ species that accumulates in plaques in the brains of patients with AD.  In the present study, we describe the in vitro and in vivo pharmacol. properties of a potent novel γ-secretase modulator, 2-(S)-(3,5-bis(4-(trifluoromethyl)phenyl)phenyl)-4-methylpentanoic acid (JNJ-40418677).  The potency and selectivity of JNJ-40418677 for Aβ redn. was investigated in human neuroblastoma cells, rat primary neurons and after treatment with single oral doses in non-transgenic mouse brains.  To evaluate the effect of JNJ-40418677 on plaque formation, Tg2576 mice were treated from 6 until 13 mo of age via the diet.  JNJ-40418677 selectively reduced Aβ42 secretion in human neuroblastoma cells and rat primary neurons, but it did not inhibit Notch processing or formation of other amyloid precursor protein cleavage products.  Oral treatment of non-transgenic mice with JNJ-40418677 resulted in an excellent brain penetration of the compd. and a dose- and time-dependent decrease of brain Aβ42 levels.  Chronic treatment of Tg2576 mice with JNJ-40418677 reduced brain Aβ levels, the area occupied by plaques and plaque no. in a dose-dependent manner compared with transgenic vehicle-treated mice.  JNJ-40418677 selectively decreased Aβ42 prodn., showed an excellent brain penetration after oral administration in mice and lowered brain Aβ burden in Tg2576 mice after chronic treatment.  JNJ-40418677 therefore warrants further investigation as a potentially effective disease-modifying therapy for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7MGWYryyTFbVg90H21EOLACvtfcHk0ljvTc-IpQFaCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1GitL0%253D&md5=aae5e894472fc12258ef3e4662a726e4</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01207.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01207.x%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DJ.-M.%26aulast%3DTreton%26aufirst%3DG.%26aulast%3DDesmidt%26aufirst%3DM.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DRamsden%26aufirst%3DN.%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DRowley%26aufirst%3DA.%26atitle%3DChronic%2520treatment%2520with%2520a%2520novel%2520%25CE%25B3-secretase%2520modulator%252C%2520JNJ-40418677%252C%2520inhibits%2520amyloid%2520plaque%2520formation%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D163%26spage%3D375%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cheng, S.; Comer, D. D.; Mao, L.; Balow, G. P.; Pleynet, D.</span><span> </span><span class="NLM_article-title">Aryl compounds and uses in modulating amyloid β</span>. Patent WO 2004110350,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=S.+Cheng&author=D.+D.+Comer&author=L.+Mao&author=G.+P.+Balow&author=D.+Pleynet&title=Aryl+compounds+and+uses+in+modulating+amyloid+%CE%B2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DS.%26atitle%3DAryl%2520compounds%2520and%2520uses%2520in%2520modulating%2520amyloid%2520%25CE%25B2%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kounnas, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">C., Soan, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleynet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digregorio, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velicelebi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauderman, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobley, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisodia, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S. L.</span><span> </span><span class="NLM_article-title">Modulation of γ -Secretase Reduces β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer’s Disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=769-780&author=M.+Z.+Kounnasauthor=A.+M.+Danksauthor=T.+C.+C.%2C+Soanauthor=E.+Ackermanauthor=X.+Zhangauthor=K.+Ahnauthor=P.+Nguyenauthor=D.+Comerauthor=L.+Maoauthor=C.+Yuauthor=D.+Pleynetauthor=P.+J.+Digregorioauthor=G.+Velicelebiauthor=K.+A.+Staudermanauthor=W.+T.+Comerauthor=W.+C.+Mobleyauthor=Y.-M.+Liauthor=S.+S.+Sisodiaauthor=R.+E.+Tanziauthor=S.+L.+Wagner&title=Modulation+of+%CE%B3+-Secretase+Reduces+%CE%B2-Amyloid+Deposition+in+a+Transgenic+Mouse+Model+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKounnas%26aufirst%3DM.%2BZ.%26aulast%3DDanks%26aufirst%3DA.%2BM.%26aulast%3DC.%252C%2BSoan%26aufirst%3DT.%2BC.%26aulast%3DAckerman%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DComer%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DPleynet%26aufirst%3DD.%26aulast%3DDigregorio%26aufirst%3DP.%2BJ.%26aulast%3DVelicelebi%26aufirst%3DG.%26aulast%3DStauderman%26aufirst%3DK.%2BA.%26aulast%3DComer%26aufirst%3DW.%2BT.%26aulast%3DMobley%26aufirst%3DW.%2BC.%26aulast%3DLi%26aufirst%3DY.-M.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DWagner%26aufirst%3DS.%2BL.%26atitle%3DModulation%2520of%2520%25CE%25B3%2520-Secretase%2520Reduces%2520%25CE%25B2-Amyloid%2520Deposition%2520in%2520a%2520Transgenic%2520Mouse%2520Model%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DNeuron%26date%3D2010%26volume%3D67%26spage%3D769%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kimura, T.; Kawano, K.; Doi, E.; Kitazawa, N.; Shin, K.; Miyagawa, T.; Kaneko, T.; Ito, K.; Takaishi, M.; Sasaki, T.; Hagiwara, H.</span><span> </span><span class="NLM_article-title">Preparation of cinnamide, 3-benzylidenepiperidin-2-one, phenylpropynamide compounds as amyloid β production inhibitors</span>. Patent WO 2005115990,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=T.+Kimura&author=K.+Kawano&author=E.+Doi&author=N.+Kitazawa&author=K.+Shin&author=T.+Miyagawa&author=T.+Kaneko&author=K.+Ito&author=M.+Takaishi&author=T.+Sasaki&author=H.+Hagiwara&title=Preparation+of+cinnamide%2C+3-benzylidenepiperidin-2-one%2C+phenylpropynamide+compounds+as+amyloid+%CE%B2+production+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520cinnamide%252C%25203-benzylidenepiperidin-2-one%252C%2520phenylpropynamide%2520compounds%2520as%2520amyloid%2520%25CE%25B2%2520production%2520inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="note"><p class="first last">Similar strategies have been used by others:</p></div><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span> </span><span class="NLM_article-title">The Discovery of Pyridone and Pyridazone Heterocycles as γ-Secretase Modulators</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml1000799" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlyjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=184-187&author=X.+Huangauthor=R.+Aslanianauthor=W.+Zhouauthor=X.+Zhuauthor=J.+Qinauthor=W.+Greenleeauthor=Z.+Zhuauthor=L.+Zhangauthor=L.+Hydeauthor=I.+Chuauthor=M.+Cohen-Williamsauthor=A.+Palani&title=The+Discovery+of+Pyridone+and+Pyridazone+Heterocycles+as+%CE%B3-Secretase+Modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of Pyridone and Pyridazone Heterocycles as γ-Secretase Modulators</span></div><div class="casAuthors">Huang, Xianhai; Aslanian, Robert; Zhou, Wei; Zhu, Xiaohong; Qin, Jun; Greenlee, William; Zhu, Zhaoning; Zhang, Lili; Hyde, Lynn; Chu, Inhou; Cohen-Williams, Mary; Palani, Anandan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">184-187</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel pyridazone and pyridone compds., e.g., I, as γ-secretase modulators were discovered.  Starting from the initial lead, structure-activity relationship studies were carried out in which an internal hydrogen bond was introduced to conformationally fix the side chain, and compds. with improved in vitro Aβ42 inhibition activity and good Aβtotal/Aβ42 selectivity were quickly discovered.  Compd. I displayed very good in vitro activity and excellent selectivity with good in vivo efficacy in both CRND8 mouse and nontransgenic rat models.  This compd. displayed a good overall profile in terms of rat pharmacokinetics and ancillary profile.  No abnormal behavior and side effects were obsd. in all of the studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqki-gEswVL97Vg90H21EOLACvtfcHk0lg8UqBZgGfYmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlyjtbo%253D&md5=2e738a3fdbcddce0c87e7e25130e9f86</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Fml1000799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1000799%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DPalani%26aufirst%3DA.%26atitle%3DThe%2520Discovery%2520of%2520Pyridone%2520and%2520Pyridazone%2520Heterocycles%2520as%2520%25CE%25B3-Secretase%2520Modulators%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D184%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Qin., J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhondi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pissarnitski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span> </span><span class="NLM_article-title">Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1016%2Fj.bmcl.2010.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=21195610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVKqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=664-669&author=J.+Qin.author=P.+Dhondiauthor=X.+Huangauthor=M.+Mandalauthor=Z.+Zhaoauthor=D.+Pissarnitskiauthor=W.+Zhouauthor=R.+Aslanianauthor=Z.+Zhuauthor=W.+Greenleeauthor=J.+Claderauthor=L.+Zhangauthor=M.+Cohen-Williamsauthor=N.+Jonesauthor=L.+Hydeauthor=A.+Palani&title=Discovery+of+fused+5%2C6-bicyclic+heterocycles+as+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators</span></div><div class="casAuthors">Qin, Jun; Dhondi, Pawan; Huang, Xianhai; Mandal, Mihirbaran; Zhao, Zhiqiang; Pissarnitski, Dmitri; Zhou, Wei; Aslanian, Robert; Zhu, Zhaoning; Greenlee, William; Clader, John; Zhang, Lili; Cohen-Williams, Mary; Jones, Nicholas; Hyde, Lynn; Palani, Anandan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">664-669</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery of four series of fused 5,6-bicyclic heterocycles, e.g., I [R = 4-FC6H4CHMe, 4-(MeO)C6H4CH2, n-pentyl, etc.], as γ-secretase modulators was reported.  The synthesis and SAR of these series were discussed.  These compds. represented a new class of γ-secretase modulators that demonstrated moderate to good in vitro potency in inhibiting Aβ42 prodn.  Specifically, compd. II demonstrated good in vitro and moderate in vivo efficacy as a γ-secretase modulator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnTq6NEaz9XbVg90H21EOLACvtfcHk0lgBS2bsJPeImw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVKqsw%253D%253D&md5=a85b7d068d89d39d18ce06d6ad748806</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DQin.%26aufirst%3DJ.%26aulast%3DDhondi%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DPissarnitski%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DN.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DPalani%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520fused%25205%252C6-bicyclic%2520heterocycles%2520as%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D664%26epage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Fischer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crispino, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span> </span><span class="NLM_article-title">Quinazolinones as γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">773</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=773-776&author=C.+Fischerauthor=S.+Shahauthor=B.+L.+Hughesauthor=G.+N.+Nikovauthor=J.+L.+Crispinoauthor=R.+E.+Middletonauthor=A.+A.+Szewczakauthor=B.+Munozauthor=M.+S.+Shearman&title=Quinazolinones+as+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DHughes%26aufirst%3DB.%2BL.%26aulast%3DNikov%26aufirst%3DG.%2BN.%26aulast%3DCrispino%26aufirst%3DJ.%2BL.%26aulast%3DMiddleton%26aufirst%3DR.%2BE.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26atitle%3DQuinazolinones%2520as%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D773%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Qin., J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhondi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Discovery of a potent pyrazolopyridine series of γ-secretase modulators</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml2000438" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVOlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=471-476&author=J.+Qin.author=W+Zhouauthor=X.+Huangauthor=P.+Dhondiauthor=A+Palaniauthor=R.+Aslanianauthor=Z.+Zhuauthor=W.+Greenleeauthor=M.+Cohen-Williamsauthor=N.+Jonesauthor=L.+Hydeauthor=L.+Zhang&title=Discovery+of+a+potent+pyrazolopyridine+series+of+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14dR"><div class="casContent"><span class="casTitleNuber">14d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent pyrazolopyridine series of γ-secretase modulators</span></div><div class="casAuthors">Qin, Jun; Zhou, Wei; Huang, Xianhai; Dhondi, Pawan; Palani, Anandan; Aslanian, Robert; Zhu, Zhaoning; Greenlee, William; Cohen-Williams, Mary; Jones, Nicholas; Hyde, Lynn; Zhang, Lili</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">471-476</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and structure-activity relationship of a novel series of pyrazolopyridines are reported.  These compds. represent a new class of γ-secretase modulators that demonstrate good in vitro potency in inhibiting Aβ42 prodn.  Examples with statistically significant in vivo efficacy in reducing the prodn. of rat cerebrospinal fluid Aβ42 were also identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2w7CtUkvQh7Vg90H21EOLACvtfcHk0lgBS2bsJPeImw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVOlsr0%253D&md5=6c36b585797281fe037510750b111d57</span></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1021%2Fml2000438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2000438%26sid%3Dliteratum%253Aachs%26aulast%3DQin.%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DW%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DDhondi%26aufirst%3DP.%26aulast%3DPalani%26aufirst%3DA%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DN.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520pyrazolopyridine%2520series%2520of%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D471%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Wan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, Y</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, J.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, Y.</span><span> </span><span class="NLM_article-title">Pyridine-derived γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4832</span><span class="NLM_x">–</span> <span class="NLM_lpage">4835</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4832-4835&author=Z.+Wanauthor=A.+Hallauthor=Y+Sangauthor=J.-N.+Xiangauthor=E.+Yangauthor=B+Smithauthor=G.+Yangauthor=H.+Yuauthor=J.+Wangauthor=L.+F.+Lauauthor=T.+Liauthor=W.+Zhaoauthor=X.+Suauthor=X.+Zhangauthor=Y.+Zhouauthor=Y.+Jinauthor=Z.+Tongauthor=Z.+Chengauthor=I.+Hussainauthor=J.+D.+Elliottauthor=Y.+Matsuoka&title=Pyridine-derived+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DZ.%26aulast%3DHall%26aufirst%3DA.%26aulast%3DSang%26aufirst%3DY%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DB%26aulast%3DYang%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLau%26aufirst%3DL.%2BF.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DSu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DTong%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DMatsuoka%26aufirst%3DY.%26atitle%3DPyridine-derived%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4832%26epage%3D4835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navaratnam, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakya, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetelino, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2906</span><span class="NLM_x">–</span> <span class="NLM_lpage">2911</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1016%2Fj.bmcl.2012.02.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=22429469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2906-2911&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=C.+Subramanyamauthor=K.+R.+Balesauthor=C.+W.+am+Endeauthor=B.+A.+Fishauthor=M.+E.+Greenauthor=G.+W.+Kauffmanauthor=R.+Liraauthor=P.+B.+Mullinsauthor=T.+Navaratnamauthor=S.+M.+Sakyaauthor=C.+M.+Stiffauthor=T.+M.+Tranauthor=B.+C.+Vetelinoauthor=L.+Xieauthor=L.+Zhangauthor=L.+R.+Pustilnikauthor=K.+M.+Woodauthor=C.+J.+O%E2%80%99Donnell&title=Design+and+synthesis+of+dihydrobenzofuran+amides+as+orally+bioavailable%2C+centrally+active+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14fR"><div class="casContent"><span class="casTitleNuber">14f</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Subramanyam, Chakrapani; Bales, Kelly R.; am Ende, Christopher W.; Fish, Benjamin A.; Green, Michael E.; Kauffman, Gregory W.; Lira, Ricardo; Mullins, Patrick B.; Navaratnam, Thayalan; Sakya, Subas M.; Stiff, Cory M.; Tran, Tuan P.; Vetelino, Beth C.; Xie, Longfei; Zhang, Liming; Pustilnik, Leslie R.; Wood, Kathleen M.; O'Donnell, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2906-2911</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and optimization of a novel series of dihydrobenzofuran amides as γ-secretase modulators (GSMs) is reported.  Strategies for aligning in vitro potency with drug-like physicochem. properties and good microsomal stability while avoiding P-gp mediated efflux are discussed.  Lead compds. such as I and II have moderate to good in vitro potency and excellent selectivity against Notch.  Good oral bioavailability was achieved as well as robust brain Aβ42 lowering activity at 100 mg/kg po dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIcSb2qlgrNLVg90H21EOLACvtfcHk0ljTsbQ0VTZDgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D&md5=63746bd0db38a20bb33b5e990e66610c</span></div><a href="/servlet/linkout?suffix=cit14f&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.059%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3DNavaratnam%26aufirst%3DT.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DTran%26aufirst%3DT.%2BM.%26aulast%3DVetelino%26aufirst%3DB.%2BC.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520dihydrobenzofuran%2520amides%2520as%2520orally%2520bioavailable%252C%2520centrally%2520active%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2906%26epage%3D2911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Fischer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zultanski, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Methot, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuthall., H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smotrov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moxham, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bays, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span> </span><span class="NLM_article-title">Triazoloamides as potent γ-secretase modulators with reduced hERG liability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3140</span><span class="NLM_x">–</span> <span class="NLM_lpage">3146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14g&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1016%2Fj.bmcl.2012.03.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14g&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=22497762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14g&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsVaisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3140-3146&author=C.+Fischerauthor=S.+L.+Zultanskiauthor=H.+Zhouauthor=J.+L.+Methotauthor=S.+Shahauthor=H.+Nuthall.author=B.+L.+Hughesauthor=N.+Smotrovauthor=A.+Hillauthor=A.+A.+Szewczakauthor=C.+M.+Moxhamauthor=N.+Baysauthor=R.+E.+Middletonauthor=B.+Munozauthor=M.+S.+Shearman&title=Triazoloamides+as+potent+%CE%B3-secretase+modulators+with+reduced+hERG+liability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14gR"><div class="casContent"><span class="casTitleNuber">14g</span><div class="casTitle"><span class="NLM_cas:atitle">Triazoloamides as potent γ-secretase modulators with reduced hERG liability</span></div><div class="casAuthors">Fischer, Christian; Zultanski, Susan L.; Zhou, Hua; Methot, Joey L.; Shah, Sanjiv; Nuthall, Hugh; Hughes, Bethany L.; Smotrov, Nadja; Hill, Armetta; Szewczak, Alexander A.; Moxham, Christopher M.; Bays, Nathan; Middleton, Richard E.; Munoz, Benito; Shearman, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3140-3146</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthesis and SAR studies of novel aryl triazoles as gamma secretase modulators (GSMs) are presented in this communication.  Starting from aryl triazole leads, optimization studies were continued and the series progressed towards novel amides and lactams.  Triazole I was identified as the most potent analog in this series, displaying single-digit nanomolar Aβ42 IC50 in cell-based assays and reduced affinity for the hERG channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiDFzfhAnInrVg90H21EOLACvtfcHk0ljmjYz_OrJRzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsVaisrg%253D&md5=6585835e1ec8b679e19bf8d687f392bb</span></div><a href="/servlet/linkout?suffix=cit14g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.03.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.03.054%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DZultanski%26aufirst%3DS.%2BL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMethot%26aufirst%3DJ.%2BL.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DNuthall.%26aufirst%3DH.%26aulast%3DHughes%26aufirst%3DB.%2BL.%26aulast%3DSmotrov%26aufirst%3DN.%26aulast%3DHill%26aufirst%3DA.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DMoxham%26aufirst%3DC.%2BM.%26aulast%3DBays%26aufirst%3DN.%26aulast%3DMiddleton%26aufirst%3DR.%2BE.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26atitle%3DTriazoloamides%2520as%2520potent%2520%25CE%25B3-secretase%2520modulators%2520with%2520reduced%2520hERG%2520liability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3140%26epage%3D3146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span>Conformational analysis was performed on molecule <b>4</b> with the Molecular Operating Environment (MOE) software (Molecular Operating Environment 2010.10 (MOE); <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">Montreal Quebec Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">, </span><a href="http://www.chemcomp.com" class="extLink">http://www.chemcomp.com</a>) using the MMFF94x force field and the LowModeMD approach with default settings. Unfavourable conformers with alternative conformations of the methoxyphenyl relative to the pyridone were at least 6.3 kcal/mol higher in energy. This suggested the preferred orientation would be significantly more likely to occur.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Conformational+analysis+was+performed+on+molecule+4+with+the+Molecular+Operating+Environment+%28MOE%29+software+%28Molecular+Operating+Environment+2010.10+%28MOE%29%3B+Chemical+Computing+Group+Inc.%3A+Montreal+Quebec+Canada%2C+2010%2C+http%3A%2F%2Fwww.chemcomp.com%29+using+the+MMFF94x+force+field+and+the+LowModeMD+approach+with+default+settings.+Unfavourable+conformers+with+alternative+conformations+of+the+methoxyphenyl+relative+to+the+pyridone+were+at+least+6.3+kcal%2Fmol+higher+in+energy.+This+suggested+the+preferred+orientation+would+be+significantly+more+likely+to+occur."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%2520Environment%25202010.10%2520%2528MOE%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gijsen, H. J. M.; Bischoff, F. P.; Zhuang, W.; Van Brandt, S. F. A.; Surkyn, M.; Zaja, M.; Berthelot, D. J.-C.; De Cleyn, M. A. J.; Macdonald, G. J.; Oehlrich, D.</span><span> </span><span class="NLM_article-title">Substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as γ-secretase modulators and their preparation and use for the treatment of diseases</span>. Patent WO 2010094647,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=H.+J.+M.+Gijsen&author=F.+P.+Bischoff&author=W.+Zhuang&author=S.+F.+A.+Van+Brandt&author=M.+Surkyn&author=M.+Zaja&author=D.+J.-C.+Berthelot&author=M.+A.+J.+De+Cleyn&author=G.+J.+Macdonald&author=D.+Oehlrich&title=Substituted+benzoxazole%2C+benzimidazole%2C+oxazolopyridine+and+imidazopyridine+derivatives+as+%CE%B3-secretase+modulators+and+their+preparation+and+use+for+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DSubstituted%2520benzoxazole%252C%2520benzimidazole%252C%2520oxazolopyridine%2520and%2520imidazopyridine%2520derivatives%2520as%2520%25CE%25B3-secretase%2520modulators%2520and%2520their%2520preparation%2520and%2520use%2520for%2520the%2520treatment%2520of%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gijsen, H. J. M.; Velter, A. I.; Macdonald, G. J.; Bischoff, F. P.; Wu, T.; Van Brandt, S. F. A.; Surkyn, M.; Zaja, M.; Pieters, S. M. A.; Berthelot, D. J.-C.; De Cleyn, M. A. J.; Oehlrich, D.</span><span> </span><span class="NLM_article-title">Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators and their preparation and use in the treatment of diseases</span>. Patent WO 2010089292,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=H.+J.+M.+Gijsen&author=A.+I.+Velter&author=G.+J.+Macdonald&author=F.+P.+Bischoff&author=T.+Wu&author=S.+F.+A.+Van+Brandt&author=M.+Surkyn&author=M.+Zaja&author=S.+M.+A.+Pieters&author=D.+J.-C.+Berthelot&author=M.+A.+J.+De+Cleyn&author=D.+Oehlrich&title=Novel+substituted+bicyclic+heterocyclic+compounds+as+gamma+secretase+modulators+and+their+preparation+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DNovel%2520substituted%2520bicyclic%2520heterocyclic%2520compounds%2520as%2520gamma%2520secretase%2520modulators%2520and%2520their%2520preparation%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gijsen, H. J. M.; Macdonald, G. J.; Bischoff, F. P.; Tresadern, G. J.; Trabanco-Suarez, A. A.; Van Brandt, S. F. A.; Berthelot, D. J.-C.</span><span> </span><span class="NLM_article-title">Preparation of substituted bicyclic imidazole derivatives as gamma secretase modulators</span>. Patent WO 2010070008,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=H.+J.+M.+Gijsen&author=G.+J.+Macdonald&author=F.+P.+Bischoff&author=G.+J.+Tresadern&author=A.+A.+Trabanco-Suarez&author=S.+F.+A.+Van+Brandt&author=D.+J.-C.+Berthelot&title=Preparation+of+substituted+bicyclic+imidazole+derivatives+as+gamma+secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DPreparation%2520of%2520substituted%2520bicyclic%2520imidazole%2520derivatives%2520as%2520gamma%2520secretase%2520modulators%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Bischoff, F. P.; Berthelot, D. J.-C.; De Cleyn, M. A. J.; Macdonald, G. J; Oehlrich, D.; Surkyn, M.; Trabanco-Suarez, A. A.; Tresadern, G. J.; Van Brandt, S. F. A.; Velter, A. I.; Borghys, H.; Masungi, C.; Mercken, M.; Gijsen., H. J. M.</span><span> </span><span class="NLM_article-title">Discovery of JNJ-42601572, a γ-Secretase Modulator with Potent, Central Activity in Mouse and Dog</span>. <span class="NLM_conf-name">242nd ACS National Meeting</span>, <span class="NLM_conf-loc">Denver, CO</span>, <span class="NLM_conf-date">August 28–September 1, 2011</span>,  <span class="NLM_fpage">Abstract MEDI-3</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bischoff%2C+F.+P.%3B+Berthelot%2C+D.+J.-C.%3B+De+Cleyn%2C+M.+A.+J.%3B+Macdonald%2C+G.+J%3B+Oehlrich%2C+D.%3B+Surkyn%2C+M.%3B+Trabanco-Suarez%2C+A.+A.%3B+Tresadern%2C+G.+J.%3B+Van+Brandt%2C+S.+F.+A.%3B+Velter%2C+A.+I.%3B+Borghys%2C+H.%3B+Masungi%2C+C.%3B+Mercken%2C+M.%3B+Gijsen.%2C+H.+J.+M.+Discovery+of+JNJ-42601572%2C+a+%CE%B3-Secretase+Modulator+with+Potent%2C+Central+Activity+in+Mouse+and+Dog.+242nd+ACS+National+Meeting%2C+Denver%2C+CO%2C+August+28%E2%80%93September+1%2C+2011%2C+Abstract+MEDI-3."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBischoff%26aufirst%3DF.%2BP.%26atitle%3DDiscovery%2520of%2520JNJ-42601572%252C%2520a%2520%25CE%25B3-Secretase%2520Modulator%2520with%2520Potent%252C%2520Central%2520Activity%2520in%2520Mouse%2520and%2520Dog%26spage%3DAbstract%2520MEDI-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Lang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zewge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houpis, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volante, R. P.</span><span> </span><span class="NLM_article-title">Amination of aryl halides using copper catalysis</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3251</span><span class="NLM_x">–</span> <span class="NLM_lpage">3254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1016%2FS0040-4039%2801%2900458-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFaktbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=3251-3254&author=F.+Langauthor=D.+Zewgeauthor=I.+N.+Houpisauthor=R.+P.+Volante&title=Amination+of+aryl+halides+using+copper+catalysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Amination of aryl halides using copper catalysis</span></div><div class="casAuthors">Lang, F.; Zewge, D.; Houpis, I. N.; Volante, R. P.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3251-3254</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Bromopyridine was converted into aminopyridine under Cu2O catalysis with an ethylene glycol soln. of ammonia in excellent yield (90%).  The amination reaction features low (0.5 mol%) catalyst loading, mild reaction temp. (80°C) and low reaction pressure (50 psi).  This protocol is further studied in the amination of a variety of aryl halides such as pyridines, benzenes, acetophenones, thiazoles and quinolines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqikX7teRRqe7Vg90H21EOLACvtfcHk0ljw3AV_W574-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFaktbY%253D&md5=e0140b081d4b0e4fa4ca600bcf8fc5bd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2900458-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252900458-0%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DF.%26aulast%3DZewge%26aufirst%3DD.%26aulast%3DHoupis%26aufirst%3DI.%2BN.%26aulast%3DVolante%26aufirst%3DR.%2BP.%26atitle%3DAmination%2520of%2520aryl%2520halides%2520using%2520copper%2520catalysis%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26spage%3D3251%26epage%3D3254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Venuti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strosberg, A. M.</span><span> </span><span class="NLM_article-title">Inhibitors of cyclic AMP phosphodiesterase. 3. Synthesis and biological evaluation of pyrido and imidazolyl analogues of 1,2,3,5-tetrahydro-2-oxoimidazo[2,1-<i>b</i>]quinazoline</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2136</span><span class="NLM_x">–</span> <span class="NLM_lpage">2145</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00119a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=2136-2145&author=M.+C.+Venutiauthor=R.+A.+Stephensonauthor=R.+Alvarezauthor=J.+J.+Brunoauthor=A.+M.+Strosberg&title=Inhibitors+of+cyclic+AMP+phosphodiesterase.+3.+Synthesis+and+biological+evaluation+of+pyrido+and+imidazolyl+analogues+of+1%2C2%2C3%2C5-tetrahydro-2-oxoimidazo%5B2%2C1-b%5Dquinazoline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm00119a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00119a014%26sid%3Dliteratum%253Aachs%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DStephenson%26aufirst%3DR.%2BA.%26aulast%3DAlvarez%26aufirst%3DR.%26aulast%3DBruno%26aufirst%3DJ.%2BJ.%26aulast%3DStrosberg%26aufirst%3DA.%2BM.%26atitle%3DInhibitors%2520of%2520cyclic%2520AMP%2520phosphodiesterase.%25203.%2520Synthesis%2520and%2520biological%2520evaluation%2520of%2520pyrido%2520and%2520imidazolyl%2520analogues%2520of%25201%252C2%252C3%252C5-tetrahydro-2-oxoimidazo%255B2%252C1-b%255Dquinazoline%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D2136%26epage%3D2145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Parlow, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, M. S.</span><span> </span><span class="NLM_article-title">Synthesis of 2-pyridones as tissue factor VIIa inhibitors</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">7695</span><span class="NLM_x">–</span> <span class="NLM_lpage">7701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2003&pages=7695-7701&author=J.+J.+Parlowauthor=M.+S.+South&title=Synthesis+of+2-pyridones+as+tissue+factor+VIIa+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParlow%26aufirst%3DJ.%2BJ.%26aulast%3DSouth%26aufirst%3DM.%2BS.%26atitle%3DSynthesis%2520of%25202-pyridones%2520as%2520tissue%2520factor%2520VIIa%2520inhibitors%26jtitle%3DTetrahedron%26date%3D2003%26volume%3D59%26spage%3D7695%26epage%3D7701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Kimura, T.; Kawano, K.; Doi, E.; Kitazawa, N.; Takaishi, M.; Ito, K.; Kaneko, T.; Sasaki, T.; Sato, N.; Miyagawa, T.; Hagiwara, H.</span><span> </span><span class="NLM_article-title">Preparation of morpholine type cinnamides as amyloid-β production inhibitors</span>. U.S. Patent US 20070117798,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+Kimura&author=K.+Kawano&author=E.+Doi&author=N.+Kitazawa&author=M.+Takaishi&author=K.+Ito&author=T.+Kaneko&author=T.+Sasaki&author=N.+Sato&author=T.+Miyagawa&author=H.+Hagiwara&title=Preparation+of+morpholine+type+cinnamides+as+amyloid-%CE%B2+production+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520morpholine%2520type%2520cinnamides%2520as%2520amyloid-%25CE%25B2%2520production%2520inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Shi, D.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dou, G.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, S.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, S.-J.</span><span> </span><span class="NLM_article-title">A novel and efficient synthesis of 2-aryl-2<i>H</i>-indazoles via SnCl<sub>2</sub>-mediated cyclization of 2-nitrobenzylamines</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">2509</span><span class="NLM_x">–</span> <span class="NLM_lpage">2512</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=2509-2512&author=D.-Q.+Shiauthor=G.-L.+Douauthor=S.-N.+Niauthor=J.-W.+Shiauthor=X.-Y.+Liauthor=X.-S.+Wangauthor=H.+Wuauthor=S.-J.+Ji&title=A+novel+and+efficient+synthesis+of+2-aryl-2H-indazoles+via+SnCl2-mediated+cyclization+of+2-nitrobenzylamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DD.-Q.%26aulast%3DDou%26aufirst%3DG.-L.%26aulast%3DNi%26aufirst%3DS.-N.%26aulast%3DShi%26aufirst%3DJ.-W.%26aulast%3DLi%26aufirst%3DX.-Y.%26aulast%3DWang%26aufirst%3DX.-S.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DS.-J.%26atitle%3DA%2520novel%2520and%2520efficient%2520synthesis%2520of%25202-aryl-2H-indazoles%2520via%2520SnCl2-mediated%2520cyclization%2520of%25202-nitrobenzylamines%26jtitle%3DSynlett%26date%3D2007%26spage%3D2509%26epage%3D2512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Dell’Erba, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrillo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavani, C.</span><span> </span><span class="NLM_article-title">A novel approach to 1<i>H</i>-indazoles via arylazidosulfides</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3529</span><span class="NLM_x">–</span> <span class="NLM_lpage">3536</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=3529-3536&author=C.+Dell%E2%80%99Erbaauthor=M.+Noviauthor=G.+Petrilloauthor=C.+Tavani&title=A+novel+approach+to+1H-indazoles+via+arylazidosulfides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDell%25E2%2580%2599Erba%26aufirst%3DC.%26aulast%3DNovi%26aufirst%3DM.%26aulast%3DPetrillo%26aufirst%3DG.%26aulast%3DTavani%26aufirst%3DC.%26atitle%3DA%2520novel%2520approach%2520to%25201H-indazoles%2520via%2520arylazidosulfides%26jtitle%3DTetrahedron%26date%3D1994%26volume%3D50%26spage%3D3529%26epage%3D3536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Evindar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batey, R. A.</span><span> </span><span class="NLM_article-title">Parallel synthesis of a library of benzoxazoles and benzothiazoles using ligand-accelerated copper-catalyzed cyclizations of <i>ortho</i>-halobenzanilides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1802</span><span class="NLM_x">–</span> <span class="NLM_lpage">1808</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo051927q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD28XoslamsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=1802-1808&author=G.+Evindarauthor=R.+A.+Batey&title=Parallel+synthesis+of+a+library+of+benzoxazoles+and+benzothiazoles+using+ligand-accelerated+copper-catalyzed+cyclizations+of+ortho-halobenzanilides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Parallel Synthesis of a Library of Benzoxazoles and Benzothiazoles Using Ligand-Accelerated Copper-Catalyzed Cyclizations of ortho-Halobenzanilides</span></div><div class="casAuthors">Evindar, Ghotas; Batey, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1802-1808</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A general method for the formation of benzoxazoles via a copper-catalyzed cyclization of o-halobenzanilides is reported.  This approach complements the more commonly used strategies for benzoxazole formation which require 2-aminophenols as substrates.  The reaction involves an intramol. C-O cross-coupling of the o-halo anilides and is believed to proceed via an oxidative insertion/reductive elimination pathway through a Cu(I)/Cu(III) manifold.  The reaction is also applicable to the formation of benzothiazoles.  A variety of ligands including 1,10-phenanthroline and N,N'-dimethylethylenediamine ligand acceleration/stabilization in the reaction.  Optimal conditions for cyclization used a catalyst combination of CuI and 1,10-phenanthroline (10 mol %).  The method was amenable to a parallel-synthesis approach, as demonstrated by the synthesis of a library of benzoxazoles and benzothiazoles substituted at various positions in the ring.  Most examples used the cyclization of o-bromo anilides, but o-iodo anilides and o-chloro anilides also undergo a reaction under these conditions.  The rate of reaction of the o-halo anilides follows the order I > Br > Cl, consistent with oxidative addn. being the rate-detg. step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPybgQDCShLbVg90H21EOLACvtfcHk0liyrqBV5py7CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XoslamsA%253D%253D&md5=db56c117b716e78b015b8fac28b1108b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjo051927q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo051927q%26sid%3Dliteratum%253Aachs%26aulast%3DEvindar%26aufirst%3DG.%26aulast%3DBatey%26aufirst%3DR.%2BA.%26atitle%3DParallel%2520synthesis%2520of%2520a%2520library%2520of%2520benzoxazoles%2520and%2520benzothiazoles%2520using%2520ligand-accelerated%2520copper-catalyzed%2520cyclizations%2520of%2520ortho-halobenzanilides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D1802%26epage%3D1808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westaway, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson-Wood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kholodenko, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherrington, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strome, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberburg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, P.,  St.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George Hyslop, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Mutant presenilins of Alzheimer’s disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=67-72&author=M.+Citronauthor=D.+Westawayauthor=W.+Xiaauthor=G.+Carlsonauthor=T.+Diehlauthor=G.+Levesqueauthor=K.+Johnson-Woodauthor=M.+Leeauthor=P.+Seubertauthor=A.+Davisauthor=D.+Kholodenkoauthor=R.+Motterauthor=R.+Sherringtonauthor=B.+Perryauthor=H.+Yaoauthor=R.+Stromeauthor=I.+Lieberburgauthor=J.+Rommensauthor=S.+Kimauthor=D.+Schenkauthor=P.+Fraserauthor=P.+George+Hyslopauthor=D.+J.+Selkoe&title=Mutant+presenilins+of+Alzheimer%E2%80%99s+disease+increase+production+of+42-residue+amyloid+%CE%B2-protein+in+both+transfected+cells+and+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DWestaway%26aufirst%3DD.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DCarlson%26aufirst%3DG.%26aulast%3DDiehl%26aufirst%3DT.%26aulast%3DLevesque%26aufirst%3DG.%26aulast%3DJohnson-Wood%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DKholodenko%26aufirst%3DD.%26aulast%3DMotter%26aufirst%3DR.%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DPerry%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DStrome%26aufirst%3DR.%26aulast%3DLieberburg%26aufirst%3DI.%26aulast%3DRommens%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DFraser%26aufirst%3DP.%26aulast%3DGeorge%2BHyslop%26aufirst%3DP.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DMutant%2520presenilins%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520increase%2520production%2520of%252042-residue%2520amyloid%2520%25CE%25B2-protein%2520in%2520both%2520transfected%2520cells%2520and%2520transgenic%2520mice%26jtitle%3DNature%2520Med.%26date%3D1997%26volume%3D3%26spage%3D67%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biesmans, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Scaffold hopping from pyridones to imidazo[1,2-<i>a</i>]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=175-179&author=G.+Tresadernauthor=J.+M.+Cidauthor=G.+J.+Macdonaldauthor=J.+A.+Vegaauthor=A.+I.+de+Lucasauthor=A.+Garciaauthor=E.+Matesanzauthor=M.+L.+Linaresauthor=D.+Oehlrichauthor=H.+Lavreysenauthor=I.+Biesmansauthor=A.+A.+Trabanco&title=Scaffold+hopping+from+pyridones+to+imidazo%5B1%2C2-a%5Dpyridines.+New+positive+allosteric+modulators+of+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DGarcia%26aufirst%3DA.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DBiesmans%26aufirst%3DI.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DScaffold%2520hopping%2520from%2520pyridones%2520to%2520imidazo%255B1%252C2-a%255Dpyridines.%2520New%2520positive%2520allosteric%2520modulators%2520of%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D175%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="note"><p class="first last">An overlay of the 3-D structures of compounds <b>3</b> and <b>40</b> is provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braggio, S.</span><span> </span><span class="NLM_article-title">Assessing brain free fraction in early drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1517%2F17425250903559873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=20102287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlSjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=337-344&author=K.+D.+Readauthor=S.+Braggio&title=Assessing+brain+free+fraction+in+early+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing brain free fraction in early drug discovery</span></div><div class="casAuthors">Read, Kevin D.; Braggio, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">337-344</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The incorporation of brain tissue binding routinely in CNS drug discovery screening strategies has markedly changed the way CNS drug discovery is performed and is proving to be a valuable tool in identifying new therapies for CNS diseases.  For many years emphasis has been placed on the magnitude of the brain to blood ratio, the bigger the better, even though, in many cases, brain total concn. (Cbrain) has no or, at best, poor correlation with receptor occupancy/pharmacodynamic readout.  Today, Cbrain values measured during in vivo expts. are cor. for the fraction unbound measured through in vitro expts. using brain tissue homogenate or brain tissue slice to obtain an est. of the brain unbound concn. (Cu,brain), and this has been demonstrated across a range of CNS targets to give a much better correlation with receptor occupancy/pharmacodynamic readout.  This apparently simple change in CNS lead optimization strategy has de facto revolutionized the vision of the brain penetration concepts.Areas covered in this review: This review will provide an overview of the use and applications of assessing brain free fraction to det. Cu,brain.Take home message: Assessing brain free fraction to det. Cu,brain in CNS lead optimization strategies is the surrogate of choice for rapidly assessing biophase concn. for the majority of CNS targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9c99W0CmXPbVg90H21EOLACvtfcHk0ljOZ_WOaXHtcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlSjtLg%253D&md5=f989ca92c918d40fc01ba01835942ded</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1517%2F17425250903559873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425250903559873%26sid%3Dliteratum%253Aachs%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DBraggio%26aufirst%3DS.%26atitle%3DAssessing%2520brain%2520free%2520fraction%2520in%2520early%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2010%26volume%3D6%26spage%3D337%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Murray, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Politzer, P.</span><span> </span><span class="NLM_article-title">Correlations between the solvent hydrogen bond acceptor parameter β and the calculated molecular electrostatic potential</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3734</span><span class="NLM_x">–</span> <span class="NLM_lpage">3739</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00011a060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1991&pages=3734-3739&author=J.+S.+Murrayauthor=S.+Ranganathanauthor=P.+Politzer&title=Correlations+between+the+solvent+hydrogen+bond+acceptor+parameter+%CE%B2+and+the+calculated+molecular+electrostatic+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjo00011a060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00011a060%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DJ.%2BS.%26aulast%3DRanganathan%26aufirst%3DS.%26aulast%3DPolitzer%26aufirst%3DP.%26atitle%3DCorrelations%2520between%2520the%2520solvent%2520hydrogen%2520bond%2520acceptor%2520parameter%2520%25CE%25B2%2520and%2520the%2520calculated%2520molecular%2520electrostatic%2520potential%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1991%26volume%3D56%26spage%3D3734%26epage%3D3739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torsten, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudkins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery</span> <span class="citation_source-journal">Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><div class="note"><p class="first last">and the references therein.</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/cn200100h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=50-68&author=A.+K.+Ghoseauthor=H.+Torstenauthor=R.+L.+Hudkinsauthor=B.+D.+Dorseyauthor=J.+P.+Mallamo&title=Knowledge-based%2C+central+nervous+system+%28CNS%29+lead+selection+and+lead+optimization+for+CNS+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Hudkins, Robert L.; Dorsey, Bruce D.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-68</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The central nervous system (CNS) is the major area that is affected by aging.  Alzheimer's disease (AD), Parkinson's disease (PD), brain cancer, and stroke are the CNS diseases that will cost trillions of dollars for their treatment.  Achievement of appropriate blood-brain barrier (BBB) penetration is often considered a significant hurdle in the CNS drug discovery process.  On the other hand, BBB penetration may be a liability for many of the non-CNS drug targets, and a clear understanding of the physicochem. and structural differences between CNS and non-CNS drugs may assist both research areas.  Because of the numerous and challenging issues in CNS drug discovery and the low success rates, pharmaceutical companies are beginning to deprioritize their drug discovery efforts in the CNS arena.  Prompted by these challenges and to aid in the design of high-quality, efficacious CNS compds., we analyzed the physicochem. property and the chem. structural profiles of 317 CNS and 626 non-CNS oral drugs.  The conclusions derived provide an ideal property profile for lead selection and the property modification strategy during the lead optimization process.  A list of substructural units that may be useful for CNS drug design was also provided here.  A classification tree was also developed to differentiate between CNS drugs and non-CNS oral drugs.  The combined anal. provided the following guidelines for designing high-quality CNS drugs: (i) topol. mol. polar surface area of <76 Å2 (25-60 Å2), (ii) at least one (one or two, including one aliph. amine) nitrogen, (iii) fewer than seven (two to four) linear chains outside of rings, (iv) fewer than three (zero or one) polar hydrogen atoms, (v) vol. of 740-970 Å3, (vi) solvent accessible surface area of 460-580 Å2, and (vii) pos. QikProp parameter CNS.  The ranges within parentheses may be used during lead optimization.  One violation to this proposed profile may be acceptable.  The chemoinformatics approaches for graphically analyzing multiple properties efficiently are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozqfO0vq2i5bVg90H21EOLACvtfcHk0lhg6ZGpLmwzsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO&md5=4c20ba34c3d5397170b50242975ce25d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcn200100h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200100h%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DTorsten%26aufirst%3DH.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge-based%252C%2520central%2520nervous%2520system%2520%2528CNS%2529%2520lead%2520selection%2520and%2520lead%2520optimization%2520for%2520CNS%2520drug%2520discovery%26jtitle%3DChem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D50%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><div class="note"><p class="first last">For a recent review regarding the correlation between in vitro potency, ADMET, and physicochemical parameters, see</p></div><span class="NLM_contrib-group">Hann, M. M.</span><span> </span><span class="NLM_article-title">Molecular obesity, potency and other addictions in drug discovery</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><div class="note"><p class="first last">and the references therein.</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1039%2Fc1md00017a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1Kht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=349-355&author=M.+M.+Hann&title=Molecular+obesity%2C+potency+and+other+addictions+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular obesity, potency and other addictions in drug discovery</span></div><div class="casAuthors">Hann, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">349-355</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Despite the increase in global biol. and chem. knowledge the discovery of effective and safe new drugs seems to become harder rather than easier.  Some of this challenge is due to increasing demands for safety and novelty, but some of the risk involved in this should be controllable if we had more effectively learned from our failures.  This perspective reflects on some of the learnings of recent years in relation to the causes of attrition.  The term Mol. Obesity is introduced to describe our tendency to build potency into mols. by the inappropriate use of lipophilicity which leads to the premature demise of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSlF7TPy6fHLVg90H21EOLACvtfcHk0lhg6ZGpLmwzsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1Kht7g%253D&md5=954870db4b1d9e846612c3bb256582f7</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fc1md00017a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00017a%26sid%3Dliteratum%253Aachs%26aulast%3DHann%26aufirst%3DM.%2BM.%26atitle%3DMolecular%2520obesity%252C%2520potency%2520and%2520other%2520addictions%2520in%2520drug%2520discovery%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D349%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><div class="note"><p class="first last">For a review on factors that influence the oral absorption of drugs, see</p></div><span class="NLM_contrib-group">Hurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loi, C.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodfuehrer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kattan, A.</span><span> </span><span class="NLM_article-title">Impact of physiological, physicochemical and biopharmaceutical; factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans</span> <span class="citation_source-journal">Expert Opin. Drug. Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">489</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1517%2F17425255.3.4.469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=17696800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptVWjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=469-489&author=S.+Hurstauthor=C.-M.+Loiauthor=J.+Brodfuehrerauthor=A.+El-Kattan&title=Impact+of+physiological%2C+physicochemical+and+biopharmaceutical%3B+factors+in+absorption+and+metabolism+mechanisms+on+the+drug+oral+bioavailability+of+rats+and+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans</span></div><div class="casAuthors">Hurst, Susan; Loi, Cho-Ming; Brodfuehrer, Joanne; El-Kattan, Ayman</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-489</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The onset, intensity and duration of therapeutic response to a compd. depend on the intrinsic pharmacol. activity of the drug and pharmacokinetic factors related to its absorption, distribution, metab. and elimination that are inherent to the biol. system.  The process of drug transfer from the site of administration to the systemic circulation and the interspecies factors that impact this process are the scope of this review.  In general, the factors that influence oral drug bioavailability via absorption and metab. can be divided into physicochem./biopharmaceutical and physiol. factors.  Physicochem. and biopharmaceutical factors that influence permeability and soly. tend to be species independent.  Although there are significant differences in the anatomy and physiol. of the gastrointestinal tract, these are not assocd. with significant differences in the rate and extent of drug absorption between rats and humans.  However, species differences in drug metab. in rats and humans did result in significant species differences in bioavailability.  Overall, this review provides a better understanding of the interplay between drug physicochem./biopharmaceutical factors and species differences/similarities in the absorption and metab. mechanisms that affect oral bioavailability in rats and humans.  This will enable a more rational approach to perform projection of oral bioavailability in human using available rat in vivo data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_n608youfiLVg90H21EOLACvtfcHk0lhg6ZGpLmwzsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptVWjtLk%253D&md5=e284a989273597c674e9ddefe49716b2</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1517%2F17425255.3.4.469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.3.4.469%26sid%3Dliteratum%253Aachs%26aulast%3DHurst%26aufirst%3DS.%26aulast%3DLoi%26aufirst%3DC.-M.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%26aulast%3DEl-Kattan%26aufirst%3DA.%26atitle%3DImpact%2520of%2520physiological%252C%2520physicochemical%2520and%2520biopharmaceutical%253B%2520factors%2520in%2520absorption%2520and%2520metabolism%2520mechanisms%2520on%2520the%2520drug%2520oral%2520bioavailability%2520of%2520rats%2520and%2520humans%26jtitle%3DExpert%2520Opin.%2520Drug.%2520Metab.%2520Toxicol.%26date%3D2007%26volume%3D3%26spage%3D469%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><div class="note"><p class="first last">For assay conditions, see:</p></div><span class="NLM_contrib-group">Kantharaj, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuytelaars, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proost, P. E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongel, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Assouw, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilissen, R. A. H. J.</span><span> </span><span class="NLM_article-title">Simultaneous measurement of drug metabolic stability and identification of metabolites using ion-trap mass spectrometry</span> <span class="citation_source-journal">Rapid Commun. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2661</span><span class="NLM_x">–</span> <span class="NLM_lpage">2668</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1002%2Frcm.1228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=14648905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpslSiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=2661-2668&author=E.+Kantharajauthor=A.+Tuytelaarsauthor=P.+E.+A.+Proostauthor=Z.+Ongelauthor=H.+P.+van+Assouwauthor=R.+A.+H.+J.+Gilissen&title=Simultaneous+measurement+of+drug+metabolic+stability+and+identification+of+metabolites+using+ion-trap+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Simultaneous measurement of drug metabolic stability and identification of metabolites using ion-trap mass spectrometry</span></div><div class="casAuthors">Kantharaj, E.; Tuytelaars, An; Proost, Pascale E. A.; Ongel, Zuleyha; van Assouw, Harrie P.; Gilissen, Ron A. H. J.</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2661-2668</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The use of in vitro drug metab. data in the understanding of in vivo pharmacokinetic, safety and toxicity data has become a large area of scientific interest.  This has stemmed from a trend in the pharmaceutical industry to use in vitro data generated from human tissue as a criterion to select compds. for further investigation.  As well as measuring metabolic stability in vitro using human liver microsomal prepns., the identification of possible metabolite(s) formed may play a vital role in Hit-to-Lead and Lead optimization processes.  The data-dependent scan function mode with the ion-trap instrumentation provides the ability to measure the metabolic stability and identification of possible metabolites of a compd.  A gradient liq. chromatog. method with a run time of 6 min/injection was developed for this purpose.  The approach of simultaneous metabolic stability measurements and rapid identification of metabolites of drugs with high (verapamil), medium (propranolol and cisapride) and low (flunarizine) metabolic stabilities using ion-trap mass spectrometry is described.  The metabolites identified after 15 min incubation for verapamil, propranolol and cisapride are in good agreement with those reported as the major metabolites in human in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ62Aoyes0hLVg90H21EOLACvtfcHk0lj-tEmAQ-mDLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpslSiurY%253D&md5=221b64f3a0058d6a9c1f49ae5f4ab051</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Frcm.1228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.1228%26sid%3Dliteratum%253Aachs%26aulast%3DKantharaj%26aufirst%3DE.%26aulast%3DTuytelaars%26aufirst%3DA.%26aulast%3DProost%26aufirst%3DP.%2BE.%2BA.%26aulast%3DOngel%26aufirst%3DZ.%26aulast%3Dvan%2BAssouw%26aufirst%3DH.%2BP.%26aulast%3DGilissen%26aufirst%3DR.%2BA.%2BH.%2BJ.%26atitle%3DSimultaneous%2520measurement%2520of%2520drug%2520metabolic%2520stability%2520and%2520identification%2520of%2520metabolites%2520using%2520ion-trap%2520mass%2520spectrometry%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2003%26volume%3D17%26spage%3D2661%26epage%3D2668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Gee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommers, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melick, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gidrol, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burris, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klemm, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeiger, E.</span><span> </span><span class="NLM_article-title">Comparison of responses of base-specific Salmonella tester strains with the traditional strains for identifying mutagens: The results of a validation study</span> <span class="citation_source-journal">Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">412</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1016%2FS1383-5718%2897%2900172-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=9539966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADyaK1cXhtlOhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=412&publication_year=1998&pages=115-130&author=P.+Geeauthor=C.+H.+Sommersauthor=A.+S.+Melickauthor=X.+M.+Gidrolauthor=M.+D.+Toddauthor=R.+B.+Burrisauthor=M.+E.+Nelsonauthor=R.+C.+Klemmauthor=E.+Zeiger&title=Comparison+of+responses+of+base-specific+Salmonella+tester+strains+with+the+traditional+strains+for+identifying+mutagens%3A+The+results+of+a+validation+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of responses of base-specific Salmonella tester strains with the traditional strains for identifying mutagens: the results of a validation study</span></div><div class="casAuthors">Gee, P.; Sommers, C. H.; Melick, A. S.; Gidrol, X. M.; Todd, M. D.; Burris, R. B.; Nelson, M. E.; Klemm, R. C.; Zeiger, E.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Genetic Toxicology and Environmental Mutagenesis</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">412</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-130</span>CODEN:
                <span class="NLM_cas:coden">MRGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1383-5718</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ability of a TA7000 series of Salmonella his- mutant tester strains to detect mutagens as classified by the traditional tester strains (TA100, TA98, TA1535, TA1537, TA97, TA102 and TA104) was evaluated using 30 coded chems., 5 of which were duplicates with different code nos.  The TA7000 series of tester strains were TA7001, TA7002, TA7003, TA7004, TA7005 and TA7006, each of which reverts by a specific base substitution.  In addn., each chem. was tested in a mixt. of the base-specific strains (the Mix), plus the traditional strains, TA98 and TA1537.  A liq. version of the Salmonella mutagenicity assay was performed in microtiter plates to allow partial automation for increased throughput.  The results were compared to those in the National Toxicol. Program (NTP) database, which were obtained from the traditional strains in the preincubation assay.  In the two strains common to both protocols, TA98 and TA1537, the agreement was 80 and 85, resp.  When compared to the NTP results for TA100, the Mix gave a 72 concordance, while the addn. of the frameshift tester strain, TA98, increased the agreement to 76.  The overall agreement on pos. or neg. classifications of mutagenicity was 88 for the 25 chems. tested.  There were three notable exceptions to the overall agreement.  Benzaldehyde was detected as a mutagen in TA7005 in contrast to its classification as a non-mutagen in the NTP database.  This does not necessarily contradict the NTP results because the base-specific strains may respond to different mutagens.  Two weak mutagens in the NTP database, 1-chloro-2-propanol and iso-Bu nitrite, were not detected as mutagens in the base-specific new strains in the liq. protocol.  While there are a no. of major differences in the two assays, it was concluded that the results from each procedure are comparable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9feY0gJJyLrVg90H21EOLACvtfcHk0li56p_OlllSBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtlOhtrs%253D&md5=fc3e67ee85d01cf4a5d3948da34184e4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS1383-5718%2897%2900172-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1383-5718%252897%252900172-1%26sid%3Dliteratum%253Aachs%26aulast%3DGee%26aufirst%3DP.%26aulast%3DSommers%26aufirst%3DC.%2BH.%26aulast%3DMelick%26aufirst%3DA.%2BS.%26aulast%3DGidrol%26aufirst%3DX.%2BM.%26aulast%3DTodd%26aufirst%3DM.%2BD.%26aulast%3DBurris%26aufirst%3DR.%2BB.%26aulast%3DNelson%26aufirst%3DM.%2BE.%26aulast%3DKlemm%26aufirst%3DR.%2BC.%26aulast%3DZeiger%26aufirst%3DE.%26atitle%3DComparison%2520of%2520responses%2520of%2520base-specific%2520Salmonella%2520tester%2520strains%2520with%2520the%2520traditional%2520strains%2520for%2520identifying%2520mutagens%253A%2520The%2520results%2520of%2520a%2520validation%2520study%26jtitle%3DMutat.%2520Res.%26date%3D1998%26volume%3D412%26spage%3D115%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Hastwell, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walmsley, R. M.</span><span> </span><span class="NLM_article-title">High-specificity and high-sensitivity genotoxicity assessment in a human cell line: Validation of the GreenScreen HC GADD45a-GFP genotoxicity assay</span> <span class="citation_source-journal">Mutat. Res., Genet. Toxicol. Environ. Mutagen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">607</span><span class="NLM_x">, </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=607&publication_year=2006&pages=160-175&author=P.+W.+Hastwellauthor=L.-L.+Chaiauthor=K.+J.+Robertsauthor=T.+W.+Websterauthor=J.+S.+Harveyauthor=R.+W.+Reesauthor=R.+M.+Walmsley&title=High-specificity+and+high-sensitivity+genotoxicity+assessment+in+a+human+cell+line%3A+Validation+of+the+GreenScreen+HC+GADD45a-GFP+genotoxicity+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHastwell%26aufirst%3DP.%2BW.%26aulast%3DChai%26aufirst%3DL.-L.%26aulast%3DRoberts%26aufirst%3DK.%2BJ.%26aulast%3DWebster%26aufirst%3DT.%2BW.%26aulast%3DHarvey%26aufirst%3DJ.%2BS.%26aulast%3DRees%26aufirst%3DR.%2BW.%26aulast%3DWalmsley%26aufirst%3DR.%2BM.%26atitle%3DHigh-specificity%2520and%2520high-sensitivity%2520genotoxicity%2520assessment%2520in%2520a%2520human%2520cell%2520line%253A%2520Validation%2520of%2520the%2520GreenScreen%2520HC%2520GADD45a-GFP%2520genotoxicity%2520assay%26jtitle%3DMutat.%2520Res.%252C%2520Genet.%2520Toxicol.%2520Environ.%2520Mutagen.%26date%3D2006%26volume%3D607%26spage%3D160%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Dressman, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reppas, C.</span><span> </span><span class="NLM_article-title">In vitro–in vivo correlations for lipophilic, poorly water soluble drugs</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_fpage">S73</span><span class="NLM_x">–</span> <span class="NLM_lpage">S78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=S73-S78&author=J.+B.+Dressmanauthor=C.+Reppas&title=In+vitro%E2%80%93in+vivo+correlations+for+lipophilic%2C+poorly+water+soluble+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDressman%26aufirst%3DJ.%2BB.%26aulast%3DReppas%26aufirst%3DC.%26atitle%3DIn%2520vitro%25E2%2580%2593in%2520vivo%2520correlations%2520for%2520lipophilic%252C%2520poorly%2520water%2520soluble%2520drugs%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2000%26spage%3DS73%26epage%3DS78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Yamaoka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stella, V. J.</span><span> </span><span class="NLM_article-title">Low melting phenytoin prodrugs as alternative oral delivery modes for phenytoin: a model for other high-melting sparingly water-soluble drugs</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">400</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1002%2Fjps.2600720420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=6864479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADyaL3sXit1WksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1983&pages=400-405&author=Y.+Yamaokaauthor=R.+D.+Robertsauthor=V.+J.+Stella&title=Low+melting+phenytoin+prodrugs+as+alternative+oral+delivery+modes+for+phenytoin%3A+a+model+for+other+high-melting+sparingly+water-soluble+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Low-melting phenytoin prodrugs as alternative oral delivery modes for phenytoin:  a model for other high-melting sparingly water-soluble drugs</span></div><div class="casAuthors">Yamaoka, Yumiko; Roberts, Richard D.; Stella, Valentino J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">400-5</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    </div><div class="casAbstract">A homologous series of 3-acyloxymethyl derivs. of phenytoin (I)  [57-41-0] (acetyl through decanoyl) were synthesized and various physicochem. properties measured.  The prodrugs were more readily sol. in various metabolizable glycerol esters such as tributyrin  [60-01-5], trioctanoin  [538-23-8], and triolein  [122-32-7] than I.  The soly. of the prodrugs in the various org. vehicles studied was closely correlated to the m.p. of the prodrug: the lower the m.p. the greater the soly.  The cleavage rates of the prodrugs in plasma and tissue homogenates followed a parabolic relationship with chain length.  The prodrug, 3-pentanoyloxymethyl-5,5-diphenylhydantoin  [85901-34-4] when administered in tributyrin gave superior oral I bioavailability in rats when compared with Na phenytoin  [630-93-3] administered as an aq. soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKaz4BgZlrPrVg90H21EOLACvtfcHk0lgMLaL1m-Gs2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXit1WksLw%253D&md5=9b9785458d6202a1a5110d017d94cbc4</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600720420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600720420%26sid%3Dliteratum%253Aachs%26aulast%3DYamaoka%26aufirst%3DY.%26aulast%3DRoberts%26aufirst%3DR.%2BD.%26aulast%3DStella%26aufirst%3DV.%2BJ.%26atitle%3DLow%2520melting%2520phenytoin%2520prodrugs%2520as%2520alternative%2520oral%2520delivery%2520modes%2520for%2520phenytoin%253A%2520a%2520model%2520for%2520other%2520high-melting%2520sparingly%2520water-soluble%2520drugs%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D1983%26volume%3D72%26spage%3D400%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Salama, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, R. J. Y.</span><span> </span><span class="NLM_article-title">MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2293</span><span class="NLM_x">–</span> <span class="NLM_lpage">2308</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=2293-2308&author=N.+N.+Salamaauthor=Z.+Yangauthor=T.+Buiauthor=R.+J.+Y.+Ho&title=MDR1+haplotypes+significantly+minimize+intracellular+uptake+and+transcellular+P-gp+substrate+transport+in+recombinant+LLC-PK1+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalama%26aufirst%3DN.%2BN.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DBui%26aufirst%3DT.%26aulast%3DHo%26aufirst%3DR.%2BJ.%2BY.%26atitle%3DMDR1%2520haplotypes%2520significantly%2520minimize%2520intracellular%2520uptake%2520and%2520transcellular%2520P-gp%2520substrate%2520transport%2520in%2520recombinant%2520LLC-PK1%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2006%26volume%3D95%26spage%3D2293%26epage%3D2308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="note"><p class="first last">The CEREP selectivity screen was performed on the following receptors and transporters: A1, A2A, A3, alpha 1, alpha 2, beta 1, AT1, BZD, B2, CCK1, CCKA, D1, D2S, ETA, GABA, GAL2, CXCR2 (IL-8B), CCR1, H1, H2, MC4, MT1 (ML1A), M1, M2, M3, NK2, NK3, Y1, Y2, NTS1 (NT1), delta 2 (DOP), kappa (KOP), mu (MOP), NOP (ORL1), 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2B, 5-HT3, 5-HT5a, 5-HT6, 5-HT7, sst, VPAC1 (VIP1), V1a, Ca2+ channel (L, verapamil site) (phenylalkylamine), KV channel, SKCa channel, Na<sup>+</sup> channel (site 2), Cl<sup>–</sup> channel (GABA-gated) norepinephrine transporter, and dopamine transporter; and on the following enzymes: PLA2, COX1, COX2, 12-lipoxygenase, PDE2A, PDE3A, PDE4D, PDE5, PDE6, ACE, ACE-2, BACE-1, ECE-1, elastase, caspase-3, caspase-8, cathepsin D, cathepsin L, HIV-1 protease, neutral endopeptidase, MMP-1, MMP-3, MMP-9, tryptase, TACE, phosphatase 1B (PTP1B), phosphatase CDC25A, phosphatase MKP1, acetylcholinesterase, MAO-A, MAO-B, HDAC3, HDAC4, HDAC6, HDAC11, sirtuin 1, sirtuin 2.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><div class="note"><p class="first last">For a comprehensive study of this modulator’s behavior in a dog model, see:</p></div><span class="NLM_contrib-group">Borghys, H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuefferd, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Broeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clessens, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cools, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straetemans, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Ridder, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span> </span><span class="NLM_article-title">A canine model to evaluate efficacy and safety of γ-secretase inhibitors and modulators</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">822</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=22072214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFejur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2012&pages=809-822&author=H+Borghysauthor=M+Tuefferdauthor=B.+Van+Broeckauthor=E.+Clessensauthor=L.+Dillenauthor=W.+Coolsauthor=P.+Vinkenauthor=R.+Straetemansauthor=F.+de+Ridderauthor=H.+Gijsenauthor=M.+Mercken&title=A+canine+model+to+evaluate+efficacy+and+safety+of+%CE%B3-secretase+inhibitors+and+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A Canine Model to Evaluate Efficacy and Safety of γ-Secretase Inhibitors and Modulators</span></div><div class="casAuthors">Borghys, Herman; Tuefferd, Marianne; Van Broeck, Bianca; Clessens, Ellen; Dillen, Lieve; Cools, Willy; Vinken, Petra; Straetemans, Roel; De Ridder, Filip; Gijsen, Harrie; Mercken, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">809-822</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Gamma-secretase, a membrane bound protease which cleaves the transmembrane protein amyloid-β protein precursor (AβPP), is a therapeutic target for Alzheimer's disease.  Gamma-secretase inhibitors (GSIs) and modulators (GSMs) are being investigated as potential disease-modifying agents.  Preclin. in vivo models to monitor the activity on gamma-secretase are described in different species such as mouse, rat, and guinea pigs.  All these models have their value in testing compds. with amyloid lowering properties, however, compd. characteristics and pharmacokinetic properties, as well as other species characteristics such as limited sampling vols. of cerebrospinal fluid (CSF), recommended the use of a larger, non-rodent animal species.  For this purpose, a screening model in dogs was developed for testing GSIs and GSMs.  We showed that GSIs and GSMs had a dose- and time-dependent effect on Aβ37, Aβ38, Aβ40, and Aβ42 in CSF.  Changes in liver function were evidenced by a transient increase in bilirubin with the GSMs and incidental increases in alanine aminotransferase for GSMs as well as GSIs.  Microarray anal. of liver biopsies enabled to elucidate potential mechanisms behind the liver function changes.  The relevance of the liver findings should be further evaluated in chronic pre-clin. safety studies and in humans.  Based on our data, we can conclude that the dog is a very appropriate species to assess efficacy and safety of compds. which have an effect on AβPP processing such as GSMs, GSIs, and BACE-inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU5WzC1CQ6UrVg90H21EOLACvtfcHk0lgMLaL1m-Gs2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFejur8%253D&md5=10f4d27ac0ac43cbf51aa71fb39bbf4c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorghys%26aufirst%3DH%26aulast%3DTuefferd%26aufirst%3DM%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DClessens%26aufirst%3DE.%26aulast%3DDillen%26aufirst%3DL.%26aulast%3DCools%26aufirst%3DW.%26aulast%3DVinken%26aufirst%3DP.%26aulast%3DStraetemans%26aufirst%3DR.%26aulast%3Dde%2BRidder%26aufirst%3DF.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DMercken%26aufirst%3DM.%26atitle%3DA%2520canine%2520model%2520to%2520evaluate%2520efficacy%2520and%2520safety%2520of%2520%25CE%25B3-secretase%2520inhibitors%2520and%2520modulators%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26volume%3D28%26spage%3D809%26epage%3D822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talreja, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuervo, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaravel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humora, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackett, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollate, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunah, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snodgrass-Belt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taveras, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R. H.</span><span> </span><span class="NLM_article-title">Discovery of BIIB042, a potent, selective, and orally bioavailable γ-secretase modulator</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">786</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200175q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=786-791&author=H.+Pengauthor=T.+Talrejaauthor=Z.+Xinauthor=J.+H.+Cuervoauthor=G.+Kumaravelauthor=M.+J.+Humoraauthor=L.+Xuauthor=E.+Rohdeauthor=L.+Ganauthor=M.+Jungauthor=M.+N.+Shackettauthor=S.+Chollateauthor=A.+W.+Dunahauthor=P.+A.+Snodgrass-Beltauthor=H.+M.+Arnoldauthor=A.+G.+Taverasauthor=K.+J.+Rhodesauthor=R.+H.+Scannevin&title=Discovery+of+BIIB042%2C+a+potent%2C+selective%2C+and+orally+bioavailable+%CE%B3-secretase+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fml200175q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200175q%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DTalreja%26aufirst%3DT.%26aulast%3DXin%26aufirst%3DZ.%26aulast%3DCuervo%26aufirst%3DJ.%2BH.%26aulast%3DKumaravel%26aufirst%3DG.%26aulast%3DHumora%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DRohde%26aufirst%3DE.%26aulast%3DGan%26aufirst%3DL.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DShackett%26aufirst%3DM.%2BN.%26aulast%3DChollate%26aufirst%3DS.%26aulast%3DDunah%26aufirst%3DA.%2BW.%26aulast%3DSnodgrass-Belt%26aufirst%3DP.%2BA.%26aulast%3DArnold%26aufirst%3DH.%2BM.%26aulast%3DTaveras%26aufirst%3DA.%2BG.%26aulast%3DRhodes%26aufirst%3DK.%2BJ.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26atitle%3DDiscovery%2520of%2520BIIB042%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520%25CE%25B3-secretase%2520modulator%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D786%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2'],'ref3':['cit3a','cit3b','cit3c','cit3d'],'ref4':['cit4a','cit4b'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b','cit7c'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10a','cit10b','cit10c','cit10d','cit10e','cit10f','cit10g','cit10h'],'ref11':['cit11a','cit11b'],'ref12':['cit12a','cit12b'],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c','cit14d','cit14e','cit14f','cit14g'],'ref15':['cit15'],'ref16':['cit16a','cit16b','cit16c','cit16d'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':[],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':[],'ref39':['cit39'],'ref40':['cit40']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 52 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ángel Santiago, Dulce C. Guzmán-Ocampo, Rodrigo Aguayo-Ortiz, <span class="NLM_string-name hlFld-ContribAuthor">Laura Dominguez</span>. </span><span class="cited-content_cbyCitation_article-title">Characterizing the Chemical Space of γ-Secretase Inhibitors and Modulators. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (15)
                                     , 2765-2775. <a href="https://doi.org/10.1021/acschemneuro.1c00313" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00313%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DCharacterizing%252Bthe%252BChemical%252BSpace%252Bof%252B%2525CE%2525B3-Secretase%252BInhibitors%252Band%252BModulators%26aulast%3DSantiago%26aufirst%3D%25C3%2581ngel%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21052021%26date%3D09072021%26date%3D22072021%26volume%3D12%26issue%3D15%26spage%3D2765%26epage%3D2775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Charlotte Juillet, Ludmila Ermolenko, Dina Boyarskaya, Blandine Baratte, Béatrice Josselin, Hristo Nedev, Stéphane Bach, Bogdan I. Iorga, Jérôme Bignon, Sandrine Ruchaud, <span class="NLM_string-name hlFld-ContribAuthor">Ali Al-Mourabit</span>. </span><span class="cited-content_cbyCitation_article-title">From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (2)
                                     , 1197-1219. <a href="https://doi.org/10.1021/acs.jmedchem.0c02064" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02064%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFrom%252BSynthetic%252BSimplified%252BMarine%252BMetabolite%252BAnalogues%252Bto%252BNew%252BSelective%252BAllosteric%252BInhibitor%252Bof%252BAurora%252BB%252BKinase%26aulast%3DJuillet%26aufirst%3DCharlotte%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D27112020%26date%3D08012021%26volume%3D64%26issue%3D2%26spage%3D1197%26epage%3D1219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mihirbaran Mandal, Alexei Buevich, John P. Caldwell, Lynn Hyde, Xianhai Huang, Xiaoxiang Liu, Brian McKittrick, Robert D. Mazzola, Dmitri Pissarnitski, Anandan Palani, Lili Zhang, Eric Parker, Li Xiao, Diane Rindgen, <span class="NLM_string-name hlFld-ContribAuthor">Zhaoning Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of Leads for γ-Secretase Modulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8216-8230. <a href="https://doi.org/10.1021/acs.jmedchem.0c00446" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00446%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGeneration%252Bof%252BLeads%252Bfor%252B%2525CE%2525B3-Secretase%252BModulation%26aulast%3DMandal%26aufirst%3DMihirbaran%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16032020%26date%3D04082020%26date%3D27072020%26volume%3D63%26issue%3D15%26spage%3D8216%26epage%3D8230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Luca Quattrini, Edoardo Luigi Maria Gelardi, Giovanni Petrarolo, Giorgia Colombo, Davide Maria Ferraris, Francesca Picarazzi, Menico Rizzi, Silvia Garavaglia, <span class="NLM_string-name hlFld-ContribAuthor">Concettina La Motta</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in the Field of Aldehyde Dehydrogenase Inhibitors: Novel Imidazo[1,2-a]pyridines against the 1A Family. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 963-970. <a href="https://doi.org/10.1021/acsmedchemlett.9b00686" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00686</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00686%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DProgress%252Bin%252Bthe%252BField%252Bof%252BAldehyde%252BDehydrogenase%252BInhibitors%25253A%252BNovel%252BImidazo%25255B1%25252C2-a%25255Dpyridines%252Bagainst%252Bthe%252B1A%252BFamily%26aulast%3DQuattrini%26aufirst%3DLuca%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03012020%26date%3D25032020%26date%3D31032020%26date%3D25032020%26volume%3D11%26issue%3D5%26spage%3D963%26epage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Ye</span>, <span class="hlFld-ContribAuthor ">Mansour  Haddad</span>, <span class="hlFld-ContribAuthor ">Virginie  Ratovelomanana-Vidal</span>, and <span class="hlFld-ContribAuthor ">Véronique  Michelet</span>  . </span><span class="cited-content_cbyCitation_article-title">Ruthenium-Catalyzed [2 + 2 + 2] Cycloaddition Reaction Forming 2-Aminopyridine Derivatives from α,ω-Diynes and Cyanamides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (5)
                                     , 1104-1107. <a href="https://doi.org/10.1021/acs.orglett.7b00130" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b00130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b00130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b00130%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRuthenium-Catalyzed%252B%25255B2%252B%25252B%252B2%252B%25252B%252B2%25255D%252BCycloaddition%252BReaction%252BForming%252B2-Aminopyridine%252BDerivatives%252Bfrom%252B%2525CE%2525B1%25252C%2525CF%252589-Diynes%252Band%252BCyanamides%26aulast%3DYe%26aufirst%3DFei%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D13012017%26date%3D22022017%26date%3D03032017%26volume%3D19%26issue%3D5%26spage%3D1104%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paula  Ruiz-Castillo</span> and <span class="hlFld-ContribAuthor ">Stephen L.  Buchwald</span>  . </span><span class="cited-content_cbyCitation_article-title">Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (19)
                                     , 12564-12649. <a href="https://doi.org/10.1021/acs.chemrev.6b00512" title="DOI URL">https://doi.org/10.1021/acs.chemrev.6b00512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.6b00512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.6b00512%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DApplications%252Bof%252BPalladium-Catalyzed%252BC%2525E2%252580%252593N%252BCross-Coupling%252BReactions%26aulast%3DRuiz-Castillo%26aufirst%3DPaula%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03082016%26date%3D30092016%26date%3D12102016%26volume%3D116%26issue%3D19%26spage%3D12564%26epage%3D12649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew G.  Bursavich</span>, <span class="hlFld-ContribAuthor ">Bryce A.  Harrison</span>, and <span class="hlFld-ContribAuthor ">Jean-François  Blain</span>  . </span><span class="cited-content_cbyCitation_article-title">Gamma Secretase Modulators: New Alzheimer’s Drugs on the Horizon?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (16)
                                     , 7389-7409. <a href="https://doi.org/10.1021/acs.jmedchem.5b01960" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01960</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01960%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGamma%252BSecretase%252BModulators%25253A%252BNew%252BAlzheimer%2525E2%252580%252599s%252BDrugs%252Bon%252Bthe%252BHorizon%25253F%26aulast%3DBursavich%26aufirst%3DMatthew%2BG.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D18122015%26date%3D05042016%26date%3D25082016%26date%3D23032016%26volume%3D59%26issue%3D16%26spage%3D7389%26epage%3D7409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinde  Chen</span>, <span class="hlFld-ContribAuthor ">Wenwei  Xu</span>, <span class="hlFld-ContribAuthor ">Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Mingguang  Mo</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Lili  Du</span>, <span class="hlFld-ContribAuthor ">Xiaojing  Yuan</span>, <span class="hlFld-ContribAuthor ">Yechun  Xu</span>, <span class="hlFld-ContribAuthor ">Yiping  Wang</span>, and <span class="hlFld-ContribAuthor ">Jianhua  Shen</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Series of Imidazo[1,2-a]pyrimidine Derivatives as Potent and Orally Bioavailable Lipoprotein-Associated Phospholipase A2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (21)
                                     , 8529-8541. <a href="https://doi.org/10.1021/acs.jmedchem.5b01024" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01024%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BSeries%252Bof%252BImidazo%25255B1%25252C2-a%25255Dpyrimidine%252BDerivatives%252Bas%252BPotent%252Band%252BOrally%252BBioavailable%252BLipoprotein-Associated%252BPhospholipase%252BA2%252BInhibitors%26aulast%3DChen%26aufirst%3DXinde%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D29062015%26date%3D28102015%26date%3D12112015%26date%3D19102015%26volume%3D58%26issue%3D21%26spage%3D8529%26epage%3D8541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pui Ying  Choy</span>, <span class="hlFld-ContribAuthor ">Kwan Chak  Luk</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Chau Ming  So</span>, <span class="hlFld-ContribAuthor ">Lai-lai  Wang</span>, and <span class="hlFld-ContribAuthor ">Fuk Yee  Kwong</span>  . </span><span class="cited-content_cbyCitation_article-title">Regioselective Direct C-3 Arylation of Imidazo[1,2-a]pyridines with Aryl Tosylates and Mesylates Promoted by Palladium–Phosphine Complexes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (3)
                                     , 1457-1463. <a href="https://doi.org/10.1021/jo502386w" title="DOI URL">https://doi.org/10.1021/jo502386w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo502386w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo502386w%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRegioselective%252BDirect%252BC-3%252BArylation%252Bof%252BImidazo%25255B1%25252C2-a%25255Dpyridines%252Bwith%252BAryl%252BTosylates%252Band%252BMesylates%252BPromoted%252Bby%252BPalladium%2525E2%252580%252593Phosphine%252BComplexes%26aulast%3DChoy%26aufirst%3DPui%2BYing%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D17102014%26date%3D21012015%26date%3D06022015%26date%3D14012015%26volume%3D80%26issue%3D3%26spage%3D1457%26epage%3D1463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Pettersson</span>, <span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>, <span class="hlFld-ContribAuthor ">Chakrapani  Subramanyam</span>, <span class="hlFld-ContribAuthor ">Kelly R.  Bales</span>, <span class="hlFld-ContribAuthor ">Christopher W.  am Ende</span>, <span class="hlFld-ContribAuthor ">Benjamin A.  Fish</span>, <span class="hlFld-ContribAuthor ">Michael E.  Green</span>, <span class="hlFld-ContribAuthor ">Gregory W.  Kauffman</span>, <span class="hlFld-ContribAuthor ">Patrick B.  Mullins</span>, <span class="hlFld-ContribAuthor ">Thayalan  Navaratnam</span>, <span class="hlFld-ContribAuthor ">Subas M.  Sakya</span>, <span class="hlFld-ContribAuthor ">Cory M.  Stiff</span>, <span class="hlFld-ContribAuthor ">Tuan P.  Tran</span>, <span class="hlFld-ContribAuthor ">Longfei  Xie</span>, <span class="hlFld-ContribAuthor ">Liming  Zhang</span>, <span class="hlFld-ContribAuthor ">Leslie R.  Pustilnik</span>, <span class="hlFld-ContribAuthor ">Beth C.  Vetelino</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Wood</span>, <span class="hlFld-ContribAuthor ">Nikolay  Pozdnyakov</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>, and <span class="hlFld-ContribAuthor ">Christopher J.  O’Donnell</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Pharmacological Evaluation of a Novel Series of Pyridopyrazine-1,6-dione γ-Secretase Modulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (3)
                                     , 1046-1062. <a href="https://doi.org/10.1021/jm401782h" title="DOI URL">https://doi.org/10.1021/jm401782h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401782h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401782h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPharmacological%252BEvaluation%252Bof%252Ba%252BNovel%252BSeries%252Bof%252BPyridopyrazine-1%25252C6-dione%252B%2525CE%2525B3-Secretase%252BModulators%26aulast%3DPettersson%26aufirst%3DMartin%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D17112013%26date%3D28012014%26date%3D13022014%26date%3D15012014%26volume%3D57%26issue%3D3%26spage%3D1046%26epage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christina J.  Crump</span>, <span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>, and <span class="hlFld-ContribAuthor ">Yue-Ming  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">Development and Mechanism of γ-Secretase Modulators for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2013,</strong> <em>52 </em>
                                    (19)
                                     , 3197-3216. <a href="https://doi.org/10.1021/bi400377p" title="DOI URL">https://doi.org/10.1021/bi400377p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi400377p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi400377p%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DDevelopment%252Band%252BMechanism%252Bof%252B%2525CE%2525B3-Secretase%252BModulators%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DCrump%26aufirst%3DChristina%2BJ.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D22032013%26date%3D23042013%26date%3D02052013%26date%3D14052013%26date%3D24042013%26volume%3D52%26issue%3D19%26spage%3D3197%26epage%3D3216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Xu</span>, <span class="hlFld-ContribAuthor ">Hong-Bo  Tan</span>, <span class="hlFld-ContribAuthor ">Ya-Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Dian-Yong  Tang</span>, <span class="hlFld-ContribAuthor ">Fenghuang  Zhan</span>, <span class="hlFld-ContribAuthor ">Hong-yu  Li</span>, <span class="hlFld-ContribAuthor ">Zhong-Zhu  Chen</span>, <span class="hlFld-ContribAuthor ">Zhi-Gang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-Free One-Pot Synthesis of Densely Substituted Pyrazole-Pyrazines as Anti-Colorectal Cancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-66137-z" title="DOI URL">https://doi.org/10.1038/s41598-020-66137-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-66137-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-66137-z%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DCatalyst-Free%252BOne-Pot%252BSynthesis%252Bof%252BDensely%252BSubstituted%252BPyrazole-Pyrazines%252Bas%252BAnti-Colorectal%252BCancer%252BAgents%26aulast%3DXu%26aufirst%3DJia%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryuichi  Sekioka</span>, <span class="hlFld-ContribAuthor ">Shugo  Honda</span>, <span class="hlFld-ContribAuthor ">Hiroki  Akashiba</span>, <span class="hlFld-ContribAuthor ">Junko  Yarimizu</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Mitani</span>, <span class="hlFld-ContribAuthor ">Shingo  Yamasaki</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization and biological evaluation of imidazopyridine derivatives as a novel scaffold for γ-secretase modulators with oral efficacy against cognitive deficits in Alzheimer’s disease model mice. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (11)
                                     , 115455. <a href="https://doi.org/10.1016/j.bmc.2020.115455" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115455</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115455%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Band%252Bbiological%252Bevaluation%252Bof%252Bimidazopyridine%252Bderivatives%252Bas%252Ba%252Bnovel%252Bscaffold%252Bfor%252B%2525CE%2525B3-secretase%252Bmodulators%252Bwith%252Boral%252Befficacy%252Bagainst%252Bcognitive%252Bdeficits%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Bmodel%252Bmice%26aulast%3DSekioka%26aufirst%3DRyuichi%26date%3D2020%26volume%3D28%26issue%3D11%26spage%3D115455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryuichi  Sekioka</span>, <span class="hlFld-ContribAuthor ">Shugo  Honda</span>, <span class="hlFld-ContribAuthor ">Eriko  Honjo</span>, <span class="hlFld-ContribAuthor ">Takayuki  Suzuki</span>, <span class="hlFld-ContribAuthor ">Hiroki  Akashiba</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Mitani</span>, <span class="hlFld-ContribAuthor ">Shingo  Yamasaki</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-ethylpyridine-2-carboxamide derivatives as a novel scaffold for orally active γ-secretase modulators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (1)
                                     , 115132. <a href="https://doi.org/10.1016/j.bmc.2019.115132" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115132%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-ethylpyridine-2-carboxamide%252Bderivatives%252Bas%252Ba%252Bnovel%252Bscaffold%252Bfor%252Borally%252Bactive%252B%2525CE%2525B3-secretase%252Bmodulators%26aulast%3DSekioka%26aufirst%3DRyuichi%26date%3D2020%26volume%3D28%26issue%3D1%26spage%3D115132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Vanda</span>, <span class="hlFld-ContribAuthor ">Paweł  Zajdel</span>, <span class="hlFld-ContribAuthor ">Miroslav  Soural</span>. </span><span class="cited-content_cbyCitation_article-title">Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>181 </em>, 111569. <a href="https://doi.org/10.1016/j.ejmech.2019.111569" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111569</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111569%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DImidazopyridine-based%252Bselective%252Band%252Bmultifunctional%252Bligands%252Bof%252Bbiological%252Btargets%252Bassociated%252Bwith%252Bpsychiatric%252Band%252Bneurodegenerative%252Bdiseases%26aulast%3DVanda%26aufirst%3DDavid%26date%3D2019%26volume%3D181%26spage%3D111569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hayrettin Ozan  Gulcan</span>, <span class="hlFld-ContribAuthor ">Açelya  Mavideniz</span>, <span class="hlFld-ContribAuthor ">Mustafa Fethi  Sahin</span>, <span class="hlFld-ContribAuthor ">Ilkay Erdogan  Orhan</span>. </span><span class="cited-content_cbyCitation_article-title">Benzimidazole-derived Compounds Designed for Different Targets of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2019,</strong> <em>26 </em>
                                    (18)
                                     , 3260-3278. <a href="https://doi.org/10.2174/0929867326666190124123208" title="DOI URL">https://doi.org/10.2174/0929867326666190124123208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867326666190124123208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867326666190124123208%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DBenzimidazole-derived%252BCompounds%252BDesigned%252Bfor%252BDifferent%252BTargets%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DGulcan%26aufirst%3DHayrettin%2BOzan%26date%3D2019%26volume%3D26%26issue%3D18%26spage%3D3260%26epage%3D3278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nalini  Schaduangrat</span>, <span class="hlFld-ContribAuthor ">Veda  Prachayasittikul</span>, <span class="hlFld-ContribAuthor ">Saowapak  Choomwattana</span>, <span class="hlFld-ContribAuthor ">Prapimpun  Wongchitrat</span>, <span class="hlFld-ContribAuthor ">Kamonrat  Phopin</span>, <span class="hlFld-ContribAuthor ">Wilasinee  Suwanjang</span>, <span class="hlFld-ContribAuthor ">Aijaz Ahmad  Malik</span>, <span class="hlFld-ContribAuthor ">Bruno  Vincent</span>, <span class="hlFld-ContribAuthor ">Chanin  Nantasenamat</span>. </span><span class="cited-content_cbyCitation_article-title">Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (5)
                                     , 1730-1778. <a href="https://doi.org/10.1002/med.21563" title="DOI URL">https://doi.org/10.1002/med.21563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21563%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMultidisciplinary%252Bapproaches%252Bfor%252Btargeting%252Bthe%252Bsecretase%252Bprotein%252Bfamily%252Bas%252Ba%252Btherapeutic%252Broute%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DSchaduangrat%26aufirst%3DNalini%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D5%26spage%3D1730%26epage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guilherme Martins  Silva</span>, <span class="hlFld-ContribAuthor ">Mariana Pegrucci  Barcelos</span>, <span class="hlFld-ContribAuthor ">João Gabriel Curtolo  Poiani</span>, <span class="hlFld-ContribAuthor ">Lorane Izabel da Silva  Hage‐Melim</span>, <span class="hlFld-ContribAuthor ">Carlos Henrique Tomich de Paula  da Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulators of Potential Targets Related to Alzheimer's Disease: a Review. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (16)
                                     , 1467-1483. <a href="https://doi.org/10.1002/cmdc.201900299" title="DOI URL">https://doi.org/10.1002/cmdc.201900299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900299%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DAllosteric%252BModulators%252Bof%252BPotential%252BTargets%252BRelated%252Bto%252BAlzheimer%252527s%252BDisease%25253A%252Ba%252BReview%26aulast%3DSilva%26aufirst%3DGuilherme%2BMartins%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D16%26spage%3D1467%26epage%3D1483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathilde  Pauton</span>, <span class="hlFld-ContribAuthor ">Raphaël  Gillet</span>, <span class="hlFld-ContribAuthor ">Catherine  Aubert</span>, <span class="hlFld-ContribAuthor ">Guillaume  Bluet</span>, <span class="hlFld-ContribAuthor ">Florence  Gruss-Leleu</span>, <span class="hlFld-ContribAuthor ">Sébastien  Roy</span>, <span class="hlFld-ContribAuthor ">Cécile  Perrio</span>. </span><span class="cited-content_cbyCitation_article-title">The first radiosynthesis of 2-amino-5-[
              18
              F]fluoropyridines
              via
              a “minimalist” radiofluorination/palladium-catalyzed amination sequence from anisyl(2-bromopyridinyl)iodonium triflate. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (26)
                                     , 6359-6363. <a href="https://doi.org/10.1039/C9OB01187K" title="DOI URL">https://doi.org/10.1039/C9OB01187K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01187K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01187K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DThe%252Bfirst%252Bradiosynthesis%252Bof%252B2-amino-5-%25255B%252B18%252BF%25255Dfluoropyridines%252Bvia%252Ba%252B%2525E2%252580%25259Cminimalist%2525E2%252580%25259D%252Bradiofluorination%25252Fpalladium-catalyzed%252Bamination%252Bsequence%252Bfrom%252Banisyl%2525282-bromopyridinyl%252529iodonium%252Btriflate%26aulast%3DPauton%26aufirst%3DMathilde%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D26%26spage%3D6359%26epage%3D6363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yung-Chih  Kuo</span>, <span class="hlFld-ContribAuthor ">Rajendiran  Rajesh</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges in the treatment of Alzheimer’s disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Neurotherapeutics</span><span> <strong>2019,</strong> <em>19 </em>
                                    (7)
                                     , 623-652. <a href="https://doi.org/10.1080/14737175.2019.1621750" title="DOI URL">https://doi.org/10.1080/14737175.2019.1621750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737175.2019.1621750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737175.2019.1621750%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Neurotherapeutics%26atitle%3DChallenges%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252Brecent%252Bprogress%252Band%252Btreatment%252Bstrategies%252Bof%252Bpharmaceuticals%252Btargeting%252Bnotable%252Bpathological%252Bfactors%26aulast%3DKuo%26aufirst%3DYung-Chih%26date%3D2019%26date%3D2019%26volume%3D19%26issue%3D7%26spage%3D623%26epage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">François P.  Bischoff</span>, <span class="hlFld-ContribAuthor ">Adriana Ingrid  Velter</span>, <span class="hlFld-ContribAuthor ">Garrett  Minne</span>, <span class="hlFld-ContribAuthor ">Serge  Pieters</span>, <span class="hlFld-ContribAuthor ">Didier  Berthelot</span>, <span class="hlFld-ContribAuthor ">Michel  De Cleyn</span>, <span class="hlFld-ContribAuthor ">Harrie J.M.  Gijsen</span>, <span class="hlFld-ContribAuthor ">Gregor  Macdonald</span>, <span class="hlFld-ContribAuthor ">Michel  Surkyn</span>, <span class="hlFld-ContribAuthor ">Sven  Van Brandt</span>, <span class="hlFld-ContribAuthor ">Yves  Van Roosbroeck</span>, <span class="hlFld-ContribAuthor ">Chiara  Zavattaro</span>, <span class="hlFld-ContribAuthor ">Marc  Mercken</span>, <span class="hlFld-ContribAuthor ">Nigel  Austin</span>, <span class="hlFld-ContribAuthor ">Deborah  Dhuyvetter</span>, <span class="hlFld-ContribAuthor ">Herman  Borghys</span>, <span class="hlFld-ContribAuthor ">Ishtiyaque  Ahmad</span>, <span class="hlFld-ContribAuthor ">Swapan Kumar  Samanta</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of a novel series of cyanoindole derivatives as potent γ-secretase modulators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (14)
                                     , 1737-1745. <a href="https://doi.org/10.1016/j.bmcl.2019.05.023" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.05.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.05.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Ba%252Bnovel%252Bseries%252Bof%252Bcyanoindole%252Bderivatives%252Bas%252Bpotent%252B%2525CE%2525B3-secretase%252Bmodulators%26aulast%3DBischoff%26aufirst%3DFran%25C3%25A7ois%2BP.%26date%3D2019%26volume%3D29%26issue%3D14%26spage%3D1737%26epage%3D1745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daseul  Im</span>, <span class="hlFld-ContribAuthor ">Hyungwoo  Moon</span>, <span class="hlFld-ContribAuthor ">Jingwoong  Kim</span>, <span class="hlFld-ContribAuthor ">Youri  Oh</span>, <span class="hlFld-ContribAuthor ">Miyoung  Jang</span>, <span class="hlFld-ContribAuthor ">Jung-Mi  Hah</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational restriction of a type II FMS inhibitor leading to discovery of 5-methyl-
              N
              -(2-aryl-1
              H
              -benzo[d]imidazo-5-yl)isoxazole-4-carboxamide analogues as selective FLT3 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2019,</strong> <em>34 </em>
                                    (1)
                                     , 1716-1721. <a href="https://doi.org/10.1080/14756366.2019.1671837" title="DOI URL">https://doi.org/10.1080/14756366.2019.1671837</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2019.1671837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2019.1671837%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DConformational%252Brestriction%252Bof%252Ba%252Btype%252BII%252BFMS%252Binhibitor%252Bleading%252Bto%252Bdiscovery%252Bof%252B5-methyl-%252BN%252B-%2525282-aryl-1%252BH%252B-benzo%25255Bd%25255Dimidazo-5-yl%252529isoxazole-4-carboxamide%252Banalogues%252Bas%252Bselective%252BFLT3%252Binhibitors%26aulast%3DIm%26aufirst%3DDaseul%26date%3D2019%26date%3D2019%26volume%3D34%26issue%3D1%26spage%3D1716%26epage%3D1721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryuichi  Sekioka</span>, <span class="hlFld-ContribAuthor ">Eriko  Honjo</span>, <span class="hlFld-ContribAuthor ">Shugo  Honda</span>, <span class="hlFld-ContribAuthor ">Hideyoshi  Fuji</span>, <span class="hlFld-ContribAuthor ">Hiroki  Akashiba</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Mitani</span>, <span class="hlFld-ContribAuthor ">Shingo  Yamasaki</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel scaffolds for γ-secretase modulators without an arylimidazole moiety. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (2)
                                     , 435-442. <a href="https://doi.org/10.1016/j.bmc.2017.11.049" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.11.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.11.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.11.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bscaffolds%252Bfor%252B%2525CE%2525B3-secretase%252Bmodulators%252Bwithout%252Ban%252Barylimidazole%252Bmoiety%26aulast%3DSekioka%26aufirst%3DRyuichi%26date%3D2018%26volume%3D26%26issue%3D2%26spage%3D435%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Ye</span>, <span class="hlFld-ContribAuthor ">Fatma  Boukattaya</span>, <span class="hlFld-ContribAuthor ">Mansour  Haddad</span>, <span class="hlFld-ContribAuthor ">Virginie  Ratovelomanana-Vidal</span>, <span class="hlFld-ContribAuthor ">Véronique  Michelet</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-aminopyridines
              via
              ruthenium-catalyzed [2+2+2] cycloaddition of 1,6- and 1,7-diynes with cyanamides: scope and limitations. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2018,</strong> <em>42 </em>
                                    (5)
                                     , 3222-3235. <a href="https://doi.org/10.1039/C7NJ04933A" title="DOI URL">https://doi.org/10.1039/C7NJ04933A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7NJ04933A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7NJ04933A%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2-aminopyridines%252Bvia%252Bruthenium-catalyzed%252B%25255B2%25252B2%25252B2%25255D%252Bcycloaddition%252Bof%252B1%25252C6-%252Band%252B1%25252C7-diynes%252Bwith%252Bcyanamides%25253A%252Bscope%252Band%252Blimitations%26aulast%3DYe%26aufirst%3DFei%26date%3D2018%26date%3D2018%26volume%3D42%26issue%3D5%26spage%3D3222%26epage%3D3235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sourav  Jana</span>, <span class="hlFld-ContribAuthor ">Sadhanendu  Samanta</span>, <span class="hlFld-ContribAuthor ">Avik K.  Bagdi</span>, <span class="hlFld-ContribAuthor ">Valerii Z.  Shirinian</span>, <span class="hlFld-ContribAuthor ">Alakananda  Hajra</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-free C–H arylation of imidazoheterocycles with aryl hydrazines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (22)
                                     , 12360-12367. <a href="https://doi.org/10.1039/C8RA01474D" title="DOI URL">https://doi.org/10.1039/C8RA01474D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA01474D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA01474D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DMetal-free%252BC%2525E2%252580%252593H%252Barylation%252Bof%252Bimidazoheterocycles%252Bwith%252Baryl%252Bhydrazines%26aulast%3DJana%26aufirst%3DSourav%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D22%26spage%3D12360%26epage%3D12367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>, <span class="hlFld-ContribAuthor ">Yue-Ming  Li</span>, <span class="hlFld-ContribAuthor ">Martin  Pettersson</span>, <span class="hlFld-ContribAuthor ">Peter H.  St George-Hyslop</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and Chemical Biology of Presenilin Complexes. </span><span class="cited-content_cbyCitation_journal-name">Cold Spring Harbor Perspectives in Medicine</span><span> <strong>2017,</strong> <em>7 </em>
                                    (12)
                                     , a024067. <a href="https://doi.org/10.1101/cshperspect.a024067" title="DOI URL">https://doi.org/10.1101/cshperspect.a024067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1101/cshperspect.a024067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1101%2Fcshperspect.a024067%26sid%3Dliteratum%253Aachs%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspectives%2520in%2520Medicine%26atitle%3DStructural%252Band%252BChemical%252BBiology%252Bof%252BPresenilin%252BComplexes%26aulast%3DJohnson%26aufirst%3DDouglas%2BS.%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D12%26spage%3Da024067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanyu  Chen</span>, <span class="hlFld-ContribAuthor ">Rong  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiujun  Peng</span>, <span class="hlFld-ContribAuthor ">Lanting  Xu</span>, <span class="hlFld-ContribAuthor ">XianHua  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium(III)-Catalyzed Directed C−H Amidation of
              N
              -Nitrosoanilines and Subsequent Formation of 1,2-Disubstituted Benzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - An Asian Journal</span><span> <strong>2017,</strong> <em>12 </em>
                                    (21)
                                     , 2804-2808. <a href="https://doi.org/10.1002/asia.201701287" title="DOI URL">https://doi.org/10.1002/asia.201701287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/asia.201701287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fasia.201701287%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520An%2520Asian%2520Journal%26atitle%3DRhodium%252528III%252529-Catalyzed%252BDirected%252BC%2525E2%252588%252592H%252BAmidation%252Bof%252BN%252B-Nitrosoanilines%252Band%252BSubsequent%252BFormation%252Bof%252B1%25252C2-Disubstituted%252BBenzimidazoles%26aulast%3DChen%26aufirst%3DYanyu%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D21%26spage%3D2804%26epage%3D2808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hasan  Saral</span>, <span class="hlFld-ContribAuthor ">Özgür  Özdamar</span>, <span class="hlFld-ContribAuthor ">İbrahim  Uçar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, structural and spectroscopic studies of two new benzimidazole derivatives: A comparative study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2017,</strong> <em>1130 </em>, 46-54. <a href="https://doi.org/10.1016/j.molstruc.2016.10.013" title="DOI URL">https://doi.org/10.1016/j.molstruc.2016.10.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2016.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2016.10.013%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%25252C%252Bstructural%252Band%252Bspectroscopic%252Bstudies%252Bof%252Btwo%252Bnew%252Bbenzimidazole%252Bderivatives%25253A%252BA%252Bcomparative%252Bstudy%26aulast%3DSaral%26aufirst%3DHasan%26date%3D2017%26volume%3D1130%26spage%3D46%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>, <span class="hlFld-ContribAuthor ">Martin  Pettersson</span>. </span><span class="cited-content_cbyCitation_article-title">γ-Secretase Modulators as Aβ42-Lowering Pharmacological Agents to Treat Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 87-118. <a href="https://doi.org/10.1007/7355_2016_19" title="DOI URL">https://doi.org/10.1007/7355_2016_19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2016_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2016_19%26sid%3Dliteratum%253Aachs%26atitle%3D%2525CE%2525B3-Secretase%252BModulators%252Bas%252BA%2525CE%2525B242-Lowering%252BPharmacological%252BAgents%252Bto%252BTreat%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DJohnson%26aufirst%3DDouglas%2BS.%26date%3D2017%26date%3D2017%26spage%3D87%26epage%3D118%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DAlzheimer%2525E2%252580%252599s%252BDisease%252BII%26aulast%3DWolfe%26aufirst%3DMichael%2BS.%26date%3D2017%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Hall</span>, <span class="hlFld-ContribAuthor ">A.I.  Velter</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting γ-Secretase for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 280-325. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13789-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13789-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13789-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13789-8%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252B%2525CE%2525B3-Secretase%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHall%26aufirst%3DA.%26date%3D2017%26spage%3D280%26epage%3D325%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wasim  Akhtar</span>, <span class="hlFld-ContribAuthor ">Mohemmed Faraz  Khan</span>, <span class="hlFld-ContribAuthor ">Garima  Verma</span>, <span class="hlFld-ContribAuthor ">M.  Shaquiquzzaman</span>, <span class="hlFld-ContribAuthor ">M.A.  Rizvi</span>, <span class="hlFld-ContribAuthor ">Syed Hassan  Mehdi</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>, <span class="hlFld-ContribAuthor ">M. Mumtaz  Alam</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic evolution of benzimidazole derivatives in the last quinquennial period. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>126 </em>, 705-753. <a href="https://doi.org/10.1016/j.ejmech.2016.12.010" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.12.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.12.010%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTherapeutic%252Bevolution%252Bof%252Bbenzimidazole%252Bderivatives%252Bin%252Bthe%252Blast%252Bquinquennial%252Bperiod%26aulast%3DAkhtar%26aufirst%3DWasim%26date%3D2017%26volume%3D126%26spage%3D705%26epage%3D753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Ye</span>, <span class="hlFld-ContribAuthor ">Mansour  Haddad</span>, <span class="hlFld-ContribAuthor ">Véronique  Michelet</span>, <span class="hlFld-ContribAuthor ">Virginie  Ratovelomanana-Vidal</span>. </span><span class="cited-content_cbyCitation_article-title">Solvent-free ruthenium trichloride-mediated [2 + 2 + 2] cycloaddition of α,ω-diynes and cyanamides: a convenient access to 2-aminopyridines. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2017,</strong> <em>4 </em>
                                    (6)
                                     , 1063-1068. <a href="https://doi.org/10.1039/C7QO00058H" title="DOI URL">https://doi.org/10.1039/C7QO00058H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7QO00058H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7QO00058H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DSolvent-free%252Bruthenium%252Btrichloride-mediated%252B%25255B2%252B%25252B%252B2%252B%25252B%252B2%25255D%252Bcycloaddition%252Bof%252B%2525CE%2525B1%25252C%2525CF%252589-diynes%252Band%252Bcyanamides%25253A%252Ba%252Bconvenient%252Baccess%252Bto%252B2-aminopyridines%26aulast%3DYe%26aufirst%3DFei%26date%3D2017%26date%3D2017%26volume%3D4%26issue%3D6%26spage%3D1063%26epage%3D1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. M. Abdul  Shakoor</span>, <span class="hlFld-ContribAuthor ">Devesh S.  Agarwal</span>, <span class="hlFld-ContribAuthor ">Anil  Kumar</span>, <span class="hlFld-ContribAuthor ">Rajeev  Sakhuja</span>. </span><span class="cited-content_cbyCitation_article-title">Copper catalyzed direct aerobic double-oxidative cross-dehydrogenative coupling of imidazoheterocycles with aryl acetaldehydes: an articulate approach for dicarbonylation at C-3 position. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (5)
                                     , 645-652. <a href="https://doi.org/10.1016/j.tet.2015.12.012" title="DOI URL">https://doi.org/10.1016/j.tet.2015.12.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2015.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2015.12.012%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DCopper%252Bcatalyzed%252Bdirect%252Baerobic%252Bdouble-oxidative%252Bcross-dehydrogenative%252Bcoupling%252Bof%252Bimidazoheterocycles%252Bwith%252Baryl%252Bacetaldehydes%25253A%252Ban%252Barticulate%252Bapproach%252Bfor%252Bdicarbonylation%252Bat%252BC-3%252Bposition%26aulast%3DShakoor%26aufirst%3DS.%2BM.%2BAbdul%26date%3D2016%26volume%3D72%26issue%3D5%26spage%3D645%26epage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T.E.  Golde</span>, <span class="hlFld-ContribAuthor ">C.B.  Lessard</span>, <span class="hlFld-ContribAuthor ">Y.  Ran</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Targeting of Aβ42. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 77-96. <a href="https://doi.org/10.1016/B978-0-12-802173-6.00005-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-802173-6.00005-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-802173-6.00005-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-802173-6.00005-8%26sid%3Dliteratum%253Aachs%26atitle%3DTherapeutic%252BTargeting%252Bof%252BA%2525CE%2525B242%26aulast%3DGolde%26aufirst%3DT.E.%26date%3D2016%26spage%3D77%26epage%3D96%26pub%3DElsevier%26atitle%3DDeveloping%252BTherapeutics%252Bfor%252BAlzheimer%252527s%252BDisease%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rangappa S.  Keri</span>, <span class="hlFld-ContribAuthor ">Asha  Hiremathad</span>, <span class="hlFld-ContribAuthor ">Srinivasa  Budagumpi</span>, <span class="hlFld-ContribAuthor ">Bhari Mallanna  Nagaraja</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive Review in Current Developments of Benzimidazole-Based Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2015,</strong> <em>86 </em>
                                    (1)
                                     , 19-65. <a href="https://doi.org/10.1111/cbdd.12462" title="DOI URL">https://doi.org/10.1111/cbdd.12462</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12462%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DComprehensive%252BReview%252Bin%252BCurrent%252BDevelopments%252Bof%252BBenzimidazole-Based%252BMedicinal%252BChemistry%26aulast%3DKeri%26aufirst%3DRangappa%2BS.%26date%3D2015%26date%3D2014%26volume%3D86%26issue%3D1%26spage%3D19%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oscar  Delgado</span>, <span class="hlFld-ContribAuthor ">Francisca  Delgado</span>, <span class="hlFld-ContribAuthor ">Juan Antonio  Vega</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>. </span><span class="cited-content_cbyCitation_article-title">N-bridged 5,6-bicyclic pyridines: Recent applications in central nervous system disorders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>97 </em>, 719-731. <a href="https://doi.org/10.1016/j.ejmech.2014.12.034" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.12.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.12.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.12.034%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-bridged%252B5%25252C6-bicyclic%252Bpyridines%25253A%252BRecent%252Bapplications%252Bin%252Bcentral%252Bnervous%252Bsystem%252Bdisorders%26aulast%3DDelgado%26aufirst%3DOscar%26date%3D2015%26volume%3D97%26spage%3D719%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas H.  Graham</span>. </span><span class="cited-content_cbyCitation_article-title">Deprotection of N-benzylbenzimidazoles and N-benzylimidazoles with triethylsilane and Pd/C. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (21)
                                     , 2688-2690. <a href="https://doi.org/10.1016/j.tetlet.2015.03.127" title="DOI URL">https://doi.org/10.1016/j.tetlet.2015.03.127</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2015.03.127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2015.03.127%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DDeprotection%252Bof%252BN-benzylbenzimidazoles%252Band%252BN-benzylimidazoles%252Bwith%252Btriethylsilane%252Band%252BPd%25252FC%26aulast%3DGraham%26aufirst%3DThomas%2BH.%26date%3D2015%26volume%3D56%26issue%3D21%26spage%3D2688%26epage%3D2690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L.  Chandrasekhara Rao</span>, <span class="hlFld-ContribAuthor ">N.  Satish Kumar</span>, <span class="hlFld-ContribAuthor ">H. M.  Meshram</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave assisted novel and regioselective functionalization of imidazopyridines with chromene acetals and β-nitrostyrenes. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (87)
                                     , 70949-70957. <a href="https://doi.org/10.1039/C5RA14674G" title="DOI URL">https://doi.org/10.1039/C5RA14674G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA14674G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA14674G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DMicrowave%252Bassisted%252Bnovel%252Band%252Bregioselective%252Bfunctionalization%252Bof%252Bimidazopyridines%252Bwith%252Bchromene%252Bacetals%252Band%252B%2525CE%2525B2-nitrostyrenes%26aulast%3DChandrasekhara%2BRao%26aufirst%3DL.%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D87%26spage%3D70949%26epage%3D70957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Wang</span>, <span class="hlFld-ContribAuthor ">Feng  Liang</span>, <span class="hlFld-ContribAuthor ">Hailiang  Hu</span>, <span class="hlFld-ContribAuthor ">Yuan  Liu</span>, <span class="hlFld-ContribAuthor ">Zhenhui  Kang</span>, <span class="hlFld-ContribAuthor ">Liang-Sheng  Liao</span>, <span class="hlFld-ContribAuthor ">Jian  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Strongly phosphorescent platinum(
              ii
              ) complexes supported by tetradentate benzazole-containing ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Materials Chemistry C</span><span> <strong>2015,</strong> <em>3 </em>
                                    (31)
                                     , 8212-8218. <a href="https://doi.org/10.1039/C5TC01449B" title="DOI URL">https://doi.org/10.1039/C5TC01449B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5TC01449B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5TC01449B%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Materials%2520Chemistry%2520C%26atitle%3DStrongly%252Bphosphorescent%252Bplatinum%252528%252Bii%252B%252529%252Bcomplexes%252Bsupported%252Bby%252Btetradentate%252Bbenzazole-containing%252Bligands%26aulast%3DWang%26aufirst%3DBin%26date%3D2015%26date%3D2015%26volume%3D3%26issue%3D31%26spage%3D8212%26epage%3D8218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adriana I.  Velter</span>, <span class="hlFld-ContribAuthor ">François P.  Bischoff</span>, <span class="hlFld-ContribAuthor ">Didier  Berthelot</span>, <span class="hlFld-ContribAuthor ">Michel  De Cleyn</span>, <span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Libuse  Jaroskova</span>, <span class="hlFld-ContribAuthor ">Gregor  Macdonald</span>, <span class="hlFld-ContribAuthor ">Garrett  Minne</span>, <span class="hlFld-ContribAuthor ">Serge  Pieters</span>, <span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Sven  Van Brandt</span>, <span class="hlFld-ContribAuthor ">Yves  Van Roosbroeck</span>, <span class="hlFld-ContribAuthor ">Michel  Surkyn</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Tongfei  Wu</span>, <span class="hlFld-ContribAuthor ">Herman  Borghys</span>, <span class="hlFld-ContribAuthor ">Marc  Mercken</span>, <span class="hlFld-ContribAuthor ">Chantal  Masungi</span>, <span class="hlFld-ContribAuthor ">Harrie  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Anilinotriazoles as potent gamma secretase modulators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (24)
                                     , 5805-5813. <a href="https://doi.org/10.1016/j.bmcl.2014.10.024" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.10.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.10.024%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAnilinotriazoles%252Bas%252Bpotent%252Bgamma%252Bsecretase%252Bmodulators%26aulast%3DVelter%26aufirst%3DAdriana%2BI.%26date%3D2014%26volume%3D24%26issue%3D24%26spage%3D5805%26epage%3D5813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weijun  Yang</span>, <span class="hlFld-ContribAuthor ">Zhigen  Yang</span>, <span class="hlFld-ContribAuthor ">Lijun  Xu</span>, <span class="hlFld-ContribAuthor ">Lili  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Xu</span>, <span class="hlFld-ContribAuthor ">Maozhong  Miao</span>, <span class="hlFld-ContribAuthor ">Hongjun  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Bi(OTf)
              3
              -Catalyzed Intramolecular Amination of Triazenylaryl Allylic Alcohols: A Stereoselective, High-Yield Synthesis of (
              E
              )-3-Alkenyl 2
              H
              -indazoles. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2014,</strong> <em>44 </em>
                                    (17)
                                     , 2478-2487. <a href="https://doi.org/10.1080/00397911.2014.903423" title="DOI URL">https://doi.org/10.1080/00397911.2014.903423</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2014.903423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2014.903423%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DBi%252528OTf%252529%252B3%252B-Catalyzed%252BIntramolecular%252BAmination%252Bof%252BTriazenylaryl%252BAllylic%252BAlcohols%25253A%252BA%252BStereoselective%25252C%252BHigh-Yield%252BSynthesis%252Bof%252B%252528%252BE%252B%252529-3-Alkenyl%252B2%252BH%252B-indazoles%26aulast%3DYang%26aufirst%3DWeijun%26date%3D2014%26date%3D2014%26volume%3D44%26issue%3D17%26spage%3D2478%26epage%3D2487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie-Aude  Hiebel</span>, <span class="hlFld-ContribAuthor ">Yacoub  Fall</span>, <span class="hlFld-ContribAuthor ">Marie-Christine  Scherrmann</span>, <span class="hlFld-ContribAuthor ">Sabine  Berteina-Raboin</span>. </span><span class="cited-content_cbyCitation_article-title">Straightforward Synthesis of Various 2,3-Diarylimidazo[1,2-
              a
              ]pyridines in PEG
              400
              Medium through One-Pot Condensation and C-H Arylation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>2014 </em>
                                    (21)
                                     , 4643-4650. <a href="https://doi.org/10.1002/ejoc.201402079" title="DOI URL">https://doi.org/10.1002/ejoc.201402079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201402079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201402079%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStraightforward%252BSynthesis%252Bof%252BVarious%252B2%25252C3-Diarylimidazo%25255B1%25252C2-%252Ba%252B%25255Dpyridines%252Bin%252BPEG%252B400%252BMedium%252Bthrough%252BOne-Pot%252BCondensation%252Band%252BC-H%252BArylation%26aulast%3DHiebel%26aufirst%3DMarie-Aude%26date%3D2014%26date%3D2014%26volume%3D2014%26issue%3D21%26spage%3D4643%26epage%3D4650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zengjun  Fang</span>, <span class="hlFld-ContribAuthor ">Yu’ning  Song</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Qingzhu  Zhang</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational restriction: an effective tactic in 'follow-on'-based drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (8)
                                     , 885-901. <a href="https://doi.org/10.4155/fmc.14.50" title="DOI URL">https://doi.org/10.4155/fmc.14.50</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.50%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DConformational%252Brestriction%25253A%252Ban%252Beffective%252Btactic%252Bin%252B%252527follow-on%252527-based%252Bdrug%252Bdiscovery%26aulast%3DFang%26aufirst%3DZengjun%26date%3D2014%26volume%3D6%26issue%3D8%26spage%3D885%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Omar  Aziz</span>, <span class="hlFld-ContribAuthor ">Roland W.  Bürli</span>, <span class="hlFld-ContribAuthor ">David F.  Fischer</span>, <span class="hlFld-ContribAuthor ">Julie  Frearson</span>, <span class="hlFld-ContribAuthor ">Michael D.  Wall</span>. </span><span class="cited-content_cbyCitation_article-title">Towards Small Molecules as Therapies for Alzheimer’s Disease and Other Neurodegenerative Disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 199-290. <a href="https://doi.org/10.1016/B978-0-12-803959-5.50004-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-803959-5.50004-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803959-5.50004-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803959-5.50004-0%26sid%3Dliteratum%253Aachs%26atitle%3DTowards%252BSmall%252BMolecules%252Bas%252BTherapies%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Band%252BOther%252BNeurodegenerative%252BDisorders%26aulast%3DAziz%26aufirst%3DOmar%26date%3D2014%26spage%3D199%26epage%3D290%26pub%3DElsevier%26atitle%3DDrug%252BDesign%252Band%252BDiscovery%252Bin%252BAlzheimer%252527s%252BDisease%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adrian  Hall</span>, <span class="hlFld-ContribAuthor ">Toshal R.  Patel</span>. </span><span class="cited-content_cbyCitation_article-title">γ-Secretase Modulators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 101-145. <a href="https://doi.org/10.1016/B978-0-444-63380-4.00003-2" title="DOI URL">https://doi.org/10.1016/B978-0-444-63380-4.00003-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-63380-4.00003-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-63380-4.00003-2%26sid%3Dliteratum%253Aachs%26atitle%3D%2525CE%2525B3-Secretase%252BModulators%26aulast%3DHall%26aufirst%3DAdrian%26date%3D2014%26spage%3D101%26epage%3D145%26pub%3DElsevier%26date%3D2014%26volume%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Todd E.  Golde</span>, <span class="hlFld-ContribAuthor ">Edward H.  Koo</span>, <span class="hlFld-ContribAuthor ">Kevin M.  Felsenstein</span>, <span class="hlFld-ContribAuthor ">Barbara A.  Osborne</span>, <span class="hlFld-ContribAuthor ">Lucio  Miele</span>. </span><span class="cited-content_cbyCitation_article-title">γ-Secretase inhibitors and modulators. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Biomembranes</span><span> <strong>2013,</strong> <em>1828 </em>
                                    (12)
                                     , 2898-2907. <a href="https://doi.org/10.1016/j.bbamem.2013.06.005" title="DOI URL">https://doi.org/10.1016/j.bbamem.2013.06.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbamem.2013.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbamem.2013.06.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Biomembranes%26atitle%3D%2525CE%2525B3-Secretase%252Binhibitors%252Band%252Bmodulators%26aulast%3DGolde%26aufirst%3DTodd%2BE.%26date%3D2013%26volume%3D1828%26issue%3D12%26spage%3D2898%26epage%3D2907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian Jeffrey  Chen</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Qian</span>, <span class="hlFld-ContribAuthor ">Kaustav  Biswas</span>, <span class="hlFld-ContribAuthor ">Chester  Yuan</span>, <span class="hlFld-ContribAuthor ">Albert  Amegadzie</span>, <span class="hlFld-ContribAuthor ">Qingyian  Liu</span>, <span class="hlFld-ContribAuthor ">Thomas  Nixey</span>, <span class="hlFld-ContribAuthor ">Joe  Zhu</span>, <span class="hlFld-ContribAuthor ">Mqhele  Ncube</span>, <span class="hlFld-ContribAuthor ">Robert M.  Rzasa</span>, <span class="hlFld-ContribAuthor ">Frank  Chavez</span>, <span class="hlFld-ContribAuthor ">Ning  Chen</span>, <span class="hlFld-ContribAuthor ">Frenel  DeMorin</span>, <span class="hlFld-ContribAuthor ">Shannon  Rumfelt</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Tegley</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Allen</span>, <span class="hlFld-ContribAuthor ">Stephen  Hitchcock</span>, <span class="hlFld-ContribAuthor ">Randy  Hungate</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Leeanne  Zalameda</span>, <span class="hlFld-ContribAuthor ">Yichin  Liu</span>, <span class="hlFld-ContribAuthor ">John D.  McCarter</span>, <span class="hlFld-ContribAuthor ">Jianhua  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Zhu</span>, <span class="hlFld-ContribAuthor ">Safura  Babu-Khan</span>, <span class="hlFld-ContribAuthor ">Yi  Luo</span>, <span class="hlFld-ContribAuthor ">Jodi  Bradley</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Darren L.  Reid</span>, <span class="hlFld-ContribAuthor ">Frank  Koegler</span>, <span class="hlFld-ContribAuthor ">Charles  Dean</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Tiffany L.  Correll</span>, <span class="hlFld-ContribAuthor ">Toni  Williamson</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (23)
                                     , 6447-6454. <a href="https://doi.org/10.1016/j.bmcl.2013.09.041" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.09.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.09.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B2-methylpyridine-based%252Bbiaryl%252Bamides%252Bas%252B%2525CE%2525B3-secretase%252Bmodulators%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DChen%26aufirst%3DJian%2BJeffrey%26date%3D2013%26volume%3D23%26issue%3D23%26spage%3D6447%26epage%3D6454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Pettersson</span>, <span class="hlFld-ContribAuthor ">Antonia F  Stepan</span>, <span class="hlFld-ContribAuthor ">Gregory W  Kauffman</span>, <span class="hlFld-ContribAuthor ">Douglas S  Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (10)
                                     , 1349-1366. <a href="https://doi.org/10.1517/13543776.2013.821465" title="DOI URL">https://doi.org/10.1517/13543776.2013.821465</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.821465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.821465%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DNovel%252B%2525CE%2525B3-secretase%252Bmodulators%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%25253A%252Ba%252Breview%252Bfocusing%252Bon%252Bpatents%252Bfrom%252B2010%252Bto%252B2012%26aulast%3DPettersson%26aufirst%3DMartin%26date%3D2013%26date%3D2013%26volume%3D23%26issue%3D10%26spage%3D1349%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Frederik J.R.  Rombouts</span>, <span class="hlFld-ContribAuthor ">Didier  Berthelot</span>, <span class="hlFld-ContribAuthor ">François P.  Bischoff</span>, <span class="hlFld-ContribAuthor ">Michel A.J.  De Cleyn</span>, <span class="hlFld-ContribAuthor ">Libuse  Jaroskova</span>, <span class="hlFld-ContribAuthor ">Gregor  Macdonald</span>, <span class="hlFld-ContribAuthor ">Marc  Mercken</span>, <span class="hlFld-ContribAuthor ">Michel  Surkyn</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Sven  Van Brandt</span>, <span class="hlFld-ContribAuthor ">Adriana I.  Velter</span>, <span class="hlFld-ContribAuthor ">Tongfei  Wu</span>, <span class="hlFld-ContribAuthor ">Harrie J.M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of bicyclic heterocycles as potent γ-secretase modulators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (17)
                                     , 4794-4800. <a href="https://doi.org/10.1016/j.bmcl.2013.06.100" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.06.100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.06.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.06.100%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bbicyclic%252Bheterocycles%252Bas%252Bpotent%252B%2525CE%2525B3-secretase%252Bmodulators%26aulast%3DOehlrich%26aufirst%3DDaniel%26date%3D2013%26volume%3D23%26issue%3D17%26spage%3D4794%26epage%3D4800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabriel C  Léger</span>, <span class="hlFld-ContribAuthor ">Fadi  Massoud</span>. </span><span class="cited-content_cbyCitation_article-title">Novel disease-modifying therapeutics for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Clinical Pharmacology</span><span> <strong>2013,</strong> <em>6 </em>
                                    (4)
                                     , 423-442. <a href="https://doi.org/10.1586/17512433.2013.811237" title="DOI URL">https://doi.org/10.1586/17512433.2013.811237</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/17512433.2013.811237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2F17512433.2013.811237%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Clinical%2520Pharmacology%26atitle%3DNovel%252Bdisease-modifying%252Btherapeutics%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DL%25C3%25A9ger%26aufirst%3DGabriel%2BC%26date%3D2013%26date%3D2014%26volume%3D6%26issue%3D4%26spage%3D423%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harrie J.M.  Gijsen</span>, <span class="hlFld-ContribAuthor ">François P.  Bischoff</span>. </span><span class="cited-content_cbyCitation_article-title">Secretase Inhibitors and Modulators as a Disease-Modifying Approach Against Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 55-69. <a href="https://doi.org/10.1016/B978-0-12-396492-2.00005-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-396492-2.00005-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396492-2.00005-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396492-2.00005-9%26sid%3Dliteratum%253Aachs%26atitle%3DSecretase%252BInhibitors%252Band%252BModulators%252Bas%252Ba%252BDisease-Modifying%252BApproach%252BAgainst%252BAlzheimer%252527s%252BDisease%26aulast%3DGijsen%26aufirst%3DHarrie%2BJ.M.%26date%3D2012%26spage%3D55%26epage%3D69%26pub%3DElsevier%26atitle%3DAnnual%252BReports%252Bin%252BMedicinal%252BChemistry%252BVolume%252B47%26date%3D2012%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harrie J. M.  Gijsen</span>, <span class="hlFld-ContribAuthor ">Marc  Mercken</span>. </span><span class="cited-content_cbyCitation_article-title">-Secretase Modulators: Can We Combine Potency with Safety?. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Alzheimer's Disease</span><span> <strong>2012,</strong> <em>2012 </em>, 1-10. <a href="https://doi.org/10.1155/2012/295207" title="DOI URL">https://doi.org/10.1155/2012/295207</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2012/295207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2012%2F295207%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3D-Secretase%252BModulators%25253A%252BCan%252BWe%252BCombine%252BPotency%252Bwith%252BSafety%25253F%26aulast%3DGijsen%26aufirst%3DHarrie%2BJ.%2BM.%26date%3D2012%26volume%3D2012%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of γ-secretase modulators. In vitro data were obtained from in-house experiments. The IC<sub>50</sub> values are a mean of at least three determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Route Towards Intermediates <b>I</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-methylimidazole, K<sub>2</sub>CO<sub>3</sub>, DMSO, 150 °C, 6 h; (b) H<sub>2</sub>, Pd(C), MeOH, 50 °C, 12 h; (c) NaNO<sub>2</sub>, H<sub>2</sub>SO<sub>4</sub>, 10 °C, 30 min, then CuBr, HBr; 10 °C to rt, 1 h; (d) 4-methylimidazole, CuI, 1,10-phenanthroline, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 130 °C, 2 d; (e) NaOMe, 1,4-dioxane, rt, 8 h; (f) AcOH, HCO<sub>2</sub>H, THF, 60 °C, 12 h; (g) 1-chloropropanone, KI, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 12 h; (h) NH<sub>4</sub>OAc, AcOH, 100 °C, 1 h; (i) Cu<sub>2</sub>O, NH<sub>4</sub>OH, ethylene glycol, 100 °C, 16 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Imidazopyridines and Benzimidazole Building Blocks<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EtOH, reflux, 4 h; (b) RCOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h; (c) AcOH, HCl, MW 150 °C, 30 min; (d) LiHMDS, R′Br, THF, 0–150 °C, 1–4 h; (e) Fe, AcOH, 60 °C, 1 h; (f) MeNH<sub>2</sub>, EtOH, 0 °C–rt, 15 h; (g) Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 15 h then AcOH, HCl, 100 °C, 2 h.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0005.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Indazole and Benzoxazole Building Blocks<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DMF–DMA, pyrrolidine, 115 °C, 22 h; (b) NaIO<sub>4</sub>, DMF/H<sub>2</sub>O, 3 h, rt; (c) PCC, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h; (d) R(CH<sub>2</sub>)<sub><i>n</i></sub>NH<sub>2</sub>, sodium triacetoxyborohydride, HOAc, 1,2-dichloroethane, rt, 3 h; (e) SnCl<sub>2</sub>·2H<sub>2</sub>O, EtOH, 40 °C, 16 h; (f) LDA, THF, −78 to 0 °C, 15 min, MeI, −78 °C to rt, 16 h; (g) (1) NaNO<sub>2</sub>, 6N aq HCl soln, H<sub>2</sub>O, 30 min, 60 °C, (2) <i>t-</i>butylmercaptan, EtOH, 1 h, 0 °C; (h) KO<i>t</i>Bu, DMSO, 2 h, rt; (i) R<sub>2</sub>SO<sub>4</sub>, toluene, 16 h, 110 °C or RBr, <i>N</i>-methyl-dicyclohexylamine, DMF, 16 h, 30 °C; (j) RCOCl, THF, rt, 15 h; (k) CuI, 1,10-phenantroline, Cs<sub>2</sub>CO<sub>3</sub>, DME, 90 °C, 15 h.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0006.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Rationale for the Synthesis of Imidazopyridine <b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Mouse in vivo at 30 mpk po after 4 h (<i>n</i> = 6) expressed as a percentage of Aβ42 lowering in brain compared with untreated animals.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Isosteres of imidazopyridines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Factors influencing the potency in the bicyclic heterocycles series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0015.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Aza benzimidazole analogues. The IC<sub>50</sub> values are a mean of at least three determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0018.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Changes in mouse brain Aβ-levels after a single 10 and 30 mg/kg dose of <b>44a</b>. Expressed as mean % change versus <i>T</i> = 0 h, <i>n</i> = 4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0019.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Changes in dog CSF Aβ-levels after a single 20 mg/kg dose of <b>44a</b>. Expressed as mean % change versus <i>T</i> = 0 h, <i>n</i> = 4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/medium/jm-2011-01710f_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0020.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Changes in rat brain and CSF Aβ and compound levels of <b>44a</b> after a single oral dose (10 mg/kg). Expressed as mean % change versus <i>T</i> = 0 h, <i>n</i> = 5.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm201710f/production/images/large/jm-2011-01710f_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201710f&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24523" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24523" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 40 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: from pathology to therapeutic approaches</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3030</span><span class="NLM_x">–</span> <span class="NLM_lpage">3059</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=3030-3059&author=R.+Jakob-Roetneauthor=H.+Jacobsen&title=Alzheimer%E2%80%99s+disease%3A+from+pathology+to+therapeutic+approaches"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DJacobsen%26aufirst%3DH.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520from%2520pathology%2520to%2520therapeutic%2520approaches%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D3030%26epage%3D3059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Berchtold, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotman, C. W.</span><span> </span><span class="NLM_article-title">Evolution in the conceptualization of dementia and Alzheimer’s disease: Greco-Roman period to the 1960s</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1016%2FS0197-4580%2898%2900052-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=9661992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A280%3ADyaK1czisVeluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=173-189&author=N.+C.+Berchtoldauthor=C.+W.+Cotman&title=Evolution+in+the+conceptualization+of+dementia+and+Alzheimer%E2%80%99s+disease%3A+Greco-Roman+period+to+the+1960s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s</span></div><div class="casAuthors">Berchtold N C; Cotman C W</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of aging</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">173-89</span>
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    </div><div class="casAbstract">Most histories of senile dementia commence with Alois Alzheimer's description in 1906 of the first case of Alzheimer's disease, yet the history of senile dementia before 1906 is quite rich, dating back to the ancient Greek and Roman philosophers and physicians.  Over the 2500 years since ancient times, the concept of senile dementia has evolved from a rather vague notion that mental decline occurred inevitably in old age, to become defined today by a distinct set of clinical and pathological features with the potential for treatment and prevention within grasp.  Throughout history, many elderly individuals with unpredictable behavior were sequestered in institutions, and the line between mental disorders and senile dementia was hazy at best.  The identification of Alzheimer's disease at the onset of the 20th century was a turning point for the understanding of senile dementia, and the concepts and histological findings presented by the early researchers of Alzheimer's disease remain relevant still today.  Indeed, these early findings are proving to be a continuing source of insight, as many of the issues debated at the turn of the century remain unresolved still today.  This paper thus traces the history of the evolution of our current conceptualization of Alzheimer's disease from the amorphous Greco-Roman concept of age-associated dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRJYW2UOwdYGwMthz5_Rx5rfW6udTcc2ebCeHLycxF7Qrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1czisVeluw%253D%253D&md5=e9ad87054b18b6d4630cf05e84550fa2</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2898%2900052-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252898%252900052-9%26sid%3Dliteratum%253Aachs%26aulast%3DBerchtold%26aufirst%3DN.%2BC.%26aulast%3DCotman%26aufirst%3DC.%2BW.%26atitle%3DEvolution%2520in%2520the%2520conceptualization%2520of%2520dementia%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Greco-Roman%2520period%2520to%2520the%25201960s%26jtitle%3DNeurobiol.%2520Aging%26date%3D1998%26volume%3D19%26spage%3D173%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Tiraboschi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corey-Bloom, J.</span><span> </span><span class="NLM_article-title">The importance of neurotic plaques and tangles to the development and evolution of AD</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1984</span><span class="NLM_x">–</span> <span class="NLM_lpage">1989</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2004&pages=1984-1989&author=P.+Tiraboschiauthor=L.+A.+Hansenauthor=L.+J.+Thalauthor=J.+Corey-Bloom&title=The+importance+of+neurotic+plaques+and+tangles+to+the+development+and+evolution+of+AD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTiraboschi%26aufirst%3DP.%26aulast%3DHansen%26aufirst%3DL.%2BA.%26aulast%3DThal%26aufirst%3DL.%2BJ.%26aulast%3DCorey-Bloom%26aufirst%3DJ.%26atitle%3DThe%2520importance%2520of%2520neurotic%2520plaques%2520and%2520tangles%2520to%2520the%2520development%2520and%2520evolution%2520of%2520AD%26jtitle%3DNeurology%26date%3D2004%26volume%3D62%26spage%3D1984%26epage%3D1989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Small, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappai, R.</span><span> </span><span class="NLM_article-title">Alois Alzheimer and Alzheimer’s disease: a centennial perspective</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">708</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1111%2Fj.1471-4159.2006.04212.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=17076655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eju7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=708-710&author=D.+H.+Smallauthor=R.+Cappai&title=Alois+Alzheimer+and+Alzheimer%E2%80%99s+disease%3A+a+centennial+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alois Alzheimer and Alzheimer's disease: a centennial perspective</span></div><div class="casAuthors">Small, David H.; Cappai, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">708-710</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The year 2006 is the centenary of the famous presentation of Alois Alzheimer which first described the neuropathol. of Alzheimer's disease (AD).  Since this presentation, enormous progress has been made in understanding the biol. of AD.  The central role of the β-amyloid protein (Aβ) in the pathogenesis of AD and the relationship between plaque and tangle pathol. is now much better understood.  In this article, we review the current status of the amyloid hypothesis of AD and its role in the development of future therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodHVyze5z1W7Vg90H21EOLACvtfcHk0lgpttNggrK5sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eju7%252FE&md5=27564c272b2bc577bbf4d568ffb7a079</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04212.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04212.x%26sid%3Dliteratum%253Aachs%26aulast%3DSmall%26aufirst%3DD.%2BH.%26aulast%3DCappai%26aufirst%3DR.%26atitle%3DAlois%2520Alzheimer%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520centennial%2520perspective%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D99%26spage%3D708%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lahiri, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y. W.</span><span> </span><span class="NLM_article-title">A proximal gene promoter region for the β-amyloid precursor protein provides a link between development, apotosis and Alzheimer’s disease</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1010</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1010&publication_year=2003&pages=643-647&author=D.+K.+Lahiriauthor=C.+Ghoshauthor=Y.+W.+Ge&title=A+proximal+gene+promoter+region+for+the+%CE%B2-amyloid+precursor+protein+provides+a+link+between+development%2C+apotosis+and+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLahiri%26aufirst%3DD.%2BK.%26aulast%3DGhosh%26aufirst%3DC.%26aulast%3DGe%26aufirst%3DY.%2BW.%26atitle%3DA%2520proximal%2520gene%2520promoter%2520region%2520for%2520the%2520%25CE%25B2-amyloid%2520precursor%2520protein%2520provides%2520a%2520link%2520between%2520development%252C%2520apotosis%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2003%26volume%3D1010%26spage%3D643%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Walsh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Deciphering the molecular basis of memory failure in Alzheimers disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=181-193&author=D.+M.+Walshauthor=D.+J.+Selkoe&title=Deciphering+the+molecular+basis+of+memory+failure+in+Alzheimers+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DDeciphering%2520the%2520molecular%2520basis%2520of%2520memory%2520failure%2520in%2520Alzheimers%2520disease%26jtitle%3DNeuron%26date%3D2004%26volume%3D44%26spage%3D181%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Tolia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Review structure and function of γ-secretase</span> <span class="citation_source-journal">Semin. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=211-218&author=A.+Toliaauthor=B.+De+Strooper&title=Review+structure+and+function+of+%CE%B3-secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTolia%26aufirst%3DA.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DReview%2520structure%2520and%2520function%2520of%2520%25CE%25B3-secretase%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2009%26volume%3D20%26spage%3D211%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Takami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagashima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima-Kawashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funtamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuo, I.</span><span> </span><span class="NLM_article-title">γ-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of β-carboxyl terminal fragment</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">13042</span><span class="NLM_x">–</span> <span class="NLM_lpage">13052</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1523%2FJNEUROSCI.2362-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=19828817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSitL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=13042-13052&author=M.+Takamiauthor=Y.+Nagashimaauthor=Y.+Sanoauthor=S.+Ishiharaauthor=M.+Morishima-Kawashimaauthor=S.+Funtamotoauthor=I.+Yasuo&title=%CE%B3-Secretase%3A+successive+tripeptide+and+tetrapeptide+release+from+the+transmembrane+domain+of+%CE%B2-carboxyl+terminal+fragment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3dR"><div class="casContent"><span class="casTitleNuber">3d</span><div class="casTitle"><span class="NLM_cas:atitle">γ-secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of β-carboxyl terminal fragment</span></div><div class="casAuthors">Takami, Mako; Nagashima, Yu; Sano, Yoshihisa; Ishihara, Seiko; Morishima-Kawashima, Maho; Funamoto, Satoru; Ihara, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">13042-13052</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Amyloid β protein (Aβ), a pathogenic mol. assocd. with Alzheimer's disease, is produced by γ-secretase, which cleaves the β-carboxyl terminal fragment (βCTF) of β-amyloid precursor protein (APP) in the middle of its transmembrane domain.  How the cleavage proceeds within the membrane has long been enigmatic.  We hypothesized previously that βCTF is cleaved first at the membrane-cytoplasm boundary, producing two long Aβs, Aβ48 and Aβ49, which are processed further by releasing three residues at each step to produce Aβ42 and Aβ40, resp.  To test this hypothesis, we used liq. chromatog. tandem mass spectrometry (LC-MS/MS) to quantify the specific tripeptides that are postulated to be released.  Using CHAPSO (3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxyl-1-propanesulfonate)-reconstituted γ-secretase system, we confirmed that Aβ49 is converted to Aβ43/40 by successively releasing two or three tripeptides and that Aβ48 is converted to Aβ42/38 by successively releasing two tripeptides or these plus an addnl. tetrapeptide.  Most unexpectedly, LC-MS/MS quantification revealed an induction period, 3-4 min, in the generation of peptides.  When extrapolated, each time line for each tripeptide appears to intercept the same point on the x-axis.  According to numerical simulation based on the successive reaction kinetics, the induction period exists.  These results strongly suggest that Aβ is generated through the stepwise processing of βCTF by γ-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYC-g_Nhz9QrVg90H21EOLACvtfcHk0lgkGvZJ4tVPhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSitL%252FM&md5=7123eb2419feeace3500a2ba4f42de43</span></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2362-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2362-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DTakami%26aufirst%3DM.%26aulast%3DNagashima%26aufirst%3DY.%26aulast%3DSano%26aufirst%3DY.%26aulast%3DIshihara%26aufirst%3DS.%26aulast%3DMorishima-Kawashima%26aufirst%3DM.%26aulast%3DFuntamoto%26aufirst%3DS.%26aulast%3DYasuo%26aufirst%3DI.%26atitle%3D%25CE%25B3-Secretase%253A%2520successive%2520tripeptide%2520and%2520tetrapeptide%2520release%2520from%2520the%2520transmembrane%2520domain%2520of%2520%25CE%25B2-carboxyl%2520terminal%2520fragment%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D13042%26epage%3D13052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kreft, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, A.</span><span> </span><span class="NLM_article-title">Recent advances in the identification of γ-secretase inhibitors to clinically test the Aβ oligomer hypothesis of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6169</span><span class="NLM_x">–</span> <span class="NLM_lpage">6188</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900188z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6169-6188&author=A.+F.+Kreftauthor=R.+Martoneauthor=A.+Porte&title=Recent+advances+in+the+identification+of+%CE%B3-secretase+inhibitors+to+clinically+test+the+A%CE%B2+oligomer+hypothesis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1021%2Fjm900188z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900188z%26sid%3Dliteratum%253Aachs%26aulast%3DKreft%26aufirst%3DA.%2BF.%26aulast%3DMartone%26aufirst%3DR.%26aulast%3DPorte%26aufirst%3DA.%26atitle%3DRecent%2520advances%2520in%2520the%2520identification%2520of%2520%25CE%25B3-secretase%2520inhibitors%2520to%2520clinically%2520test%2520the%2520A%25CE%25B2%2520oligomer%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6169%26epage%3D6188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">D’Onofrio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panza, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frisardi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solfrizzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paroni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascavilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seripa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilotto, A.</span><span> </span><span class="NLM_article-title">Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=19-37&author=G.+D%E2%80%99Onofrioauthor=F.+Panzaauthor=V.+Frisardiauthor=V.+Solfrizziauthor=B.+P.+Imbimboauthor=G.+Paroniauthor=L.+Cascavillaauthor=D.+Seripaauthor=A.+Pilotto&title=Advances+in+the+identification+of+%CE%B3-secretase+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Onofrio%26aufirst%3DG.%26aulast%3DPanza%26aufirst%3DF.%26aulast%3DFrisardi%26aufirst%3DV.%26aulast%3DSolfrizzi%26aufirst%3DV.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DParoni%26aufirst%3DG.%26aulast%3DCascavilla%26aufirst%3DL.%26aulast%3DSeripa%26aufirst%3DD.%26aulast%3DPilotto%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520the%2520identification%2520of%2520%25CE%25B3-secretase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D19%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mitani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarimizu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akashiba, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shitaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, N.</span><span> </span><span class="NLM_article-title">Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2037</span><span class="NLM_x">–</span> <span class="NLM_lpage">2050</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1523%2FJNEUROSCI.4264-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=22323718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFantbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=2037-2050&author=Y.+Mitaniauthor=J.+Yarimizuauthor=K.+Saitaauthor=H.+Uchinoauthor=H.+Akashibaauthor=Y.+Shitakaauthor=K.+Niauthor=N.+Matsuoka&title=Differential+effects+between+%CE%B3-secretase+inhibitors+and+modulators+on+cognitive+function+in+amyloid+precursor+protein-transgenic+and+nontransgenic+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice</span></div><div class="casAuthors">Mitani, Yasuyuki; Yarimizu, Junko; Saita, Kyoko; Uchino, Hiroshi; Akashiba, Hiroki; Shitaka, Yoshitsugu; Ni, Keni; Matsuoka, Nobuya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2037-2050</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">γ-Secretase inhibitors (GSIs) reduce amyloid-β (Aβ) peptides but inevitably increase the β-C-terminal fragment (β-CTF) of amyloid precursor protein (APP), potentially having undesirable effects on synapses.  In contrast, γ-secretase modulators (GSMs) reduce Aβ42 without increasing β-CTF.  Although the Aβ-lowering effects of these compds. have been extensively studied, little effort has been made to investigate their effects on cognition.  Here, we compared the effects of two GSIs-(2S)-2-hydroxy-3-methyl-N-[(2S)-1-{[(1S)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-3-benzazepin-1-yl]amino}-1-oxopropan-2-yl]butanamide (LY450139, semagacestat) and (2R)-2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxazol-3-yl)phenyl]methyl]amino-5,5,5-trifluoropentanamide (BMS-708163)-and a second-generation GSM [{(2S,4R)-1-[(4R)-1,1,1-trifluoro-7-methyloctan-4-yl]-2-[4-(trifluoromethyl)phenyl]piperidin-4-yl}acetic acid (GSM-2)] on spatial working memory in APP-transgenic (Tg2576) and nontransgenic mice using the Y-maze task.  While acute dosing with either GSI ameliorated memory deficits in 5.5-mo-old Tg2576 mice, these effects disappeared after 8 d subchronic dosing.  Subchronic dosing with either GSI rather impaired normal cognition in 3-mo-old Tg2576 mice, with no inhibition on the processing of other γ-secretase substrates, such as Notch, N-cadherin, or EphA4, in the brain.  LY450139 also impaired normal cognition in wild-type mice; however, the potency was 10-fold lower than that in Tg2576 mice, indicating an APP-dependent mechanism likely with β-CTF accumulation.  Immunofluorescence studies revealed that the β-CTF accumulation was localized in the presynaptic terminals of the hippocampal stratum lucidum and dentate hilus, implying an effect on presynaptic function in the mossy fibers.  In contrast, both acute and subchronic dosing with GSM-2 significantly ameliorated memory deficits in Tg2576 mice and did not affect normal cognition in wild-type mice.  We demonstrated a clear difference between GSI and GSM in effects on functional consequences, providing new insights into strategies for developing these drugs against Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCQSvDeM5057Vg90H21EOLACvtfcHk0lj9hbZjauZfkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFantbw%253D&md5=8b822c8ce2e99faaf881dde88c50224b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4264-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4264-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DMitani%26aufirst%3DY.%26aulast%3DYarimizu%26aufirst%3DJ.%26aulast%3DSaita%26aufirst%3DK.%26aulast%3DUchino%26aufirst%3DH.%26aulast%3DAkashiba%26aufirst%3DH.%26aulast%3DShitaka%26aufirst%3DY.%26aulast%3DNi%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DN.%26atitle%3DDifferential%2520effects%2520between%2520%25CE%25B3-secretase%2520inhibitors%2520and%2520modulators%2520on%2520cognitive%2520function%2520in%2520amyloid%2520precursor%2520protein-transgenic%2520and%2520nontransgenic%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D2037%26epage%3D2050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D. J. -C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J. M.</span><span> </span><span class="NLM_article-title">γ-Secretase modulators as potential disease modifying anti-Alzheimer’s drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101168r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=669-698&author=D.+Oehlrichauthor=D.+J.+-C.+Berthelotauthor=H.+J.+M.+Gijsen&title=%CE%B3-Secretase+modulators+as+potential+disease+modifying+anti-Alzheimer%E2%80%99s+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm101168r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101168r%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DBerthelot%26aufirst%3DD.%2BJ.%2B-C.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3D%25CE%25B3-Secretase%2520modulators%2520as%2520potential%2520disease%2520modifying%2520anti-Alzheimer%25E2%2580%2599s%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D669%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hardy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-5&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bergmans, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">γ-Secretases: from cell biology to therapeutic strategies</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=215-225&author=B.+A.+Bergmansauthor=B.+De+Strooper&title=%CE%B3-Secretases%3A+from+cell+biology+to+therapeutic+strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBergmans%26aufirst%3DB.%2BA.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3D%25CE%25B3-Secretases%253A%2520from%2520cell%2520biology%2520to%2520therapeutic%2520strategies%26jtitle%3DNeurology%26date%3D2010%26volume%3D9%26spage%3D215%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Panza, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solfrizzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frisardi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capurso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Introno, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colacicco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendemiale, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capurso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbibo, B. P.</span><span> </span><span class="NLM_article-title">Disease-modifying approach to the treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.2165%2F11315770-000000000-00000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=19655822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOju7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2009&pages=537-555&author=F.+Panzaauthor=V.+Solfrizziauthor=V.+Frisardiauthor=C.+Capursoauthor=A.+D%E2%80%99Intronoauthor=A.+M.+Colaciccoauthor=G.+Vendemialeauthor=A.+Capursoauthor=B.+P.+Imbibo&title=Disease-modifying+approach+to+the+treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Disease-modifying approach to the treatment of Alzheimer's disease: from α-secretase activators to γ-secretase inhibitors and modulators</span></div><div class="casAuthors">Panza, Francesco; Solfrizzi, Vincenzo; Frisardi, Vincenza; Capurso, Cristiano; D'Introno, Alessia; Colacicco, Anna M.; Vendemiale, Gianluigi; Capurso, Antonio; Imbimbo, Bruno P.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">537-555</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">A review.  In the last decade, advances in understanding the neurobiol. of Alzheimer's disease (AD) have translated into an increase in clin. trials assessing various potential AD treatments.  At present, drugs used for the treatment of AD only slightly delay the inevitable symptomatic progression of the disease and do not affect the main neuropathol. hallmarks of the disease, i.e. senile plaques and neurofibrillary tangles.  Brain accumulation of oligomeric species of β-amyloid (Aβ) peptides, the principal components of senile plaques, is believed to play a crucial role in the development of AD.  Based on this hypothesis, huge efforts are being made to identify drugs able to interfere with proteases regulating Aβ formation from amyloid precursor protein (APP).  Compds. that stimulate α-secretase, the enzyme responsible for non-amyloidogenic metab. of APP, are being developed and one of these, EHT-0202, has recently commenced evaluation in a phase II study.  The discovery of inhibitors of β-secretase (memapsin-2, β-amyloid cleaving enzyme-1 [BACE-1]), the enzyme that regulates the first step of amyloidogenic APP metab., has proved to be particularly difficult because of inherent medicinal chem. issues and only one compd. (CTS-21166) has proceeded to clin. testing.  Conversely, several compds. that inhibit γ-secretase, the pivotal enzyme that generates Aβ, have been identified, the most advanced being LY-450139 (semagacestat), presently in phase III clin. development.  There has been considerable disappointment over the failure of a phase III study of tarenflurbil, a compd. believed to modulate the activity of y-secretase, after encouraging phase II findings.  Nevertheless, other promising y-secretase modulators are being developed and are approaching clin. testing.  All these therapeutic approaches increase the hope of slowing the rate of decline in patients with AD and modifying the natural history of this devastating disease within the next 5 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzAE5mGxaRkLVg90H21EOLACvtfcHk0lhsfV8Il7Qj8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOju7rE&md5=4c311efa2d1d777d67eba5ef68285e6e</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.2165%2F11315770-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11315770-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DPanza%26aufirst%3DF.%26aulast%3DSolfrizzi%26aufirst%3DV.%26aulast%3DFrisardi%26aufirst%3DV.%26aulast%3DCapurso%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Introno%26aufirst%3DA.%26aulast%3DColacicco%26aufirst%3DA.%2BM.%26aulast%3DVendemiale%26aufirst%3DG.%26aulast%3DCapurso%26aufirst%3DA.%26aulast%3DImbibo%26aufirst%3DB.%2BP.%26atitle%3DDisease-modifying%2520approach%2520to%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DDrugs%2520Aging%26date%3D2009%26volume%3D26%26spage%3D537%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Chávez-Gutiérrez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bammens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benilova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandersteen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benurwar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lismont, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Cleynenbreugel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esselmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltfang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serneels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schymkowitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousseau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broersen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The mechanism of γ-secretase dysfunction in familial Alzheimer disease</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2261</span><span class="NLM_x">–</span> <span class="NLM_lpage">2274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=2261-2274&author=L.+Ch%C3%A1vez-Guti%C3%A9rrezauthor=L.+Bammensauthor=I.+Benilovaauthor=A.+Vandersteenauthor=M.+Benurwarauthor=M.+Borgersauthor=S.+Lismontauthor=L.+Zhouauthor=S.+Van+Cleynenbreugelauthor=H.+Esselmannauthor=J.+Wiltfangauthor=L.+Serneelsauthor=E.+Karranauthor=H.+Gijsenauthor=J.+Schymkowitzauthor=F.+Rousseauauthor=K.+Broersenauthor=B.+De+Strooper&title=The+mechanism+of+%CE%B3-secretase+dysfunction+in+familial+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCh%25C3%25A1vez-Guti%25C3%25A9rrez%26aufirst%3DL.%26aulast%3DBammens%26aufirst%3DL.%26aulast%3DBenilova%26aufirst%3DI.%26aulast%3DVandersteen%26aufirst%3DA.%26aulast%3DBenurwar%26aufirst%3DM.%26aulast%3DBorgers%26aufirst%3DM.%26aulast%3DLismont%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DVan%2BCleynenbreugel%26aufirst%3DS.%26aulast%3DEsselmann%26aufirst%3DH.%26aulast%3DWiltfang%26aufirst%3DJ.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DSchymkowitz%26aufirst%3DJ.%26aulast%3DRousseau%26aufirst%3DF.%26aulast%3DBroersen%26aufirst%3DK.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520mechanism%2520of%2520%25CE%25B3-secretase%2520dysfunction%2520in%2520familial%2520Alzheimer%2520disease%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26spage%3D2261%26epage%3D2274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="note"><p class="first last">For comprehensive reviews on work on γ-secretase modulators see: ref <a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">6</a></p></div><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%00empty%00"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Novel γ-secretase modulators: a review of patents from 2008 to 2010</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1517%2F13543776.2011.547479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=21231889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=205-225&author=M.+Petterssonauthor=G.+W.+Kauffmanauthor=C.+W.+am+Endeauthor=N.+C.+Patelauthor=C.+Stiffauthor=T.+P.+Tranauthor=D.+S.+Johnson&title=Novel+%CE%B3-secretase+modulators%3A+a+review+of+patents+from+2008+to+2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel γ-secretase modulators: a review of patents from 2008 to 2010</span></div><div class="casAuthors">Pettersson, Martin; Kauffman, Gregory W.; am Ende, Christopher W.; Patel, Nandini C.; Stiff, Cory; Tran, Tuan P.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-226</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The amyloid precursor protein is first cleaved by β-secretase to generate a 99-residue membrane-bound CTF (C99 or β-CTF), which is subsequently cleaved by γ-secretase to generate amyloid β (Aβ) peptides and the APP intracellular domain.  The amyloidogenic Aβ42 has attracted considerable attention because it is thought to be the most pathogenic species assocd. with Alzheimer's disease progression.  New classes of compds., called γ-secretase modulators (GSMs), have been shown to selectively lower Aβ42 prodn. without shutting down key γ-secretase-dependent signaling pathways.  This has become an important therapeutic strategy aimed at modulating Aβ prodn.  The progress on the clin. development of γ-secretase inhibitors is briefly covered in this review, followed by a discussion of the potential differentiating attributes of GSMs.  Then, the patent literature covering novel GSMs is reviewed, focusing on patents from 2008 to 2010.  Much progress has been made in the past 2 years on developing GSMs with improved potency for lowering the prodn. of Aβ42.  However, many of these chemotypes are in a challenging chem. space and generally possess higher lipophilicity than most CNS drugs.  It will be important to gain a better understanding of the specific target(s) that these GSMs interact with in order to facilitate future drug design efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocCQHiTfGSILVg90H21EOLACvtfcHk0lj-zWaRL1JPQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D&md5=9e52482a492eea96f9f88b59742e38ce</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.547479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.547479%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520%25CE%25B3-secretase%2520modulators%253A%2520a%2520review%2520of%2520patents%2520from%25202008%2520to%25202010%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D205%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zettl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, G.</span><span> </span><span class="NLM_article-title">Exploring the chemical space of γ-secretase modulators</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=402-410&author=H.+Zettlauthor=S.+Weggenauthor=P.+Schneiderauthor=G.+Schneider&title=Exploring+the+chemical+space+of+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZettl%26aufirst%3DH.%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DG.%26atitle%3DExploring%2520the%2520chemical%2520space%2520of%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2010%26volume%3D31%26spage%3D402%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Baumann, S.; Hötteke, N.; Narlawar, R.; Schmidt, B.</span><span> </span><span class="NLM_article-title">γ-Secretase as a target for AD</span>. In  <span class="citation_source-book">Medicinal Chemistry of Alzheimer’s Disease</span>; <span class="NLM_contrib-group">Gil, A. M.</span>, Eds.; <span class="NLM_publisher-name">Transworld Research Network</span>: <span class="NLM_publisher-loc">Trivandrum, India</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=193-224&author=S.+Baumann&author=N.+H%C3%B6tteke&author=R.+Narlawar&author=B.+Schmidtauthor=A.+M.+Gil&title=Medicinal+Chemistry+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBaumann%26aufirst%3DS.%26atitle%3D%25CE%25B3-Secretase%2520as%2520a%2520target%2520for%2520AD%26btitle%3DMedicinal%2520Chemistry%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26aulast%3DGil%26aufirst%3DA.%2BM.%26pub%3DTransworld%2520Research%2520Network%26date%3D2008%26spage%3D193%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Garofalo, A. W.</span><span> </span><span class="NLM_article-title">Patents targeting γ-secretase inhibition and modulation for the treatment of Alzheimer’s disease: 2004–2008</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">703</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1517%2F13543776.18.7.693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntlGgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=693-703&author=A.+W.+Garofalo&title=Patents+targeting+%CE%B3-secretase+inhibition+and+modulation+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+2004%E2%80%932008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10eR"><div class="casContent"><span class="casTitleNuber">10e</span><div class="casTitle"><span class="NLM_cas:atitle">Patents targeting γ-secretase inhibition and modulation for the treatment of Alzheimer's disease: 2004 - 2008</span></div><div class="casAuthors">Garofalo, Albert W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">693-703</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Although Alzheimer's disease has been defined for over a century, at present there is no effective treatment.  Amyloid deposition and plaque formation are widely believed to contribute to the pathol. of the disease.  As the etiol. of plaque formation has become better understood, the search for therapies has bred small mols. capable of inhibiting or regulating the activity of γ-secretase.  This paper reviews patents from the past 4 years claiming modulators or inhibitors of γ-secretase as a treatment for Alzheimer's disease.  One or two compds. from each patent were selected to represent the claimed chem. space.  Compd. selection was influenced by literature accounts, which are also discussed.  Although an attempt has been made to include major contributions in the field, the list of patents reviewed should not be considered exhaustive.  This review seeks to expand upon a previous review covering patents from 2000-2004.  Since then there has been an increase in the no. of structural and mechanistic approaches being pursued and several compds. have entered the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptzyUbNbn4uLVg90H21EOLACvtfcHk0ljt3y5UKKEHtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntlGgu78%253D&md5=a26891676fdd05b0b3c2501824ced28f</span></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.7.693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.7.693%26sid%3Dliteratum%253Aachs%26aulast%3DGarofalo%26aufirst%3DA.%2BW.%26atitle%3DPatents%2520targeting%2520%25CE%25B3-secretase%2520inhibition%2520and%2520modulation%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%25202004%25E2%2580%25932008%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D693%26epage%3D703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Tomita, T.</span><span> </span><span class="NLM_article-title">Secretase inhibitors and modulators for Alzheimer’s disease treatment</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1586%2Fern.09.24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=19402777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Cltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=661-679&author=T.+Tomita&title=Secretase+inhibitors+and+modulators+for+Alzheimer%E2%80%99s+disease+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10fR"><div class="casContent"><span class="casTitleNuber">10f</span><div class="casTitle"><span class="NLM_cas:atitle">Secretase inhibitors and modulators for Alzheimer's disease treatment</span></div><div class="casAuthors">Tomita, Taisuke</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">661-679</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Genetic and biol. studies provide strong evidence that the deposition of amyloid-β peptide (Aβ) contributes to the etiol. of Alzheimer's disease (AD).  Aβ is generated from amyloid-β precursor protein by β- and γ-secretases, which are plausible mol. targets for AD treatment.  Thus, drugs that regulate the prodn. of Aβ by inhibiting or modulating secretase activity could provide effective therapeutics for AD.  Both secretases are transmembrane proteases: β-site amyloid-β precursor protein cleaving enzyme 1, the main neuronal β-secretase, is a single span transmembrane aspartyl protease; γ-secretase is a multiprotein complex comprising four core subunits that are all transmembrane proteins: presenilin, nicastrin, anterior pharynx-defective 1 and presenilin enhancer 2.  Mol. biochem., enzymol. and genetic analyses reveal the mol. mechanisms of these secretases in the generation of Aβ.  Moreover, extensive drug screening and development have enabled some secretase inhibitors and modulators to advance into late-Phase clin. trials.  This review focuses on recent progresses in β- and γ-secretase biol., including the proteolytic mechanism, regulation and compn. of these enzymes.  Moreover, this review discusses the recent development of inhibitors, and provides a direction for the effective treatment of AD through inhibition/modulation of β- and γ-secretase activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSTaWWoZqbULVg90H21EOLACvtfcHk0lhsWQXzYAZYag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Cltrw%253D&md5=7a3ef95c7c264863698d10fafb347c45</span></div><a href="/servlet/linkout?suffix=cit10f&amp;dbid=16384&amp;doi=10.1586%2Fern.09.24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fern.09.24%26sid%3Dliteratum%253Aachs%26aulast%3DTomita%26aufirst%3DT.%26atitle%3DSecretase%2520inhibitors%2520and%2520modulators%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2009%26volume%3D9%26spage%3D661%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Pissarnitski, D.</span><span> </span><span class="NLM_article-title">Advances in γ-secretase modulation</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=392-402&author=D.+Pissarnitski&title=Advances+in+%CE%B3-secretase+modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPissarnitski%26aufirst%3DD.%26atitle%3DAdvances%2520in%2520%25CE%25B3-secretase%2520modulation%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%26date%3D2007%26volume%3D10%26spage%3D392%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Peretto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Porta, E.</span><span> </span><span class="NLM_article-title">γ-Secretase modulation and its promise for Alzheimer’s disease: a medicinal chemistry perspective</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10h&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.2174%2F156802608783334097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10h&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=18220931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10h&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWnt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=38-46&author=I.+Perettoauthor=E.+La+Porta&title=%CE%B3-Secretase+modulation+and+its+promise+for+Alzheimer%E2%80%99s+disease%3A+a+medicinal+chemistry+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10hR"><div class="casContent"><span class="casTitleNuber">10h</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase modulation and its promise for Alzheimer's disease: a medicinal chemistry perspective</span></div><div class="casAuthors">Peretto, Ilaria; La Porta, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-46</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  γ-Secretase modulation holds the promise for the development of a disease-modifying therapy for Alzheimer's disease (AD).  This novel concept of manipulating the cleavage specificity of the γ-secretase enzyme by pharmacol. means implies that steady state levels of the potentially disease-causing amyloid-β(1-42) peptide can be lowered without the undesired side effects assocd. with full inhibition of this aspartyl-type protease.  Following on from the initial discovery that certain non-steroidal anti-inflammatory drugs (NSAIDs) exhibit properties characteristic of γ-secretase modulators, this class of compds. has been extensively studied and exploited, leading to the discovery of NSAIDs derivs. endowed with improved potency for the redn. of amyloid-β(1-42) peptide prodn.  In addn., a very limited no. of non-NSAID derived γ-secretase modulators has also been recently claimed in the patent literature, suggesting that only a restricted no. of pharmacophores might be involved in the modulation of γ-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYysZpzm8stLVg90H21EOLACvtfcHk0li_xkXFpUqLrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWnt74%253D&md5=0771c6dc024355e125e2554c446d2423</span></div><a href="/servlet/linkout?suffix=cit10h&amp;dbid=16384&amp;doi=10.2174%2F156802608783334097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608783334097%26sid%3Dliteratum%253Aachs%26aulast%3DPeretto%26aufirst%3DI.%26aulast%3DLa%2BPorta%26aufirst%3DE.%26atitle%3D%25CE%25B3-Secretase%2520modulation%2520and%2520its%2520promise%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D38%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Abdul-Hay, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edirisinghe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatcher, G. R. J.</span><span> </span><span class="NLM_article-title">Selective modulation of amyloid-β peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Aβ levels</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1111%2Fj.1471-4159.2009.06355.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=19702658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOqtLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2009&pages=683-695&author=S.+O.+Abdul-Hayauthor=P.+Edirisingheauthor=G.+R.+J.+Thatcher&title=Selective+modulation+of+amyloid-%CE%B2+peptide+degradation+by+flurbiprofen%2C+fenofibrate%2C+and+related+compounds+regulates+A%CE%B2+levels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Selective modulation of amyloid-β peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Aβ levels</span></div><div class="casAuthors">Abdul-Hay, Samer O.; Edirisinghe, Praneeth; Thatcher, Gregory R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">683-695</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Gamma-secretase modulators (GSMs) include selected non-steroidal anti-inflammatory drugs such as flurbiprofen that selectively lowers the neurotoxic amyloid-β peptide Aβ1-42.  GSMs are attractive targets for Alzheimer's disease, in contrast to 'inverse GSMs,' such as fenofibrate, which selectively increase the level of Aβ1-42.  A methodol. for screening of Aβ modulating drugs was developed utilizing an Aβ-producing neuroblastoma cell line stably transfected with mutant human amyloid precursor protein, immunopptn. of Aβ peptides, and mass spectroscopic quantitation of Aβ1-37/Aβ1-38/Aβ1-40/Aβ1-42 using an Aβ internal std.  The unexpected conclusion of this work was that in this system, drug effects are independent of γ-secretase.  The methodol. recapitulated reported results for modulation of Aβ by GSMs.  However, control expts. in which exogenous Aβ1-40/Aβ1-42 was added (i) to drug-treated wild-type cells or (ii) to conditioned media from these wild-type cells, gave comparable patterns of Aβ modulation.  These results, suggesting that drugs modulate the ability of cell-derived factors to degrade Aβ, was interrogated by adding protease inhibitors and performing mol. wt. cut-off fractionation.  The results confirmed that modulation of Aβ1-40/Aβ1-42 was mediated by selective proteolysis.  Treatment of N2a cells with flurbiprofen or fenofibric acid selectively enhanced Aβ1-42 clearance by extracellular proteolysis; treatment with HCT-1026 or fenofibrate (esters of flurbiprofen and fenobric acid) inhibited clearance of Aβ1-40 and Aβ1-42.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVSboU5xjr9LVg90H21EOLACvtfcHk0liNTkIZppMuoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOqtLfN&md5=57d300269647eb3336290c27f7b7b574</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.06355.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.06355.x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul-Hay%26aufirst%3DS.%2BO.%26aulast%3DEdirisinghe%26aufirst%3DP.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26atitle%3DSelective%2520modulation%2520of%2520amyloid-%25CE%25B2%2520peptide%2520degradation%2520by%2520flurbiprofen%252C%2520fenofibrate%252C%2520and%2520related%2520compounds%2520regulates%2520A%25CE%25B2%2520levels%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D111%26spage%3D683%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Van Broeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsden, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, A.</span><span> </span><span class="NLM_article-title">Chronic treatment with a novel γ-secretase modulator, JNJ-40418677, inhibits amyloid plaque formation in a mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1111%2Fj.1476-5381.2011.01207.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=21232036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1GitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2011&pages=375-389&author=B.+Van+Broeckauthor=J.-M.+Chenauthor=G.+Tretonauthor=M.+Desmidtauthor=C.+Hopfauthor=N.+Ramsdenauthor=E.+Karranauthor=M.+Merckenauthor=A.+Rowley&title=Chronic+treatment+with+a+novel+%CE%B3-secretase+modulator%2C+JNJ-40418677%2C+inhibits+amyloid+plaque+formation+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic treatment with a novel γ-secretase modulator, JNJ-40418677, inhibits amyloid plaque formation in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Van Broeck, B.; Chen, J.-M.; Treton, G.; Desmidt, M.; Hopf, C.; Ramsden, N.; Karran, E.; Mercken, M.; Rowley, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">375-389</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">γ-Secretase modulators represent a promising therapeutic approach for Alzheimer's disease (AD) because they selectively decrease amyloid β 42 (Aβ42), a particularly neurotoxic Aβ species that accumulates in plaques in the brains of patients with AD.  In the present study, we describe the in vitro and in vivo pharmacol. properties of a potent novel γ-secretase modulator, 2-(S)-(3,5-bis(4-(trifluoromethyl)phenyl)phenyl)-4-methylpentanoic acid (JNJ-40418677).  The potency and selectivity of JNJ-40418677 for Aβ redn. was investigated in human neuroblastoma cells, rat primary neurons and after treatment with single oral doses in non-transgenic mouse brains.  To evaluate the effect of JNJ-40418677 on plaque formation, Tg2576 mice were treated from 6 until 13 mo of age via the diet.  JNJ-40418677 selectively reduced Aβ42 secretion in human neuroblastoma cells and rat primary neurons, but it did not inhibit Notch processing or formation of other amyloid precursor protein cleavage products.  Oral treatment of non-transgenic mice with JNJ-40418677 resulted in an excellent brain penetration of the compd. and a dose- and time-dependent decrease of brain Aβ42 levels.  Chronic treatment of Tg2576 mice with JNJ-40418677 reduced brain Aβ levels, the area occupied by plaques and plaque no. in a dose-dependent manner compared with transgenic vehicle-treated mice.  JNJ-40418677 selectively decreased Aβ42 prodn., showed an excellent brain penetration after oral administration in mice and lowered brain Aβ burden in Tg2576 mice after chronic treatment.  JNJ-40418677 therefore warrants further investigation as a potentially effective disease-modifying therapy for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7MGWYryyTFbVg90H21EOLACvtfcHk0ljW-vgN1sBirg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1GitL0%253D&md5=aae5e894472fc12258ef3e4662a726e4</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01207.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01207.x%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DJ.-M.%26aulast%3DTreton%26aufirst%3DG.%26aulast%3DDesmidt%26aufirst%3DM.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DRamsden%26aufirst%3DN.%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DRowley%26aufirst%3DA.%26atitle%3DChronic%2520treatment%2520with%2520a%2520novel%2520%25CE%25B3-secretase%2520modulator%252C%2520JNJ-40418677%252C%2520inhibits%2520amyloid%2520plaque%2520formation%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D163%26spage%3D375%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cheng, S.; Comer, D. D.; Mao, L.; Balow, G. P.; Pleynet, D.</span><span> </span><span class="NLM_article-title">Aryl compounds and uses in modulating amyloid β</span>. Patent WO 2004110350,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=S.+Cheng&author=D.+D.+Comer&author=L.+Mao&author=G.+P.+Balow&author=D.+Pleynet&title=Aryl+compounds+and+uses+in+modulating+amyloid+%CE%B2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DS.%26atitle%3DAryl%2520compounds%2520and%2520uses%2520in%2520modulating%2520amyloid%2520%25CE%25B2%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kounnas, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">C., Soan, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleynet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digregorio, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velicelebi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauderman, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobley, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisodia, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S. L.</span><span> </span><span class="NLM_article-title">Modulation of γ -Secretase Reduces β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer’s Disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=769-780&author=M.+Z.+Kounnasauthor=A.+M.+Danksauthor=T.+C.+C.%2C+Soanauthor=E.+Ackermanauthor=X.+Zhangauthor=K.+Ahnauthor=P.+Nguyenauthor=D.+Comerauthor=L.+Maoauthor=C.+Yuauthor=D.+Pleynetauthor=P.+J.+Digregorioauthor=G.+Velicelebiauthor=K.+A.+Staudermanauthor=W.+T.+Comerauthor=W.+C.+Mobleyauthor=Y.-M.+Liauthor=S.+S.+Sisodiaauthor=R.+E.+Tanziauthor=S.+L.+Wagner&title=Modulation+of+%CE%B3+-Secretase+Reduces+%CE%B2-Amyloid+Deposition+in+a+Transgenic+Mouse+Model+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKounnas%26aufirst%3DM.%2BZ.%26aulast%3DDanks%26aufirst%3DA.%2BM.%26aulast%3DC.%252C%2BSoan%26aufirst%3DT.%2BC.%26aulast%3DAckerman%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DComer%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DPleynet%26aufirst%3DD.%26aulast%3DDigregorio%26aufirst%3DP.%2BJ.%26aulast%3DVelicelebi%26aufirst%3DG.%26aulast%3DStauderman%26aufirst%3DK.%2BA.%26aulast%3DComer%26aufirst%3DW.%2BT.%26aulast%3DMobley%26aufirst%3DW.%2BC.%26aulast%3DLi%26aufirst%3DY.-M.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DWagner%26aufirst%3DS.%2BL.%26atitle%3DModulation%2520of%2520%25CE%25B3%2520-Secretase%2520Reduces%2520%25CE%25B2-Amyloid%2520Deposition%2520in%2520a%2520Transgenic%2520Mouse%2520Model%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DNeuron%26date%3D2010%26volume%3D67%26spage%3D769%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kimura, T.; Kawano, K.; Doi, E.; Kitazawa, N.; Shin, K.; Miyagawa, T.; Kaneko, T.; Ito, K.; Takaishi, M.; Sasaki, T.; Hagiwara, H.</span><span> </span><span class="NLM_article-title">Preparation of cinnamide, 3-benzylidenepiperidin-2-one, phenylpropynamide compounds as amyloid β production inhibitors</span>. Patent WO 2005115990,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=T.+Kimura&author=K.+Kawano&author=E.+Doi&author=N.+Kitazawa&author=K.+Shin&author=T.+Miyagawa&author=T.+Kaneko&author=K.+Ito&author=M.+Takaishi&author=T.+Sasaki&author=H.+Hagiwara&title=Preparation+of+cinnamide%2C+3-benzylidenepiperidin-2-one%2C+phenylpropynamide+compounds+as+amyloid+%CE%B2+production+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520cinnamide%252C%25203-benzylidenepiperidin-2-one%252C%2520phenylpropynamide%2520compounds%2520as%2520amyloid%2520%25CE%25B2%2520production%2520inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="note"><p class="first last">Similar strategies have been used by others:</p></div><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span> </span><span class="NLM_article-title">The Discovery of Pyridone and Pyridazone Heterocycles as γ-Secretase Modulators</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml1000799" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlyjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=184-187&author=X.+Huangauthor=R.+Aslanianauthor=W.+Zhouauthor=X.+Zhuauthor=J.+Qinauthor=W.+Greenleeauthor=Z.+Zhuauthor=L.+Zhangauthor=L.+Hydeauthor=I.+Chuauthor=M.+Cohen-Williamsauthor=A.+Palani&title=The+Discovery+of+Pyridone+and+Pyridazone+Heterocycles+as+%CE%B3-Secretase+Modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of Pyridone and Pyridazone Heterocycles as γ-Secretase Modulators</span></div><div class="casAuthors">Huang, Xianhai; Aslanian, Robert; Zhou, Wei; Zhu, Xiaohong; Qin, Jun; Greenlee, William; Zhu, Zhaoning; Zhang, Lili; Hyde, Lynn; Chu, Inhou; Cohen-Williams, Mary; Palani, Anandan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">184-187</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel pyridazone and pyridone compds., e.g., I, as γ-secretase modulators were discovered.  Starting from the initial lead, structure-activity relationship studies were carried out in which an internal hydrogen bond was introduced to conformationally fix the side chain, and compds. with improved in vitro Aβ42 inhibition activity and good Aβtotal/Aβ42 selectivity were quickly discovered.  Compd. I displayed very good in vitro activity and excellent selectivity with good in vivo efficacy in both CRND8 mouse and nontransgenic rat models.  This compd. displayed a good overall profile in terms of rat pharmacokinetics and ancillary profile.  No abnormal behavior and side effects were obsd. in all of the studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqki-gEswVL97Vg90H21EOLACvtfcHk0lgH5OtB41nHmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlyjtbo%253D&md5=2e738a3fdbcddce0c87e7e25130e9f86</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Fml1000799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1000799%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DPalani%26aufirst%3DA.%26atitle%3DThe%2520Discovery%2520of%2520Pyridone%2520and%2520Pyridazone%2520Heterocycles%2520as%2520%25CE%25B3-Secretase%2520Modulators%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D184%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Qin., J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhondi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pissarnitski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span> </span><span class="NLM_article-title">Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1016%2Fj.bmcl.2010.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=21195610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVKqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=664-669&author=J.+Qin.author=P.+Dhondiauthor=X.+Huangauthor=M.+Mandalauthor=Z.+Zhaoauthor=D.+Pissarnitskiauthor=W.+Zhouauthor=R.+Aslanianauthor=Z.+Zhuauthor=W.+Greenleeauthor=J.+Claderauthor=L.+Zhangauthor=M.+Cohen-Williamsauthor=N.+Jonesauthor=L.+Hydeauthor=A.+Palani&title=Discovery+of+fused+5%2C6-bicyclic+heterocycles+as+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators</span></div><div class="casAuthors">Qin, Jun; Dhondi, Pawan; Huang, Xianhai; Mandal, Mihirbaran; Zhao, Zhiqiang; Pissarnitski, Dmitri; Zhou, Wei; Aslanian, Robert; Zhu, Zhaoning; Greenlee, William; Clader, John; Zhang, Lili; Cohen-Williams, Mary; Jones, Nicholas; Hyde, Lynn; Palani, Anandan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">664-669</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery of four series of fused 5,6-bicyclic heterocycles, e.g., I [R = 4-FC6H4CHMe, 4-(MeO)C6H4CH2, n-pentyl, etc.], as γ-secretase modulators was reported.  The synthesis and SAR of these series were discussed.  These compds. represented a new class of γ-secretase modulators that demonstrated moderate to good in vitro potency in inhibiting Aβ42 prodn.  Specifically, compd. II demonstrated good in vitro and moderate in vivo efficacy as a γ-secretase modulator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnTq6NEaz9XbVg90H21EOLACvtfcHk0ljVYZpRXPhXEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVKqsw%253D%253D&md5=a85b7d068d89d39d18ce06d6ad748806</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DQin.%26aufirst%3DJ.%26aulast%3DDhondi%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DPissarnitski%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DN.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DPalani%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520fused%25205%252C6-bicyclic%2520heterocycles%2520as%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D664%26epage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Fischer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crispino, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span> </span><span class="NLM_article-title">Quinazolinones as γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">773</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=773-776&author=C.+Fischerauthor=S.+Shahauthor=B.+L.+Hughesauthor=G.+N.+Nikovauthor=J.+L.+Crispinoauthor=R.+E.+Middletonauthor=A.+A.+Szewczakauthor=B.+Munozauthor=M.+S.+Shearman&title=Quinazolinones+as+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DHughes%26aufirst%3DB.%2BL.%26aulast%3DNikov%26aufirst%3DG.%2BN.%26aulast%3DCrispino%26aufirst%3DJ.%2BL.%26aulast%3DMiddleton%26aufirst%3DR.%2BE.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26atitle%3DQuinazolinones%2520as%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D773%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Qin., J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhondi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Discovery of a potent pyrazolopyridine series of γ-secretase modulators</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml2000438" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVOlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=471-476&author=J.+Qin.author=W+Zhouauthor=X.+Huangauthor=P.+Dhondiauthor=A+Palaniauthor=R.+Aslanianauthor=Z.+Zhuauthor=W.+Greenleeauthor=M.+Cohen-Williamsauthor=N.+Jonesauthor=L.+Hydeauthor=L.+Zhang&title=Discovery+of+a+potent+pyrazolopyridine+series+of+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14dR"><div class="casContent"><span class="casTitleNuber">14d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent pyrazolopyridine series of γ-secretase modulators</span></div><div class="casAuthors">Qin, Jun; Zhou, Wei; Huang, Xianhai; Dhondi, Pawan; Palani, Anandan; Aslanian, Robert; Zhu, Zhaoning; Greenlee, William; Cohen-Williams, Mary; Jones, Nicholas; Hyde, Lynn; Zhang, Lili</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">471-476</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and structure-activity relationship of a novel series of pyrazolopyridines are reported.  These compds. represent a new class of γ-secretase modulators that demonstrate good in vitro potency in inhibiting Aβ42 prodn.  Examples with statistically significant in vivo efficacy in reducing the prodn. of rat cerebrospinal fluid Aβ42 were also identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2w7CtUkvQh7Vg90H21EOLACvtfcHk0lhx-nttpL6X4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVOlsr0%253D&md5=6c36b585797281fe037510750b111d57</span></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1021%2Fml2000438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2000438%26sid%3Dliteratum%253Aachs%26aulast%3DQin.%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DW%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DDhondi%26aufirst%3DP.%26aulast%3DPalani%26aufirst%3DA%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DN.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520pyrazolopyridine%2520series%2520of%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D471%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Wan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, Y</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, J.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, Y.</span><span> </span><span class="NLM_article-title">Pyridine-derived γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4832</span><span class="NLM_x">–</span> <span class="NLM_lpage">4835</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4832-4835&author=Z.+Wanauthor=A.+Hallauthor=Y+Sangauthor=J.-N.+Xiangauthor=E.+Yangauthor=B+Smithauthor=G.+Yangauthor=H.+Yuauthor=J.+Wangauthor=L.+F.+Lauauthor=T.+Liauthor=W.+Zhaoauthor=X.+Suauthor=X.+Zhangauthor=Y.+Zhouauthor=Y.+Jinauthor=Z.+Tongauthor=Z.+Chengauthor=I.+Hussainauthor=J.+D.+Elliottauthor=Y.+Matsuoka&title=Pyridine-derived+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DZ.%26aulast%3DHall%26aufirst%3DA.%26aulast%3DSang%26aufirst%3DY%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DB%26aulast%3DYang%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLau%26aufirst%3DL.%2BF.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DSu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DTong%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DMatsuoka%26aufirst%3DY.%26atitle%3DPyridine-derived%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4832%26epage%3D4835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navaratnam, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakya, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetelino, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2906</span><span class="NLM_x">–</span> <span class="NLM_lpage">2911</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1016%2Fj.bmcl.2012.02.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=22429469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2906-2911&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=C.+Subramanyamauthor=K.+R.+Balesauthor=C.+W.+am+Endeauthor=B.+A.+Fishauthor=M.+E.+Greenauthor=G.+W.+Kauffmanauthor=R.+Liraauthor=P.+B.+Mullinsauthor=T.+Navaratnamauthor=S.+M.+Sakyaauthor=C.+M.+Stiffauthor=T.+M.+Tranauthor=B.+C.+Vetelinoauthor=L.+Xieauthor=L.+Zhangauthor=L.+R.+Pustilnikauthor=K.+M.+Woodauthor=C.+J.+O%E2%80%99Donnell&title=Design+and+synthesis+of+dihydrobenzofuran+amides+as+orally+bioavailable%2C+centrally+active+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14fR"><div class="casContent"><span class="casTitleNuber">14f</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Subramanyam, Chakrapani; Bales, Kelly R.; am Ende, Christopher W.; Fish, Benjamin A.; Green, Michael E.; Kauffman, Gregory W.; Lira, Ricardo; Mullins, Patrick B.; Navaratnam, Thayalan; Sakya, Subas M.; Stiff, Cory M.; Tran, Tuan P.; Vetelino, Beth C.; Xie, Longfei; Zhang, Liming; Pustilnik, Leslie R.; Wood, Kathleen M.; O'Donnell, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2906-2911</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and optimization of a novel series of dihydrobenzofuran amides as γ-secretase modulators (GSMs) is reported.  Strategies for aligning in vitro potency with drug-like physicochem. properties and good microsomal stability while avoiding P-gp mediated efflux are discussed.  Lead compds. such as I and II have moderate to good in vitro potency and excellent selectivity against Notch.  Good oral bioavailability was achieved as well as robust brain Aβ42 lowering activity at 100 mg/kg po dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIcSb2qlgrNLVg90H21EOLACvtfcHk0lh863GKvyuo4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D&md5=63746bd0db38a20bb33b5e990e66610c</span></div><a href="/servlet/linkout?suffix=cit14f&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.059%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3DNavaratnam%26aufirst%3DT.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DTran%26aufirst%3DT.%2BM.%26aulast%3DVetelino%26aufirst%3DB.%2BC.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520dihydrobenzofuran%2520amides%2520as%2520orally%2520bioavailable%252C%2520centrally%2520active%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2906%26epage%3D2911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Fischer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zultanski, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Methot, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuthall., H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smotrov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moxham, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bays, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span> </span><span class="NLM_article-title">Triazoloamides as potent γ-secretase modulators with reduced hERG liability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3140</span><span class="NLM_x">–</span> <span class="NLM_lpage">3146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14g&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1016%2Fj.bmcl.2012.03.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14g&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=22497762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14g&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsVaisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3140-3146&author=C.+Fischerauthor=S.+L.+Zultanskiauthor=H.+Zhouauthor=J.+L.+Methotauthor=S.+Shahauthor=H.+Nuthall.author=B.+L.+Hughesauthor=N.+Smotrovauthor=A.+Hillauthor=A.+A.+Szewczakauthor=C.+M.+Moxhamauthor=N.+Baysauthor=R.+E.+Middletonauthor=B.+Munozauthor=M.+S.+Shearman&title=Triazoloamides+as+potent+%CE%B3-secretase+modulators+with+reduced+hERG+liability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14gR"><div class="casContent"><span class="casTitleNuber">14g</span><div class="casTitle"><span class="NLM_cas:atitle">Triazoloamides as potent γ-secretase modulators with reduced hERG liability</span></div><div class="casAuthors">Fischer, Christian; Zultanski, Susan L.; Zhou, Hua; Methot, Joey L.; Shah, Sanjiv; Nuthall, Hugh; Hughes, Bethany L.; Smotrov, Nadja; Hill, Armetta; Szewczak, Alexander A.; Moxham, Christopher M.; Bays, Nathan; Middleton, Richard E.; Munoz, Benito; Shearman, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3140-3146</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthesis and SAR studies of novel aryl triazoles as gamma secretase modulators (GSMs) are presented in this communication.  Starting from aryl triazole leads, optimization studies were continued and the series progressed towards novel amides and lactams.  Triazole I was identified as the most potent analog in this series, displaying single-digit nanomolar Aβ42 IC50 in cell-based assays and reduced affinity for the hERG channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiDFzfhAnInrVg90H21EOLACvtfcHk0lgEKz-zzTFvPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsVaisrg%253D&md5=6585835e1ec8b679e19bf8d687f392bb</span></div><a href="/servlet/linkout?suffix=cit14g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.03.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.03.054%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DZultanski%26aufirst%3DS.%2BL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMethot%26aufirst%3DJ.%2BL.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DNuthall.%26aufirst%3DH.%26aulast%3DHughes%26aufirst%3DB.%2BL.%26aulast%3DSmotrov%26aufirst%3DN.%26aulast%3DHill%26aufirst%3DA.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DMoxham%26aufirst%3DC.%2BM.%26aulast%3DBays%26aufirst%3DN.%26aulast%3DMiddleton%26aufirst%3DR.%2BE.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26atitle%3DTriazoloamides%2520as%2520potent%2520%25CE%25B3-secretase%2520modulators%2520with%2520reduced%2520hERG%2520liability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3140%26epage%3D3146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span>Conformational analysis was performed on molecule <b>4</b> with the Molecular Operating Environment (MOE) software (Molecular Operating Environment 2010.10 (MOE); <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">Montreal Quebec Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">, </span><a href="http://www.chemcomp.com" class="extLink">http://www.chemcomp.com</a>) using the MMFF94x force field and the LowModeMD approach with default settings. Unfavourable conformers with alternative conformations of the methoxyphenyl relative to the pyridone were at least 6.3 kcal/mol higher in energy. This suggested the preferred orientation would be significantly more likely to occur.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Conformational+analysis+was+performed+on+molecule+4+with+the+Molecular+Operating+Environment+%28MOE%29+software+%28Molecular+Operating+Environment+2010.10+%28MOE%29%3B+Chemical+Computing+Group+Inc.%3A+Montreal+Quebec+Canada%2C+2010%2C+http%3A%2F%2Fwww.chemcomp.com%29+using+the+MMFF94x+force+field+and+the+LowModeMD+approach+with+default+settings.+Unfavourable+conformers+with+alternative+conformations+of+the+methoxyphenyl+relative+to+the+pyridone+were+at+least+6.3+kcal%2Fmol+higher+in+energy.+This+suggested+the+preferred+orientation+would+be+significantly+more+likely+to+occur."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%2520Environment%25202010.10%2520%2528MOE%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gijsen, H. J. M.; Bischoff, F. P.; Zhuang, W.; Van Brandt, S. F. A.; Surkyn, M.; Zaja, M.; Berthelot, D. J.-C.; De Cleyn, M. A. J.; Macdonald, G. J.; Oehlrich, D.</span><span> </span><span class="NLM_article-title">Substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as γ-secretase modulators and their preparation and use for the treatment of diseases</span>. Patent WO 2010094647,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=H.+J.+M.+Gijsen&author=F.+P.+Bischoff&author=W.+Zhuang&author=S.+F.+A.+Van+Brandt&author=M.+Surkyn&author=M.+Zaja&author=D.+J.-C.+Berthelot&author=M.+A.+J.+De+Cleyn&author=G.+J.+Macdonald&author=D.+Oehlrich&title=Substituted+benzoxazole%2C+benzimidazole%2C+oxazolopyridine+and+imidazopyridine+derivatives+as+%CE%B3-secretase+modulators+and+their+preparation+and+use+for+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DSubstituted%2520benzoxazole%252C%2520benzimidazole%252C%2520oxazolopyridine%2520and%2520imidazopyridine%2520derivatives%2520as%2520%25CE%25B3-secretase%2520modulators%2520and%2520their%2520preparation%2520and%2520use%2520for%2520the%2520treatment%2520of%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gijsen, H. J. M.; Velter, A. I.; Macdonald, G. J.; Bischoff, F. P.; Wu, T.; Van Brandt, S. F. A.; Surkyn, M.; Zaja, M.; Pieters, S. M. A.; Berthelot, D. J.-C.; De Cleyn, M. A. J.; Oehlrich, D.</span><span> </span><span class="NLM_article-title">Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators and their preparation and use in the treatment of diseases</span>. Patent WO 2010089292,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=H.+J.+M.+Gijsen&author=A.+I.+Velter&author=G.+J.+Macdonald&author=F.+P.+Bischoff&author=T.+Wu&author=S.+F.+A.+Van+Brandt&author=M.+Surkyn&author=M.+Zaja&author=S.+M.+A.+Pieters&author=D.+J.-C.+Berthelot&author=M.+A.+J.+De+Cleyn&author=D.+Oehlrich&title=Novel+substituted+bicyclic+heterocyclic+compounds+as+gamma+secretase+modulators+and+their+preparation+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DNovel%2520substituted%2520bicyclic%2520heterocyclic%2520compounds%2520as%2520gamma%2520secretase%2520modulators%2520and%2520their%2520preparation%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gijsen, H. J. M.; Macdonald, G. J.; Bischoff, F. P.; Tresadern, G. J.; Trabanco-Suarez, A. A.; Van Brandt, S. F. A.; Berthelot, D. J.-C.</span><span> </span><span class="NLM_article-title">Preparation of substituted bicyclic imidazole derivatives as gamma secretase modulators</span>. Patent WO 2010070008,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=H.+J.+M.+Gijsen&author=G.+J.+Macdonald&author=F.+P.+Bischoff&author=G.+J.+Tresadern&author=A.+A.+Trabanco-Suarez&author=S.+F.+A.+Van+Brandt&author=D.+J.-C.+Berthelot&title=Preparation+of+substituted+bicyclic+imidazole+derivatives+as+gamma+secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DPreparation%2520of%2520substituted%2520bicyclic%2520imidazole%2520derivatives%2520as%2520gamma%2520secretase%2520modulators%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Bischoff, F. P.; Berthelot, D. J.-C.; De Cleyn, M. A. J.; Macdonald, G. J; Oehlrich, D.; Surkyn, M.; Trabanco-Suarez, A. A.; Tresadern, G. J.; Van Brandt, S. F. A.; Velter, A. I.; Borghys, H.; Masungi, C.; Mercken, M.; Gijsen., H. J. M.</span><span> </span><span class="NLM_article-title">Discovery of JNJ-42601572, a γ-Secretase Modulator with Potent, Central Activity in Mouse and Dog</span>. <span class="NLM_conf-name">242nd ACS National Meeting</span>, <span class="NLM_conf-loc">Denver, CO</span>, <span class="NLM_conf-date">August 28–September 1, 2011</span>,  <span class="NLM_fpage">Abstract MEDI-3</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bischoff%2C+F.+P.%3B+Berthelot%2C+D.+J.-C.%3B+De+Cleyn%2C+M.+A.+J.%3B+Macdonald%2C+G.+J%3B+Oehlrich%2C+D.%3B+Surkyn%2C+M.%3B+Trabanco-Suarez%2C+A.+A.%3B+Tresadern%2C+G.+J.%3B+Van+Brandt%2C+S.+F.+A.%3B+Velter%2C+A.+I.%3B+Borghys%2C+H.%3B+Masungi%2C+C.%3B+Mercken%2C+M.%3B+Gijsen.%2C+H.+J.+M.+Discovery+of+JNJ-42601572%2C+a+%CE%B3-Secretase+Modulator+with+Potent%2C+Central+Activity+in+Mouse+and+Dog.+242nd+ACS+National+Meeting%2C+Denver%2C+CO%2C+August+28%E2%80%93September+1%2C+2011%2C+Abstract+MEDI-3."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBischoff%26aufirst%3DF.%2BP.%26atitle%3DDiscovery%2520of%2520JNJ-42601572%252C%2520a%2520%25CE%25B3-Secretase%2520Modulator%2520with%2520Potent%252C%2520Central%2520Activity%2520in%2520Mouse%2520and%2520Dog%26spage%3DAbstract%2520MEDI-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Lang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zewge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houpis, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volante, R. P.</span><span> </span><span class="NLM_article-title">Amination of aryl halides using copper catalysis</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3251</span><span class="NLM_x">–</span> <span class="NLM_lpage">3254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1016%2FS0040-4039%2801%2900458-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFaktbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=3251-3254&author=F.+Langauthor=D.+Zewgeauthor=I.+N.+Houpisauthor=R.+P.+Volante&title=Amination+of+aryl+halides+using+copper+catalysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Amination of aryl halides using copper catalysis</span></div><div class="casAuthors">Lang, F.; Zewge, D.; Houpis, I. N.; Volante, R. P.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3251-3254</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Bromopyridine was converted into aminopyridine under Cu2O catalysis with an ethylene glycol soln. of ammonia in excellent yield (90%).  The amination reaction features low (0.5 mol%) catalyst loading, mild reaction temp. (80°C) and low reaction pressure (50 psi).  This protocol is further studied in the amination of a variety of aryl halides such as pyridines, benzenes, acetophenones, thiazoles and quinolines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqikX7teRRqe7Vg90H21EOLACvtfcHk0ljLycCLImOQcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFaktbY%253D&md5=e0140b081d4b0e4fa4ca600bcf8fc5bd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2900458-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252900458-0%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DF.%26aulast%3DZewge%26aufirst%3DD.%26aulast%3DHoupis%26aufirst%3DI.%2BN.%26aulast%3DVolante%26aufirst%3DR.%2BP.%26atitle%3DAmination%2520of%2520aryl%2520halides%2520using%2520copper%2520catalysis%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26spage%3D3251%26epage%3D3254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Venuti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strosberg, A. M.</span><span> </span><span class="NLM_article-title">Inhibitors of cyclic AMP phosphodiesterase. 3. Synthesis and biological evaluation of pyrido and imidazolyl analogues of 1,2,3,5-tetrahydro-2-oxoimidazo[2,1-<i>b</i>]quinazoline</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2136</span><span class="NLM_x">–</span> <span class="NLM_lpage">2145</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00119a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=2136-2145&author=M.+C.+Venutiauthor=R.+A.+Stephensonauthor=R.+Alvarezauthor=J.+J.+Brunoauthor=A.+M.+Strosberg&title=Inhibitors+of+cyclic+AMP+phosphodiesterase.+3.+Synthesis+and+biological+evaluation+of+pyrido+and+imidazolyl+analogues+of+1%2C2%2C3%2C5-tetrahydro-2-oxoimidazo%5B2%2C1-b%5Dquinazoline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm00119a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00119a014%26sid%3Dliteratum%253Aachs%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DStephenson%26aufirst%3DR.%2BA.%26aulast%3DAlvarez%26aufirst%3DR.%26aulast%3DBruno%26aufirst%3DJ.%2BJ.%26aulast%3DStrosberg%26aufirst%3DA.%2BM.%26atitle%3DInhibitors%2520of%2520cyclic%2520AMP%2520phosphodiesterase.%25203.%2520Synthesis%2520and%2520biological%2520evaluation%2520of%2520pyrido%2520and%2520imidazolyl%2520analogues%2520of%25201%252C2%252C3%252C5-tetrahydro-2-oxoimidazo%255B2%252C1-b%255Dquinazoline%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D2136%26epage%3D2145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Parlow, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, M. S.</span><span> </span><span class="NLM_article-title">Synthesis of 2-pyridones as tissue factor VIIa inhibitors</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">7695</span><span class="NLM_x">–</span> <span class="NLM_lpage">7701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2003&pages=7695-7701&author=J.+J.+Parlowauthor=M.+S.+South&title=Synthesis+of+2-pyridones+as+tissue+factor+VIIa+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParlow%26aufirst%3DJ.%2BJ.%26aulast%3DSouth%26aufirst%3DM.%2BS.%26atitle%3DSynthesis%2520of%25202-pyridones%2520as%2520tissue%2520factor%2520VIIa%2520inhibitors%26jtitle%3DTetrahedron%26date%3D2003%26volume%3D59%26spage%3D7695%26epage%3D7701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Kimura, T.; Kawano, K.; Doi, E.; Kitazawa, N.; Takaishi, M.; Ito, K.; Kaneko, T.; Sasaki, T.; Sato, N.; Miyagawa, T.; Hagiwara, H.</span><span> </span><span class="NLM_article-title">Preparation of morpholine type cinnamides as amyloid-β production inhibitors</span>. U.S. Patent US 20070117798,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+Kimura&author=K.+Kawano&author=E.+Doi&author=N.+Kitazawa&author=M.+Takaishi&author=K.+Ito&author=T.+Kaneko&author=T.+Sasaki&author=N.+Sato&author=T.+Miyagawa&author=H.+Hagiwara&title=Preparation+of+morpholine+type+cinnamides+as+amyloid-%CE%B2+production+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520morpholine%2520type%2520cinnamides%2520as%2520amyloid-%25CE%25B2%2520production%2520inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Shi, D.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dou, G.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, S.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, S.-J.</span><span> </span><span class="NLM_article-title">A novel and efficient synthesis of 2-aryl-2<i>H</i>-indazoles via SnCl<sub>2</sub>-mediated cyclization of 2-nitrobenzylamines</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">2509</span><span class="NLM_x">–</span> <span class="NLM_lpage">2512</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=2509-2512&author=D.-Q.+Shiauthor=G.-L.+Douauthor=S.-N.+Niauthor=J.-W.+Shiauthor=X.-Y.+Liauthor=X.-S.+Wangauthor=H.+Wuauthor=S.-J.+Ji&title=A+novel+and+efficient+synthesis+of+2-aryl-2H-indazoles+via+SnCl2-mediated+cyclization+of+2-nitrobenzylamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DD.-Q.%26aulast%3DDou%26aufirst%3DG.-L.%26aulast%3DNi%26aufirst%3DS.-N.%26aulast%3DShi%26aufirst%3DJ.-W.%26aulast%3DLi%26aufirst%3DX.-Y.%26aulast%3DWang%26aufirst%3DX.-S.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DS.-J.%26atitle%3DA%2520novel%2520and%2520efficient%2520synthesis%2520of%25202-aryl-2H-indazoles%2520via%2520SnCl2-mediated%2520cyclization%2520of%25202-nitrobenzylamines%26jtitle%3DSynlett%26date%3D2007%26spage%3D2509%26epage%3D2512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Dell’Erba, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrillo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavani, C.</span><span> </span><span class="NLM_article-title">A novel approach to 1<i>H</i>-indazoles via arylazidosulfides</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3529</span><span class="NLM_x">–</span> <span class="NLM_lpage">3536</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=3529-3536&author=C.+Dell%E2%80%99Erbaauthor=M.+Noviauthor=G.+Petrilloauthor=C.+Tavani&title=A+novel+approach+to+1H-indazoles+via+arylazidosulfides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDell%25E2%2580%2599Erba%26aufirst%3DC.%26aulast%3DNovi%26aufirst%3DM.%26aulast%3DPetrillo%26aufirst%3DG.%26aulast%3DTavani%26aufirst%3DC.%26atitle%3DA%2520novel%2520approach%2520to%25201H-indazoles%2520via%2520arylazidosulfides%26jtitle%3DTetrahedron%26date%3D1994%26volume%3D50%26spage%3D3529%26epage%3D3536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Evindar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batey, R. A.</span><span> </span><span class="NLM_article-title">Parallel synthesis of a library of benzoxazoles and benzothiazoles using ligand-accelerated copper-catalyzed cyclizations of <i>ortho</i>-halobenzanilides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1802</span><span class="NLM_x">–</span> <span class="NLM_lpage">1808</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo051927q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD28XoslamsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=1802-1808&author=G.+Evindarauthor=R.+A.+Batey&title=Parallel+synthesis+of+a+library+of+benzoxazoles+and+benzothiazoles+using+ligand-accelerated+copper-catalyzed+cyclizations+of+ortho-halobenzanilides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Parallel Synthesis of a Library of Benzoxazoles and Benzothiazoles Using Ligand-Accelerated Copper-Catalyzed Cyclizations of ortho-Halobenzanilides</span></div><div class="casAuthors">Evindar, Ghotas; Batey, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1802-1808</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A general method for the formation of benzoxazoles via a copper-catalyzed cyclization of o-halobenzanilides is reported.  This approach complements the more commonly used strategies for benzoxazole formation which require 2-aminophenols as substrates.  The reaction involves an intramol. C-O cross-coupling of the o-halo anilides and is believed to proceed via an oxidative insertion/reductive elimination pathway through a Cu(I)/Cu(III) manifold.  The reaction is also applicable to the formation of benzothiazoles.  A variety of ligands including 1,10-phenanthroline and N,N'-dimethylethylenediamine ligand acceleration/stabilization in the reaction.  Optimal conditions for cyclization used a catalyst combination of CuI and 1,10-phenanthroline (10 mol %).  The method was amenable to a parallel-synthesis approach, as demonstrated by the synthesis of a library of benzoxazoles and benzothiazoles substituted at various positions in the ring.  Most examples used the cyclization of o-bromo anilides, but o-iodo anilides and o-chloro anilides also undergo a reaction under these conditions.  The rate of reaction of the o-halo anilides follows the order I > Br > Cl, consistent with oxidative addn. being the rate-detg. step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPybgQDCShLbVg90H21EOLACvtfcHk0ljKnsGwtVuZ5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XoslamsA%253D%253D&md5=db56c117b716e78b015b8fac28b1108b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjo051927q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo051927q%26sid%3Dliteratum%253Aachs%26aulast%3DEvindar%26aufirst%3DG.%26aulast%3DBatey%26aufirst%3DR.%2BA.%26atitle%3DParallel%2520synthesis%2520of%2520a%2520library%2520of%2520benzoxazoles%2520and%2520benzothiazoles%2520using%2520ligand-accelerated%2520copper-catalyzed%2520cyclizations%2520of%2520ortho-halobenzanilides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D1802%26epage%3D1808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westaway, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson-Wood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kholodenko, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherrington, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strome, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberburg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, P.,  St.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George Hyslop, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Mutant presenilins of Alzheimer’s disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=67-72&author=M.+Citronauthor=D.+Westawayauthor=W.+Xiaauthor=G.+Carlsonauthor=T.+Diehlauthor=G.+Levesqueauthor=K.+Johnson-Woodauthor=M.+Leeauthor=P.+Seubertauthor=A.+Davisauthor=D.+Kholodenkoauthor=R.+Motterauthor=R.+Sherringtonauthor=B.+Perryauthor=H.+Yaoauthor=R.+Stromeauthor=I.+Lieberburgauthor=J.+Rommensauthor=S.+Kimauthor=D.+Schenkauthor=P.+Fraserauthor=P.+George+Hyslopauthor=D.+J.+Selkoe&title=Mutant+presenilins+of+Alzheimer%E2%80%99s+disease+increase+production+of+42-residue+amyloid+%CE%B2-protein+in+both+transfected+cells+and+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DWestaway%26aufirst%3DD.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DCarlson%26aufirst%3DG.%26aulast%3DDiehl%26aufirst%3DT.%26aulast%3DLevesque%26aufirst%3DG.%26aulast%3DJohnson-Wood%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DKholodenko%26aufirst%3DD.%26aulast%3DMotter%26aufirst%3DR.%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DPerry%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DStrome%26aufirst%3DR.%26aulast%3DLieberburg%26aufirst%3DI.%26aulast%3DRommens%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DFraser%26aufirst%3DP.%26aulast%3DGeorge%2BHyslop%26aufirst%3DP.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DMutant%2520presenilins%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520increase%2520production%2520of%252042-residue%2520amyloid%2520%25CE%25B2-protein%2520in%2520both%2520transfected%2520cells%2520and%2520transgenic%2520mice%26jtitle%3DNature%2520Med.%26date%3D1997%26volume%3D3%26spage%3D67%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biesmans, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Scaffold hopping from pyridones to imidazo[1,2-<i>a</i>]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=175-179&author=G.+Tresadernauthor=J.+M.+Cidauthor=G.+J.+Macdonaldauthor=J.+A.+Vegaauthor=A.+I.+de+Lucasauthor=A.+Garciaauthor=E.+Matesanzauthor=M.+L.+Linaresauthor=D.+Oehlrichauthor=H.+Lavreysenauthor=I.+Biesmansauthor=A.+A.+Trabanco&title=Scaffold+hopping+from+pyridones+to+imidazo%5B1%2C2-a%5Dpyridines.+New+positive+allosteric+modulators+of+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DGarcia%26aufirst%3DA.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DBiesmans%26aufirst%3DI.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DScaffold%2520hopping%2520from%2520pyridones%2520to%2520imidazo%255B1%252C2-a%255Dpyridines.%2520New%2520positive%2520allosteric%2520modulators%2520of%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D175%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="note"><p class="first last">An overlay of the 3-D structures of compounds <b>3</b> and <b>40</b> is provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braggio, S.</span><span> </span><span class="NLM_article-title">Assessing brain free fraction in early drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1517%2F17425250903559873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=20102287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlSjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=337-344&author=K.+D.+Readauthor=S.+Braggio&title=Assessing+brain+free+fraction+in+early+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing brain free fraction in early drug discovery</span></div><div class="casAuthors">Read, Kevin D.; Braggio, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">337-344</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The incorporation of brain tissue binding routinely in CNS drug discovery screening strategies has markedly changed the way CNS drug discovery is performed and is proving to be a valuable tool in identifying new therapies for CNS diseases.  For many years emphasis has been placed on the magnitude of the brain to blood ratio, the bigger the better, even though, in many cases, brain total concn. (Cbrain) has no or, at best, poor correlation with receptor occupancy/pharmacodynamic readout.  Today, Cbrain values measured during in vivo expts. are cor. for the fraction unbound measured through in vitro expts. using brain tissue homogenate or brain tissue slice to obtain an est. of the brain unbound concn. (Cu,brain), and this has been demonstrated across a range of CNS targets to give a much better correlation with receptor occupancy/pharmacodynamic readout.  This apparently simple change in CNS lead optimization strategy has de facto revolutionized the vision of the brain penetration concepts.Areas covered in this review: This review will provide an overview of the use and applications of assessing brain free fraction to det. Cu,brain.Take home message: Assessing brain free fraction to det. Cu,brain in CNS lead optimization strategies is the surrogate of choice for rapidly assessing biophase concn. for the majority of CNS targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9c99W0CmXPbVg90H21EOLACvtfcHk0lg4vpN7RRBfBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlSjtLg%253D&md5=f989ca92c918d40fc01ba01835942ded</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1517%2F17425250903559873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425250903559873%26sid%3Dliteratum%253Aachs%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DBraggio%26aufirst%3DS.%26atitle%3DAssessing%2520brain%2520free%2520fraction%2520in%2520early%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2010%26volume%3D6%26spage%3D337%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Murray, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Politzer, P.</span><span> </span><span class="NLM_article-title">Correlations between the solvent hydrogen bond acceptor parameter β and the calculated molecular electrostatic potential</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3734</span><span class="NLM_x">–</span> <span class="NLM_lpage">3739</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00011a060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1991&pages=3734-3739&author=J.+S.+Murrayauthor=S.+Ranganathanauthor=P.+Politzer&title=Correlations+between+the+solvent+hydrogen+bond+acceptor+parameter+%CE%B2+and+the+calculated+molecular+electrostatic+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjo00011a060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00011a060%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DJ.%2BS.%26aulast%3DRanganathan%26aufirst%3DS.%26aulast%3DPolitzer%26aufirst%3DP.%26atitle%3DCorrelations%2520between%2520the%2520solvent%2520hydrogen%2520bond%2520acceptor%2520parameter%2520%25CE%25B2%2520and%2520the%2520calculated%2520molecular%2520electrostatic%2520potential%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1991%26volume%3D56%26spage%3D3734%26epage%3D3739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torsten, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudkins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery</span> <span class="citation_source-journal">Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><div class="note"><p class="first last">and the references therein.</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/cn200100h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=50-68&author=A.+K.+Ghoseauthor=H.+Torstenauthor=R.+L.+Hudkinsauthor=B.+D.+Dorseyauthor=J.+P.+Mallamo&title=Knowledge-based%2C+central+nervous+system+%28CNS%29+lead+selection+and+lead+optimization+for+CNS+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Hudkins, Robert L.; Dorsey, Bruce D.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-68</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The central nervous system (CNS) is the major area that is affected by aging.  Alzheimer's disease (AD), Parkinson's disease (PD), brain cancer, and stroke are the CNS diseases that will cost trillions of dollars for their treatment.  Achievement of appropriate blood-brain barrier (BBB) penetration is often considered a significant hurdle in the CNS drug discovery process.  On the other hand, BBB penetration may be a liability for many of the non-CNS drug targets, and a clear understanding of the physicochem. and structural differences between CNS and non-CNS drugs may assist both research areas.  Because of the numerous and challenging issues in CNS drug discovery and the low success rates, pharmaceutical companies are beginning to deprioritize their drug discovery efforts in the CNS arena.  Prompted by these challenges and to aid in the design of high-quality, efficacious CNS compds., we analyzed the physicochem. property and the chem. structural profiles of 317 CNS and 626 non-CNS oral drugs.  The conclusions derived provide an ideal property profile for lead selection and the property modification strategy during the lead optimization process.  A list of substructural units that may be useful for CNS drug design was also provided here.  A classification tree was also developed to differentiate between CNS drugs and non-CNS oral drugs.  The combined anal. provided the following guidelines for designing high-quality CNS drugs: (i) topol. mol. polar surface area of <76 Å2 (25-60 Å2), (ii) at least one (one or two, including one aliph. amine) nitrogen, (iii) fewer than seven (two to four) linear chains outside of rings, (iv) fewer than three (zero or one) polar hydrogen atoms, (v) vol. of 740-970 Å3, (vi) solvent accessible surface area of 460-580 Å2, and (vii) pos. QikProp parameter CNS.  The ranges within parentheses may be used during lead optimization.  One violation to this proposed profile may be acceptable.  The chemoinformatics approaches for graphically analyzing multiple properties efficiently are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozqfO0vq2i5bVg90H21EOLACvtfcHk0lg0hzC6hjDsKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO&md5=4c20ba34c3d5397170b50242975ce25d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcn200100h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200100h%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DTorsten%26aufirst%3DH.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge-based%252C%2520central%2520nervous%2520system%2520%2528CNS%2529%2520lead%2520selection%2520and%2520lead%2520optimization%2520for%2520CNS%2520drug%2520discovery%26jtitle%3DChem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D50%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><div class="note"><p class="first last">For a recent review regarding the correlation between in vitro potency, ADMET, and physicochemical parameters, see</p></div><span class="NLM_contrib-group">Hann, M. M.</span><span> </span><span class="NLM_article-title">Molecular obesity, potency and other addictions in drug discovery</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><div class="note"><p class="first last">and the references therein.</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1039%2Fc1md00017a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1Kht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=349-355&author=M.+M.+Hann&title=Molecular+obesity%2C+potency+and+other+addictions+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular obesity, potency and other addictions in drug discovery</span></div><div class="casAuthors">Hann, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">349-355</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Despite the increase in global biol. and chem. knowledge the discovery of effective and safe new drugs seems to become harder rather than easier.  Some of this challenge is due to increasing demands for safety and novelty, but some of the risk involved in this should be controllable if we had more effectively learned from our failures.  This perspective reflects on some of the learnings of recent years in relation to the causes of attrition.  The term Mol. Obesity is introduced to describe our tendency to build potency into mols. by the inappropriate use of lipophilicity which leads to the premature demise of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSlF7TPy6fHLVg90H21EOLACvtfcHk0lhgxFypyOHulw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1Kht7g%253D&md5=954870db4b1d9e846612c3bb256582f7</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fc1md00017a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00017a%26sid%3Dliteratum%253Aachs%26aulast%3DHann%26aufirst%3DM.%2BM.%26atitle%3DMolecular%2520obesity%252C%2520potency%2520and%2520other%2520addictions%2520in%2520drug%2520discovery%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D349%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><div class="note"><p class="first last">For a review on factors that influence the oral absorption of drugs, see</p></div><span class="NLM_contrib-group">Hurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loi, C.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodfuehrer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kattan, A.</span><span> </span><span class="NLM_article-title">Impact of physiological, physicochemical and biopharmaceutical; factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans</span> <span class="citation_source-journal">Expert Opin. Drug. Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">489</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1517%2F17425255.3.4.469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=17696800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptVWjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=469-489&author=S.+Hurstauthor=C.-M.+Loiauthor=J.+Brodfuehrerauthor=A.+El-Kattan&title=Impact+of+physiological%2C+physicochemical+and+biopharmaceutical%3B+factors+in+absorption+and+metabolism+mechanisms+on+the+drug+oral+bioavailability+of+rats+and+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans</span></div><div class="casAuthors">Hurst, Susan; Loi, Cho-Ming; Brodfuehrer, Joanne; El-Kattan, Ayman</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-489</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The onset, intensity and duration of therapeutic response to a compd. depend on the intrinsic pharmacol. activity of the drug and pharmacokinetic factors related to its absorption, distribution, metab. and elimination that are inherent to the biol. system.  The process of drug transfer from the site of administration to the systemic circulation and the interspecies factors that impact this process are the scope of this review.  In general, the factors that influence oral drug bioavailability via absorption and metab. can be divided into physicochem./biopharmaceutical and physiol. factors.  Physicochem. and biopharmaceutical factors that influence permeability and soly. tend to be species independent.  Although there are significant differences in the anatomy and physiol. of the gastrointestinal tract, these are not assocd. with significant differences in the rate and extent of drug absorption between rats and humans.  However, species differences in drug metab. in rats and humans did result in significant species differences in bioavailability.  Overall, this review provides a better understanding of the interplay between drug physicochem./biopharmaceutical factors and species differences/similarities in the absorption and metab. mechanisms that affect oral bioavailability in rats and humans.  This will enable a more rational approach to perform projection of oral bioavailability in human using available rat in vivo data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_n608youfiLVg90H21EOLACvtfcHk0liqRni3sYBtUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptVWjtLk%253D&md5=e284a989273597c674e9ddefe49716b2</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1517%2F17425255.3.4.469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.3.4.469%26sid%3Dliteratum%253Aachs%26aulast%3DHurst%26aufirst%3DS.%26aulast%3DLoi%26aufirst%3DC.-M.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%26aulast%3DEl-Kattan%26aufirst%3DA.%26atitle%3DImpact%2520of%2520physiological%252C%2520physicochemical%2520and%2520biopharmaceutical%253B%2520factors%2520in%2520absorption%2520and%2520metabolism%2520mechanisms%2520on%2520the%2520drug%2520oral%2520bioavailability%2520of%2520rats%2520and%2520humans%26jtitle%3DExpert%2520Opin.%2520Drug.%2520Metab.%2520Toxicol.%26date%3D2007%26volume%3D3%26spage%3D469%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><div class="note"><p class="first last">For assay conditions, see:</p></div><span class="NLM_contrib-group">Kantharaj, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuytelaars, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proost, P. E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongel, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Assouw, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilissen, R. A. H. J.</span><span> </span><span class="NLM_article-title">Simultaneous measurement of drug metabolic stability and identification of metabolites using ion-trap mass spectrometry</span> <span class="citation_source-journal">Rapid Commun. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2661</span><span class="NLM_x">–</span> <span class="NLM_lpage">2668</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1002%2Frcm.1228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=14648905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpslSiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=2661-2668&author=E.+Kantharajauthor=A.+Tuytelaarsauthor=P.+E.+A.+Proostauthor=Z.+Ongelauthor=H.+P.+van+Assouwauthor=R.+A.+H.+J.+Gilissen&title=Simultaneous+measurement+of+drug+metabolic+stability+and+identification+of+metabolites+using+ion-trap+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Simultaneous measurement of drug metabolic stability and identification of metabolites using ion-trap mass spectrometry</span></div><div class="casAuthors">Kantharaj, E.; Tuytelaars, An; Proost, Pascale E. A.; Ongel, Zuleyha; van Assouw, Harrie P.; Gilissen, Ron A. H. J.</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2661-2668</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The use of in vitro drug metab. data in the understanding of in vivo pharmacokinetic, safety and toxicity data has become a large area of scientific interest.  This has stemmed from a trend in the pharmaceutical industry to use in vitro data generated from human tissue as a criterion to select compds. for further investigation.  As well as measuring metabolic stability in vitro using human liver microsomal prepns., the identification of possible metabolite(s) formed may play a vital role in Hit-to-Lead and Lead optimization processes.  The data-dependent scan function mode with the ion-trap instrumentation provides the ability to measure the metabolic stability and identification of possible metabolites of a compd.  A gradient liq. chromatog. method with a run time of 6 min/injection was developed for this purpose.  The approach of simultaneous metabolic stability measurements and rapid identification of metabolites of drugs with high (verapamil), medium (propranolol and cisapride) and low (flunarizine) metabolic stabilities using ion-trap mass spectrometry is described.  The metabolites identified after 15 min incubation for verapamil, propranolol and cisapride are in good agreement with those reported as the major metabolites in human in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ62Aoyes0hLVg90H21EOLACvtfcHk0liqRni3sYBtUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpslSiurY%253D&md5=221b64f3a0058d6a9c1f49ae5f4ab051</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Frcm.1228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.1228%26sid%3Dliteratum%253Aachs%26aulast%3DKantharaj%26aufirst%3DE.%26aulast%3DTuytelaars%26aufirst%3DA.%26aulast%3DProost%26aufirst%3DP.%2BE.%2BA.%26aulast%3DOngel%26aufirst%3DZ.%26aulast%3Dvan%2BAssouw%26aufirst%3DH.%2BP.%26aulast%3DGilissen%26aufirst%3DR.%2BA.%2BH.%2BJ.%26atitle%3DSimultaneous%2520measurement%2520of%2520drug%2520metabolic%2520stability%2520and%2520identification%2520of%2520metabolites%2520using%2520ion-trap%2520mass%2520spectrometry%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2003%26volume%3D17%26spage%3D2661%26epage%3D2668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Gee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommers, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melick, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gidrol, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burris, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klemm, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeiger, E.</span><span> </span><span class="NLM_article-title">Comparison of responses of base-specific Salmonella tester strains with the traditional strains for identifying mutagens: The results of a validation study</span> <span class="citation_source-journal">Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">412</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1016%2FS1383-5718%2897%2900172-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=9539966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADyaK1cXhtlOhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=412&publication_year=1998&pages=115-130&author=P.+Geeauthor=C.+H.+Sommersauthor=A.+S.+Melickauthor=X.+M.+Gidrolauthor=M.+D.+Toddauthor=R.+B.+Burrisauthor=M.+E.+Nelsonauthor=R.+C.+Klemmauthor=E.+Zeiger&title=Comparison+of+responses+of+base-specific+Salmonella+tester+strains+with+the+traditional+strains+for+identifying+mutagens%3A+The+results+of+a+validation+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of responses of base-specific Salmonella tester strains with the traditional strains for identifying mutagens: the results of a validation study</span></div><div class="casAuthors">Gee, P.; Sommers, C. H.; Melick, A. S.; Gidrol, X. M.; Todd, M. D.; Burris, R. B.; Nelson, M. E.; Klemm, R. C.; Zeiger, E.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Genetic Toxicology and Environmental Mutagenesis</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">412</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-130</span>CODEN:
                <span class="NLM_cas:coden">MRGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1383-5718</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ability of a TA7000 series of Salmonella his- mutant tester strains to detect mutagens as classified by the traditional tester strains (TA100, TA98, TA1535, TA1537, TA97, TA102 and TA104) was evaluated using 30 coded chems., 5 of which were duplicates with different code nos.  The TA7000 series of tester strains were TA7001, TA7002, TA7003, TA7004, TA7005 and TA7006, each of which reverts by a specific base substitution.  In addn., each chem. was tested in a mixt. of the base-specific strains (the Mix), plus the traditional strains, TA98 and TA1537.  A liq. version of the Salmonella mutagenicity assay was performed in microtiter plates to allow partial automation for increased throughput.  The results were compared to those in the National Toxicol. Program (NTP) database, which were obtained from the traditional strains in the preincubation assay.  In the two strains common to both protocols, TA98 and TA1537, the agreement was 80 and 85, resp.  When compared to the NTP results for TA100, the Mix gave a 72 concordance, while the addn. of the frameshift tester strain, TA98, increased the agreement to 76.  The overall agreement on pos. or neg. classifications of mutagenicity was 88 for the 25 chems. tested.  There were three notable exceptions to the overall agreement.  Benzaldehyde was detected as a mutagen in TA7005 in contrast to its classification as a non-mutagen in the NTP database.  This does not necessarily contradict the NTP results because the base-specific strains may respond to different mutagens.  Two weak mutagens in the NTP database, 1-chloro-2-propanol and iso-Bu nitrite, were not detected as mutagens in the base-specific new strains in the liq. protocol.  While there are a no. of major differences in the two assays, it was concluded that the results from each procedure are comparable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9feY0gJJyLrVg90H21EOLACvtfcHk0lg_hHhU18Uc6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtlOhtrs%253D&md5=fc3e67ee85d01cf4a5d3948da34184e4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS1383-5718%2897%2900172-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1383-5718%252897%252900172-1%26sid%3Dliteratum%253Aachs%26aulast%3DGee%26aufirst%3DP.%26aulast%3DSommers%26aufirst%3DC.%2BH.%26aulast%3DMelick%26aufirst%3DA.%2BS.%26aulast%3DGidrol%26aufirst%3DX.%2BM.%26aulast%3DTodd%26aufirst%3DM.%2BD.%26aulast%3DBurris%26aufirst%3DR.%2BB.%26aulast%3DNelson%26aufirst%3DM.%2BE.%26aulast%3DKlemm%26aufirst%3DR.%2BC.%26aulast%3DZeiger%26aufirst%3DE.%26atitle%3DComparison%2520of%2520responses%2520of%2520base-specific%2520Salmonella%2520tester%2520strains%2520with%2520the%2520traditional%2520strains%2520for%2520identifying%2520mutagens%253A%2520The%2520results%2520of%2520a%2520validation%2520study%26jtitle%3DMutat.%2520Res.%26date%3D1998%26volume%3D412%26spage%3D115%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Hastwell, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walmsley, R. M.</span><span> </span><span class="NLM_article-title">High-specificity and high-sensitivity genotoxicity assessment in a human cell line: Validation of the GreenScreen HC GADD45a-GFP genotoxicity assay</span> <span class="citation_source-journal">Mutat. Res., Genet. Toxicol. Environ. Mutagen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">607</span><span class="NLM_x">, </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=607&publication_year=2006&pages=160-175&author=P.+W.+Hastwellauthor=L.-L.+Chaiauthor=K.+J.+Robertsauthor=T.+W.+Websterauthor=J.+S.+Harveyauthor=R.+W.+Reesauthor=R.+M.+Walmsley&title=High-specificity+and+high-sensitivity+genotoxicity+assessment+in+a+human+cell+line%3A+Validation+of+the+GreenScreen+HC+GADD45a-GFP+genotoxicity+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHastwell%26aufirst%3DP.%2BW.%26aulast%3DChai%26aufirst%3DL.-L.%26aulast%3DRoberts%26aufirst%3DK.%2BJ.%26aulast%3DWebster%26aufirst%3DT.%2BW.%26aulast%3DHarvey%26aufirst%3DJ.%2BS.%26aulast%3DRees%26aufirst%3DR.%2BW.%26aulast%3DWalmsley%26aufirst%3DR.%2BM.%26atitle%3DHigh-specificity%2520and%2520high-sensitivity%2520genotoxicity%2520assessment%2520in%2520a%2520human%2520cell%2520line%253A%2520Validation%2520of%2520the%2520GreenScreen%2520HC%2520GADD45a-GFP%2520genotoxicity%2520assay%26jtitle%3DMutat.%2520Res.%252C%2520Genet.%2520Toxicol.%2520Environ.%2520Mutagen.%26date%3D2006%26volume%3D607%26spage%3D160%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Dressman, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reppas, C.</span><span> </span><span class="NLM_article-title">In vitro–in vivo correlations for lipophilic, poorly water soluble drugs</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_fpage">S73</span><span class="NLM_x">–</span> <span class="NLM_lpage">S78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=S73-S78&author=J.+B.+Dressmanauthor=C.+Reppas&title=In+vitro%E2%80%93in+vivo+correlations+for+lipophilic%2C+poorly+water+soluble+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDressman%26aufirst%3DJ.%2BB.%26aulast%3DReppas%26aufirst%3DC.%26atitle%3DIn%2520vitro%25E2%2580%2593in%2520vivo%2520correlations%2520for%2520lipophilic%252C%2520poorly%2520water%2520soluble%2520drugs%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2000%26spage%3DS73%26epage%3DS78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Yamaoka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stella, V. J.</span><span> </span><span class="NLM_article-title">Low melting phenytoin prodrugs as alternative oral delivery modes for phenytoin: a model for other high-melting sparingly water-soluble drugs</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">400</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm201710f&amp;key=10.1002%2Fjps.2600720420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=6864479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADyaL3sXit1WksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1983&pages=400-405&author=Y.+Yamaokaauthor=R.+D.+Robertsauthor=V.+J.+Stella&title=Low+melting+phenytoin+prodrugs+as+alternative+oral+delivery+modes+for+phenytoin%3A+a+model+for+other+high-melting+sparingly+water-soluble+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Low-melting phenytoin prodrugs as alternative oral delivery modes for phenytoin:  a model for other high-melting sparingly water-soluble drugs</span></div><div class="casAuthors">Yamaoka, Yumiko; Roberts, Richard D.; Stella, Valentino J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">400-5</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    </div><div class="casAbstract">A homologous series of 3-acyloxymethyl derivs. of phenytoin (I)  [57-41-0] (acetyl through decanoyl) were synthesized and various physicochem. properties measured.  The prodrugs were more readily sol. in various metabolizable glycerol esters such as tributyrin  [60-01-5], trioctanoin  [538-23-8], and triolein  [122-32-7] than I.  The soly. of the prodrugs in the various org. vehicles studied was closely correlated to the m.p. of the prodrug: the lower the m.p. the greater the soly.  The cleavage rates of the prodrugs in plasma and tissue homogenates followed a parabolic relationship with chain length.  The prodrug, 3-pentanoyloxymethyl-5,5-diphenylhydantoin  [85901-34-4] when administered in tributyrin gave superior oral I bioavailability in rats when compared with Na phenytoin  [630-93-3] administered as an aq. soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKaz4BgZlrPrVg90H21EOLACvtfcHk0lh7aKpx1whrqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXit1WksLw%253D&md5=9b9785458d6202a1a5110d017d94cbc4</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600720420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600720420%26sid%3Dliteratum%253Aachs%26aulast%3DYamaoka%26aufirst%3DY.%26aulast%3DRoberts%26aufirst%3DR.%2BD.%26aulast%3DStella%26aufirst%3DV.%2BJ.%26atitle%3DLow%2520melting%2520phenytoin%2520prodrugs%2520as%2520alternative%2520oral%2520delivery%2520modes%2520for%2520phenytoin%253A%2520a%2520model%2520for%2520other%2520high-melting%2520sparingly%2520water-soluble%2520drugs%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D1983%26volume%3D72%26spage%3D400%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Salama, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, R. J. Y.</span><span> </span><span class="NLM_article-title">MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2293</span><span class="NLM_x">–</span> <span class="NLM_lpage">2308</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=2293-2308&author=N.+N.+Salamaauthor=Z.+Yangauthor=T.+Buiauthor=R.+J.+Y.+Ho&title=MDR1+haplotypes+significantly+minimize+intracellular+uptake+and+transcellular+P-gp+substrate+transport+in+recombinant+LLC-PK1+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalama%26aufirst%3DN.%2BN.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DBui%26aufirst%3DT.%26aulast%3DHo%26aufirst%3DR.%2BJ.%2BY.%26atitle%3DMDR1%2520haplotypes%2520significantly%2520minimize%2520intracellular%2520uptake%2520and%2520transcellular%2520P-gp%2520substrate%2520transport%2520in%2520recombinant%2520LLC-PK1%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2006%26volume%3D95%26spage%3D2293%26epage%3D2308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="note"><p class="first last">The CEREP selectivity screen was performed on the following receptors and transporters: A1, A2A, A3, alpha 1, alpha 2, beta 1, AT1, BZD, B2, CCK1, CCKA, D1, D2S, ETA, GABA, GAL2, CXCR2 (IL-8B), CCR1, H1, H2, MC4, MT1 (ML1A), M1, M2, M3, NK2, NK3, Y1, Y2, NTS1 (NT1), delta 2 (DOP), kappa (KOP), mu (MOP), NOP (ORL1), 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2B, 5-HT3, 5-HT5a, 5-HT6, 5-HT7, sst, VPAC1 (VIP1), V1a, Ca2+ channel (L, verapamil site) (phenylalkylamine), KV channel, SKCa channel, Na<sup>+</sup> channel (site 2), Cl<sup>–</sup> channel (GABA-gated) norepinephrine transporter, and dopamine transporter; and on the following enzymes: PLA2, COX1, COX2, 12-lipoxygenase, PDE2A, PDE3A, PDE4D, PDE5, PDE6, ACE, ACE-2, BACE-1, ECE-1, elastase, caspase-3, caspase-8, cathepsin D, cathepsin L, HIV-1 protease, neutral endopeptidase, MMP-1, MMP-3, MMP-9, tryptase, TACE, phosphatase 1B (PTP1B), phosphatase CDC25A, phosphatase MKP1, acetylcholinesterase, MAO-A, MAO-B, HDAC3, HDAC4, HDAC6, HDAC11, sirtuin 1, sirtuin 2.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><div class="note"><p class="first last">For a comprehensive study of this modulator’s behavior in a dog model, see:</p></div><span class="NLM_contrib-group">Borghys, H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuefferd, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Broeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clessens, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cools, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straetemans, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Ridder, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span> </span><span class="NLM_article-title">A canine model to evaluate efficacy and safety of γ-secretase inhibitors and modulators</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">822</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm201710f&amp;key=22072214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm201710f&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFejur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2012&pages=809-822&author=H+Borghysauthor=M+Tuefferdauthor=B.+Van+Broeckauthor=E.+Clessensauthor=L.+Dillenauthor=W.+Coolsauthor=P.+Vinkenauthor=R.+Straetemansauthor=F.+de+Ridderauthor=H.+Gijsenauthor=M.+Mercken&title=A+canine+model+to+evaluate+efficacy+and+safety+of+%CE%B3-secretase+inhibitors+and+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A Canine Model to Evaluate Efficacy and Safety of γ-Secretase Inhibitors and Modulators</span></div><div class="casAuthors">Borghys, Herman; Tuefferd, Marianne; Van Broeck, Bianca; Clessens, Ellen; Dillen, Lieve; Cools, Willy; Vinken, Petra; Straetemans, Roel; De Ridder, Filip; Gijsen, Harrie; Mercken, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">809-822</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Gamma-secretase, a membrane bound protease which cleaves the transmembrane protein amyloid-β protein precursor (AβPP), is a therapeutic target for Alzheimer's disease.  Gamma-secretase inhibitors (GSIs) and modulators (GSMs) are being investigated as potential disease-modifying agents.  Preclin. in vivo models to monitor the activity on gamma-secretase are described in different species such as mouse, rat, and guinea pigs.  All these models have their value in testing compds. with amyloid lowering properties, however, compd. characteristics and pharmacokinetic properties, as well as other species characteristics such as limited sampling vols. of cerebrospinal fluid (CSF), recommended the use of a larger, non-rodent animal species.  For this purpose, a screening model in dogs was developed for testing GSIs and GSMs.  We showed that GSIs and GSMs had a dose- and time-dependent effect on Aβ37, Aβ38, Aβ40, and Aβ42 in CSF.  Changes in liver function were evidenced by a transient increase in bilirubin with the GSMs and incidental increases in alanine aminotransferase for GSMs as well as GSIs.  Microarray anal. of liver biopsies enabled to elucidate potential mechanisms behind the liver function changes.  The relevance of the liver findings should be further evaluated in chronic pre-clin. safety studies and in humans.  Based on our data, we can conclude that the dog is a very appropriate species to assess efficacy and safety of compds. which have an effect on AβPP processing such as GSMs, GSIs, and BACE-inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU5WzC1CQ6UrVg90H21EOLACvtfcHk0liCBB6UpcNJYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFejur8%253D&md5=10f4d27ac0ac43cbf51aa71fb39bbf4c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorghys%26aufirst%3DH%26aulast%3DTuefferd%26aufirst%3DM%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DClessens%26aufirst%3DE.%26aulast%3DDillen%26aufirst%3DL.%26aulast%3DCools%26aufirst%3DW.%26aulast%3DVinken%26aufirst%3DP.%26aulast%3DStraetemans%26aufirst%3DR.%26aulast%3Dde%2BRidder%26aufirst%3DF.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DMercken%26aufirst%3DM.%26atitle%3DA%2520canine%2520model%2520to%2520evaluate%2520efficacy%2520and%2520safety%2520of%2520%25CE%25B3-secretase%2520inhibitors%2520and%2520modulators%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26volume%3D28%26spage%3D809%26epage%3D822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talreja, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuervo, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaravel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humora, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackett, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollate, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunah, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snodgrass-Belt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taveras, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R. H.</span><span> </span><span class="NLM_article-title">Discovery of BIIB042, a potent, selective, and orally bioavailable γ-secretase modulator</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">786</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200175q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=786-791&author=H.+Pengauthor=T.+Talrejaauthor=Z.+Xinauthor=J.+H.+Cuervoauthor=G.+Kumaravelauthor=M.+J.+Humoraauthor=L.+Xuauthor=E.+Rohdeauthor=L.+Ganauthor=M.+Jungauthor=M.+N.+Shackettauthor=S.+Chollateauthor=A.+W.+Dunahauthor=P.+A.+Snodgrass-Beltauthor=H.+M.+Arnoldauthor=A.+G.+Taverasauthor=K.+J.+Rhodesauthor=R.+H.+Scannevin&title=Discovery+of+BIIB042%2C+a+potent%2C+selective%2C+and+orally+bioavailable+%CE%B3-secretase+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fml200175q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200175q%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DTalreja%26aufirst%3DT.%26aulast%3DXin%26aufirst%3DZ.%26aulast%3DCuervo%26aufirst%3DJ.%2BH.%26aulast%3DKumaravel%26aufirst%3DG.%26aulast%3DHumora%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DRohde%26aufirst%3DE.%26aulast%3DGan%26aufirst%3DL.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DShackett%26aufirst%3DM.%2BN.%26aulast%3DChollate%26aufirst%3DS.%26aulast%3DDunah%26aufirst%3DA.%2BW.%26aulast%3DSnodgrass-Belt%26aufirst%3DP.%2BA.%26aulast%3DArnold%26aufirst%3DH.%2BM.%26aulast%3DTaveras%26aufirst%3DA.%2BG.%26aulast%3DRhodes%26aufirst%3DK.%2BJ.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26atitle%3DDiscovery%2520of%2520BIIB042%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520%25CE%25B3-secretase%2520modulator%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D786%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i78"><a href="/doi/suppl/10.1021/jm201710f">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_45306"></div></div></div></div></div><hr /></hr><p class="last">Synthesis and analytical data of all intermediates and final compounds not described in the <a class="ref internalNav" href="#sec6">Experimental Section</a>. Details of the PK studies in mouse, rat, and dog for <b>44a</b>. Description of molecular modeling. Confidence intervals for the cellular Aβ42 IC<sub>50</sub> values. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm201710f/suppl_file/jm201710f_si_001.pdf">jm201710f_si_001.pdf (715.33 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm201710f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-21%3Barticle%3Aarticle%3A10.1021%2Fjm201710f%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm201710f" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679993e1ccba1995","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
